Study name,Accession,Primary GPA,DAC,External Data Source,PI,Registration Status
The Oral Microbiome and Head and Neck Cancer,,Claire Zhu,NCI DAC,,Jiyoung Ahn,Review by PI
GENEVA GWAS of Lung Cancer and Smoking,phs000093.v2.p2,Geoffrey Tobias,NCI DAC,,Neil Caporaso,Released
CGEMS Breast Cancer,phs000147.v3.p1,Geoffrey Tobias,NCI DAC,,Stephen Chanock,Released
High Density SNP Association Analysis of Melanoma: Case-Control and Outcomes Investigation,phs000187.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Christopher Amos,Released
Acquired Copy Number Alterations in Adult Acute Myeloid Leukemia Genomes,phs000201.v2.p1,Ian Fingerman,NCI DAC,,Timothy Ley,Released
CGEMS Pancreatic Cancer (PanScan),phs000206.v6.p3,Geoffrey Tobias,NCI DAC,,Rachael Stolzenberg-Solomon,Released
CGEMS Prostate Cancer,phs000207.v1.p1,Geoffrey Tobias,NCI DAC,,Stephen Chanock,Released
�TARGET,phs000218.v26.p8,Freddie Pruitt,NCI DAC,Yes,Jean Zenklusen,Released
�The Cancer Genome Characterization Initiative,phs000235.v21.p6,Freddie Pruitt,NCI DAC,Yes,Jean Zenklusen,Released
Hepatitis C Pathogenesis and the Human Genome,phs000248.v1.p1,Jonathan Pollock,JAAMH,,David Thomas,Released
Foregut microbiome in development of esophageal adenocarcinoma,phs000260.v4.p2,Ian Fingerman,NCI DAC,,Zhiheng Pei,Released
Skin Microbiome in Disease States: Atopic Dermatitis and Immunodeficiency,phs000266.v4.p1,Asur Srinath,NIAMS,,Julie Segre,Released
Genentech whole-genome sequencing of a non-small cell lung carcinoma,phs000299.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Zemin Zhang,Released
GENEVA Prostate Cancer,phs000306.v4.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Christopher Haiman,Released
Genome-wide Analysis of Lymphoma,phs000328.v3.p1,Freddie Pruitt,NCI DAC,,Riccardo Dalla-Favera,Released
Genome-Wide Association Study of Lung Cancer Risk,phs000336.v1.p1,Geoffrey Tobias,NCI DAC,,Neil Caporaso,Released
CREST: an algorithm that directly maps structural variants for next-generation sequencing data,phs000340.v3.p1,Freddie Pruitt,NCI DAC,Yes,Charles Mullighan,Released
St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project: Whole Genome Sequencing of Childhood Hypodiploid Acute Lymphoblastic Leukemia,phs000341.v2.p1,Freddie Pruitt,NCI DAC,Yes,Charles Mullighan,Released
Genome-Wide Association Study for Bladder Cancer Risk,phs000346.v2.p2,Geoffrey Tobias,NCI DAC,,Nathaniel Rothman,Released
Towards a Genomic Understanding of Myeloma,phs000348.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Todd Golub,Released
CIDR Whole-exome sequencing in families with aggressive prostate cancer,phs000350.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Janet Stanford,Released
Genome-Wide Association Study of Renal Cell Carcinoma,phs000351.v1.p1,Geoffrey Tobias,NCI DAC,,Mark Purdue,Released
St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project(PCGP): Whole Genome Sequencing of Childhood Retinoblastoma,phs000352.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Michael Dyer,Released
"Population Architecture using Genomics and Epidemiology, summary data (PAGE-summary)",phs000356.v2.p1,Sharna Tingle,NHGRI,,Tara Matise,Released
Genome-Wide Association Study in Upper Gastrointestinal Cancers (Asian),phs000361.v1.p1,Geoffrey Tobias,NCI DAC,,Philip Taylor,Released
Genome-wide Analysis of Chronic Lymphocytic Leukemia,phs000364.v2.p1,Ian Fingerman,NCI DAC,,Riccardo Dalla-Favera,Released
Genomic Sequencing of Breast Carcinoma,phs000369.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Matthew Meyerson,Released
Genomic Sequencing of Head and Neck Cancer,phs000370.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Levi Garraway,Released
Genentech Whole-Genome Sequencing of Four Hepatocellular Carcinoma Patients,phs000384.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Zemin Zhang,Released
Epigenetic Profiling of Human Colorectal Cancer,phs000385.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Peter Laird,Released
CIDR_Genetics of Mammographic Density,phs000395.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Elad Ziv,Released
DCEG Imputation Reference Dataset,phs000396.v1.p1,Geoffrey Tobias,NCI DAC,,Stephen Chanock,Released
St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project(PCGP): Whole Genome Sequencing of Childhood Medulloblastoma,phs000409.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Richard Gilbertson,Released
St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project (PCGP): Somatic Mutations in Pediatric AML FAB-M7 Subtype by Whole Transcriptome Sequencing,phs000413.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,James Downing,Released
St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project (PCGP): Whole Genome Sequencing of Core Binding Factor Acute Myeloid Leukemia,phs000414.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,James Downing,Released
Temporal Dissection of Tumorigenesis in Primary cancers,phs000418.v2.p1,Ian Fingerman,NCI DAC,,Raymond Cho,Released
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma,phs000419.v1.p1,Geoffrey Tobias,NCI DAC,,Kevin Brown,Released
MPC_Transcriptome sequencing to identify non-coding RNAs in prostate cancer,phs000443.v1.p1,Freddie Pruitt,NCI DAC,,Arul Chinnaiyan,Released
Genome Variation among HIV-Resistant People with Hemophilia,phs000445.v1.p1,Geoffrey Tobias,NCI DAC,,James Goedert,Released
TARGET: Acute Lymphoblastic Leukemia (ALL) Phase I Pilot,phs000463.v23.p8,Freddie Pruitt,NCI DAC,,Jean Zenklusen,Released
TARGET: Acute Lymphoblastic Leukemia (ALL) Phase II,phs000464.v23.p8,Freddie Pruitt,NCI DAC,,Jean Zenklusen,Released
TARGET: Acute Myeloid Leukemia (AML),phs000465.v23.p8,Freddie Pruitt,NCI DAC,,Soheil Meshinchi,Released
TARGET: Kidney - Clear Cell Sarcoma of the Kidney (CCSK),phs000466.v23.p8,Freddie Pruitt,NCI DAC,,Jean Zenklusen,Released
TARGET: Neuroblastoma (NBL),phs000467.v23.p8,Freddie Pruitt,NCI DAC,,Jean Zenklusen,Released
TARGET: Osteosarcoma (OS),phs000468.v23.p8,Freddie Pruitt,NCI DAC,,Ching Lau,Released
TARGET: PPTP Cell Lines,phs000469.v23.p8,Freddie Pruitt,NCI DAC,,Jean Zenklusen,Released
TARGET: Kidney - Rhabdoid Tumor (RT),phs000470.v23.p8,Freddie Pruitt,NCI DAC,,Jean Zenklusen,Released
TARGET: Kidney - Wilms Tumor (WT),phs000471.v23.p8,Freddie Pruitt,NCI DAC,,Jean Zenklusen,Released
CIDR_Exome Sequencing for Breast Cancer Predisposition in Hispanic and Caucasian families,phs000480.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Fergus Couch,Released
Functionally Active Copy Number Variants Associated with Prostate Cancer Risk,phs000487.v2.p1,Natalie Abrams,NCI DAC,,Mark Rubin,Released
Whole-Genome and Exome Sequencing in clear-cell Renal Cell Carcinoma,phs000491.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,James Brugarolas,Released
Genome-wide analysis of Splenic Marginal Zone Lymphoma,phs000502.v1.p1,Freddie Pruitt,NCI DAC,,Laura Pasqualucci,Released
Genomic Sequencing of Medulloblastoma,phs000504.v2.p2,Sharna Tingle,NHGRI,,Eric Lander,Released
RNA sequencing of human glioma stem cells,phs000505.v2.p1,Ian Fingerman,NCI DAC,,Antonio Iavarone,Released
Genomic Sequencing of Pediatric Rhabdoid Cancers,phs000508.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Todd Golub,Released
Rearrangements of the MAST Kinase and Notch Gene Families in Breast Cancer,phs000513.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Arul Chinnaiyan,Released
GWAS of Breast Cancer in the Multiethnic Cohort,phs000517.v3.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Christopher Haiman,Released
CIDR_Melanoma GWAS,phs000519.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Nicholas Hayward,Released
RNA-seq of Hyperdiploid Pediatric Acute Lymphoblastic Leukemia,phs000522.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Patrick Brown,Released
Expressed Pseudogenes in the Translational Landscape of Human Cancers,phs000525.v1.p1,Freddie Pruitt,NCI DAC,,Arul Chinnaiyan,Released
CGCI: Burkitt Lymphoma Genome Sequencing Project,phs000527.v18.p6,Freddie Pruitt,NCI DAC,,Jean Zenklusen,Released
CGCI: HIV+ Tumor Molecular Characterization Project (HTMCP) � Cervical Cancer (CC),phs000528.v18.p6,Freddie Pruitt,NCI DAC,,Jean Zenklusen,Released
CGCI: HIV+ Tumor Molecular Characterization Project (HTMCP) � Diffuse Large B-cell Lymphoma (DLBCL),phs000529.v18.p6,Freddie Pruitt,NCI DAC,,Jean Zenklusen,Released
CGCI: HIV+ Tumor Molecular Characterization Project (HTMCP) � Lung Cancer (LC),phs000530.v18.p6,Freddie Pruitt,NCI DAC,,Jean Zenklusen,Released
CGCI: Medulloblastoma,phs000531.v18.p6,Freddie Pruitt,NCI DAC,,Jean Zenklusen,Released
CGCI: Non-Hodgkin Lymphoma (NHL),phs000532.v18.p6,Freddie Pruitt,NCI DAC,,Jean Zenklusen,Released
DNA Sequencing in Bladder Cancer,phs000535.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,David Solit,Released
Genomic Sequencing of Pleuropulmonary blastoma,phs000543.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Matthew Meyerson,Released
Genome-Wide Characterization of Pancreatic Adenocarcinoma Patients Using Next Generation Sequencing,phs000550.v1.p1,Freddie Pruitt,NCI DAC,,David Craig,Released
Genomic Characterization of Meningiomas,phs000552.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Rameen Beroukhim,Released
Mutational Landscape of Lethal Castrate Resistant Prostate Cancer,phs000554.v1.p1,Freddie Pruitt,NCI DAC,,Arul Chinnaiyan,Released
The Genetic Landscape of Mutations in Burkitt Lymphoma,phs000562.v1.p1,Freddie Pruitt,NCI DAC,,Sandeep Dave,Released
The Genomics of Pilocytic Astrocytoma Formation in Neurofibromatosis type 1,phs000563.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,David Gutmann,Released
Genomic Sequencing of solitary fibrous tumors,phs000568.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Matthew Meyerson,Released
Genetic Heterogeneity of Diffuse Large B-Cell Lymphoma,phs000573.v1.p1,Freddie Pruitt,NCI DAC,,Sandeep Dave,Released
Small Bowel Neuroendocrine Tumors (Carcinoid Tumors),phs000579.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Matthew Meyerson,Released
International Consortium for Blood Pressure GWAS 2011 discovery dataset,phs000585.v2.p1,Hiromi Ono,NHLBI,,Daniel Levy,Released
MPC_ Deep Sequencing Reveals Distinct Pattern of DNA Methylation in Prostate Cancer,phs000597.v1.p1,Freddie Pruitt,NCI DAC,,Arul Chinnaiyan,Released
Esophageal Adenocarcinoma,phs000598.v2.p2,Sharna Tingle,NHGRI,,Adam Bass,Released
Genomic Sequencing of Cervical Cancers,phs000600.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Matthew Meyerson,Released
Identifying the Genetic Explanation for Heritable Breast Cancer,phs000601.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Melissa Southey,Released
Identification of Targetable FGFR Gene Fusions in Diverse Cancers,phs000602.v2.p1,Natalie Abrams,NCI DAC,,Arul Chinnaiyan,Released
CIDR Mapping Genes for Mammographic Breast Density,phs000604.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Julie Douglas,Released
Genomic Analysis of Pediatric low-grade gliomas,phs000614.v1.p1,Freddie Pruitt,NCI DAC,,Keith Ligon,Released
Genome wide association studies in ECOG 2997 trial,phs000621.v1.p1,Freddie Pruitt,NCI DAC,,Richard Weinshilboum,Released
Identification of Driver Genes in Hepatocellular Carcinoma by Exome Sequencing,phs000627.v1.p1,Freddie Pruitt,NCI DAC,,Derek Chiang,Released
Integrative sequencing analysis of a metastatic cervical carcinoma patient reveals human papillomavirus 18 integration,phs000628.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,David Craig,Released
CIDR_GWAS of Familial Lung Cancer,phs000629.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Ann Schwartz,Released
A genome wide study of lung cancer in never smokers,phs000634.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Olga Gorlova,Released
The effect of the menstrual cycle on the normal human breast,phs000644.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Susan Clare,Released
Breakpoint detection using long insert whole genome sequencing,phs000646.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,David Craig,Released
CIDR_NCI_Validation and Fine Scale Mapping of Pancreatic Cancer Susceptibility Loci,phs000648.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Alison Klein,Released
Cohort-based Genome-Wide Association Study of Glioma (GliomaScan),phs000652.v1.p1,Geoffrey Tobias,NCI DAC,,Preetha Rajaraman,Released
A pilot study using next generation sequencing in advanced cancers: feasibility and challenges,phs000657.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Winnie Liang,Released
Somatic mutations in variant and IGHV4-34 expressing hairy cell leukemia,phs000671.v1.p1,Kathleen Calzone,NCI DAC,,Paul Meltzer,Released
Sequence-based analysis of human breast tissues,phs000676.v2.p2,Freddie Pruitt,NCI DAC,,Charles Perou,Released
APOBEC Cytidine Deaminase Mutagenesis Pattern is Widespread in Human Cancers,phs000677.v1.p1,Freddie Pruitt,NCI DAC,,Dmitry Gordenin,Released
Genomic Analysis of Peripheral T-Cell Lymphomas,phs000689.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Adolfo Ferrando,Released
Osteosarcoma Genomics,phs000699.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Todd Golub,Released
RAD50 Hypomorphism and Response to Chemotherapy,phs000706.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,David Solit,Released
Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma,phs000709.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Sanford Simon,Released
Genome-Wide Association Study of Lung Cancer Among Never Smoking Asian Females,phs000716.v1.p1,Geoffrey Tobias,NCI DAC,,Qing Lan,Released
Whole exome sequencing of circulating tumor cells (CTCs) as a window into metastatic cancer,phs000717.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Todd Golub,Released
Genomic sequencing of Pediatric Rhabdomyosarcoma,phs000720.v4.p1,Kathleen Calzone,NCI DAC,,Javed Khan,Released
Sequencing of Cervical Cancer,phs000723.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Ling Lin,Released
Follicular Lymphoma,phs000729.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Sami Malek,Released
CIDR High Density GWAS of Familial Prostate Cancer,phs000733.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Lisa Albright,Released
A Genome-wide Association Study (GWAS) of Risk for Osteosarcoma,phs000734.v1.p1,Geoffrey Tobias,NCI DAC,,Sharon Savage,Released
Genomic analysis of ameloblastomas identifies SMO and BRAF mutations that activate the pharmacologically accessible Hedgehog and MAP kinase signaling pathways,phs000739.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Robert West,Released
Whole Genome Sequencing of Waldenstrom�s Macroglobulinemia,phs000740.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Steven Treon,Released
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profiles,phs000748.v7.p4,Emilie Charlisse Caga-Anan,NCI DAC,Yes,Sagar Lonial,Released
High Density SNP Association Analysis of Lung Cancer,phs000753.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Xifeng Wu,Released
Spectrum of mutations in myeloid neoplasms,phs000759.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Kevin White,Released
The UC San Diego Chronic Lymphocytic Leukemia (CLL) Study,phs000767.v1.p1,Freddie Pruitt,NCI DAC,,Thomas Kipps,Released
Genomic Sequencing of Pediatric Ewing�s Sarcoma,phs000768.v2.p1,Kathleen Calzone,NCI DAC,,Javed Khan,Released
Genome-Wide Study to Identify SNPs and CNPs Associated with Normal Tissue Toxicity following Radiation Therapy of Prostate Cancer,phs000772.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Barry Rosenstein,Released
Personalized Treatment of S�zary Syndrome through a CTLA4:CD28 Fusion,phs000773.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Winnie Liang,Released
Hepatocellular Carcinoma,phs000782.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Brandon Higgs,Released
Comparative Sequencing Analysis Between Primary and Metastatic Colorectal Cancer Lesions,phs000790.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Michael Berger,Released
Oncogenomics of Malignant Peripheral Nerve Sheath Tumors,phs000792.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Ping Chi,Released
Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia,phs000794.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Esteban Braggio,Released
Gastric cancer genetic analysis of metastasis,phs000795.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Hanlee Ji,Released
Shanghai breast cancer genetic study,phs000799.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Wei Zheng,Released
�Genome-Wide Association Study of Non-Hodgkin Lymphoma (NHL),phs000801.v2.p1,Geoffrey Tobias,NCI DAC,,Nathaniel Rothman,Released
NHL GWAS: Chronic Lymphocytic Leukemia (CLL) Cases,phs000802.v2.p1,Geoffrey Tobias,NCI DAC,,Nathaniel Rothman,Released
Characterizing Genetic Susceptibility to Breast and Prostate Cancer - BPC3,phs000812.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Peter Kraft,Released
"CIDR, NCI, NIDA Sequencing of Targeted Genomic Regions Associated with Smoking",phs000813.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Laura Bierut,Released
NHL GWAS: Control set,phs000818.v2.p1,Geoffrey Tobias,NCI DAC,,Nathaniel Rothman,Released
Development and validation of a predictive algorithm for the degree of benefit from adjuvant trastuzumab: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) Protocol B-31,phs000826.v1.p1,Freddie Pruitt,NCI DAC,,Katherine Pogue-Geile,Released
Genomic Analysis of Hepatocellular Carcinoma,phs000828.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Julien Sage,Released
"Transcription restores DNA repair to heterochromatin, Determining regional mutation rates in cancer genomes",phs000830.v1.p1,Mariam Eljanne,NCI DAC,,Raymond Cho,Released
A genome-wide association study of prostate cancer in West African men,phs000838.v1.p1,Geoffrey Tobias,NCI DAC,,Michael Cook,Released
Genome-Wide Association Study of Renal Cell Carcinoma among African Americans,phs000863.v1.p1,Geoffrey Tobias,NCI DAC,,Joanne Colt,Released
Transcriptome sequencing of Pediatric Neuroblastoma,phs000868.v1.p1,Kathleen Calzone,NCI DAC,,Javed Khan,Released
Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS),phs000869.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Thomas Vaughan,Released
�Transdisciplinary Research Into Cancer of the Lung (TRICL),phs000876.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Christopher Amos,Released
Transdisciplinary Research Into Cancer of the Lung (TRICL) - Meta-analysis,phs000877.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Christopher Amos,Released
Transdisciplinary Research Into Cancer of the Lung (TRICL): CIDR Lung Cancer Whole Exome Sequencing Project,phs000878.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Christopher Amos,Released
National Cancer Institute (NCI) Prostate Cancer Genome-wide Association Study for Uncommon Susceptibility Loci (PEGASUS),phs000882.v1.p1,Geoffrey Tobias,NCI DAC,,Sonja Berndt,Released
Gut Microbiome Profiles and Risk of Colorectal Cancer,phs000884.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Jiyoung Ahn,Released
CAGE profiling of ncRNAs in hepatocellular carcinoma reveals a strong activation of retroviral LTR promoters in virus-induced tumors,phs000885.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Piero Carninci,Released
NHL GWAS: Diffuse Large B-Cell Lymphoma (DLBCL) Cases,phs000889.v1.p1,Geoffrey Tobias,NCI DAC,,Nathaniel Rothman,Released
NHL GWAS: Follicular Lymphoma (FL) Cases,phs000890.v1.p1,Geoffrey Tobias,NCI DAC,,Nathaniel Rothman,Released
NHL GWAS: Marginal Zone Lymphoma (MZL) Cases,phs000891.v1.p1,Geoffrey Tobias,NCI DAC,,Nathaniel Rothman,Released
Genome-Wide Association Study of Endometrial Cancer,phs000893.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Immaculata Devivo,Released
Genomic analysis of stage I serous carcinomas of the ovary,phs000897.v1.p1,Freddie Pruitt,NCI DAC,,Scott Kaufmann,Released
Megabase-scale Haplotyped Genomic Analysis of Normal and Cancer Genomes,phs000898.v2.p1,Sharna Tingle,NHGRI,,Hanlee Ji,Released
Functionally-defined Therapeutic Targets in Diffuse Intrinsic Pontine Glioma,phs000900.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Charles Keller,Released
Next Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases,phs000907.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Paul Paik,Released
Admixture mapping for Breast Cancer in Latinas,phs000912.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Elad Ziv,Released
Genomic Analysis of Mycosis Fungoides and S�zary Syndrome Identifies Recurrent Alterations in TNFR2,phs000913.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Paul Khavari,Released
CIDR GWAS of Breast Cancer in High Risk Women,phs000929.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Christopher Haiman,Released
A Somatic Reference Standard for Cancer Genome Sequencing,phs000932.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,David Craig,Released
Melanoma Exome Sequencing,phs000933.v4.p1,Freddie Pruitt,NCI DAC,,Ruth Halaban,Released
CSER: The CHOP/UPenn Pediatric Genetic Sequencing Project,phs000935.v1.p1,Sharna Tingle,NHGRI,,Ian Krantz,Released
The Landscape of Antisense Gene Expression in Human Cancers,phs000937.v1.p1,Natalie Abrams,NCI DAC,,Arul Chinnaiyan,Released
Phylogenetic Analyses of Melanoma Reveal Complex Patterns of Metastatic Dissemination,phs000941.v1.p1,Mariam Eljanne,NCI DAC,,Raymond Cho,Released
Use of Whole Genome Sequencing for Diagnosis and Discovery in the Cancer Genetics Clinic,phs000942.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Theodora Ross,Released
Whole Exome Sequencing and RNAseq of SEER Ovarian FFPE Tissues,phs000950.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Danielle Carrick,Released
Whole Exome Sequencing of Microdissected Pancreatic Cancer,phs000953.v1.p1,Freddie Pruitt,NCI DAC,,James Willson,Released
VITamins And Lifestyle (VITAL),phs000965.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Emily White,Released
The Genomic Landscape of Juvenile Myelomonocytic Leukemia,phs000973.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Todd Golub,Released
Whole Genome Association Study of Mammographic Density,phs000975.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Rulla Tamimi,Released
Genetic analysis of desmoplastic melanoma,phs000977.v1.p1,Ian Fingerman,NCI DAC,,Boris Bastian,Released
Whole-genome sequencing of a malignant granular cell tumor with metabolic response to pazopanib,phs000978.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Carl Morrison,Released
Mutational Landscape Determines Sensitivity to PD-1 Blockade in Non-Small Cell Lung Cancer,phs000980.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Timothy Chan,Released
Functional Significance of Prostate Cancer risk-SNPs,phs000985.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Stephen Thibodeau,Released
The mutational landscape of CTCL and S�zary syndrome,phs000994.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Teresa Palomero,Released
Analysis of Genetic Factors in Melanoma-Antigen Discovery,phs001005.v2.p1,Sharna Tingle,NHGRI,,Richard Wilson,Released
Lobular Carcinomas In Situ Display Intra-Lesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Disease,phs001006.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Tari King,Released
The Genetic Landscape of Metastasis and Recurrence in HNSCC,phs001007.v1.p1,Freddie Pruitt,NCI DAC,,Jennifer Grandis,Released
Epigenetic studies in Acute Myeloid Leukemia,phs001027.v4.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Francine Garrett-Bakelman,Released
Ovarian Tumor Risk and Environmental and Genetic Factors,phs001034.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Daniel Cramer,Released
Comprehensive Genomic Characterization of Acral Melanoma,phs001036.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Jeffrey Trent,Released
DNA Methylation Inhibitors in Immunotherapy,phs001038.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Timothy Chan,Released
Genetic basis for clinical response to CTLA-4 blockade in melanoma,phs001041.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Timothy Chan,Released
Breast Cancer Risk Pathways,phs001044.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Andrea Bild,Released
Molecular Epidemiology of Colorectal Cancer (MECC) Metastasis Study/Omni Platform,phs001045.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Stephen Gruber,Released
Comprehensive Omics Analysis of Pediatric Tumors and Establishment of a Repository for Related Biological Studies,phs001052.v3.p1,Kathleen Calzone,NCI DAC,,Javed Khan,Released
"Diet, Activity, and Lifestyle Study (DALS)",phs001056.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Martha Slattery,Released
Patient-derived xenografts of HER2-positive breast cancer brain metastases facilitate discovery of a therapeutic strategy yielding durable remissions,phs001063.v1.p1,Freddie Pruitt,NCI DAC,,Jean Zhao,Released
Genomic Characterization of Plasmacytoid/Signet-ring Carcinoma (PC/SRC) of the Bladder,phs001064.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Hikmat Al-Ahmadie,Released
"Whole Genome, Exome, Transcriptome, and Validation Sequencing of an Acute Lymphoblastic Leukemia",phs001066.v1.p1,Ian Fingerman,NCI DAC,,Richard Wilson,Released
Relapsed Acute Lymphoblastic Leukemia (ALL): Genomic Analysis in Pediatric Patients,phs001072.v1.p1,Ian Fingerman,NCI DAC,,Raul Rabadan,Released
Women's Health Initiative (WHI),phs001077.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Ross Prentice,Released
"�Common Variant GWAS, Genetics & Epidemiology of Colorectal Cancer Consortium (GECCO)",phs001078.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Ulrike Peters,Released
Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) - Meta-Analysis,phs001081.v2.p2,Emilie Charlisse Caga-Anan,NCI DAC,,Christopher Haiman,Released
Small Cell Lung Cancer,phs001083.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Dong Shen,Released
Differential Mutations In Matched Primary and Metastatic Colorectal Cancers,phs001084.v1.p1,Freddie Pruitt,NCI DAC,,Timothy Yeatman,Released
Clonal evolution of platinum resistant urothelial carcinoma,phs001087.v4.p1,Ian Fingerman,NCI DAC,,Mark Rubin,Released
DRIVE: Shanghai Breast Cancer Genetics Study,phs001088.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Wei Zheng,Released
Postmenopausal Hormones Supplementary Study to the Colon Cancer Family Registry (PMH-CCFR),phs001092.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Polly Newcomb,Released
"Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)",phs001094.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Sonja Berndt,Released
French Association STudy Evaluating RISK for sporadic colorectal cancer (ASTERISK),phs001104.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Stephane Bezieau,Released
Patient-specific factors influence somatic variation patterns in von Hippel-Lindau disease renal tumors,phs001107.v1.p1,Kathleen Calzone,NCI DAC,,William Linehan,Released
Mutational classification of colorectal cancer,phs001111.v1.p1,Freddie Pruitt,NCI DAC,,Timothy Yeatman,Released
Chromosome X Mosaicism Methylation Study,phs001112.v1.p1,Geoffrey Tobias,NCI DAC,,Stephen Chanock,Released
Darmkrebs: Chancen der Verh�tung durch Screening (DACHS),phs001113.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Jenny Chang-Claude,Released
Health Professionals Follow-up Study (HPFS),phs001114.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Andrew Chan,Released
Collection of Tissue Specimens and Clinical Data from Patients with Melanoma for Genetic Analysis (DFCI Protocol 06-375),phs001115.v1.p1,Ian Fingerman,NCI DAC,,Carl Novina,Released
�Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE),phs001120.v2.p2,Emilie Charlisse Caga-Anan,NCI DAC,,Christopher Haiman,Released
Integrated genetic and pharmacologic interrogation of rare cancers,phs001121.v1.p1,Freddie Pruitt,NCI DAC,,William Hahn,Released
ELLIPSE De Novo Genotyping,phs001125.v2.p2,Emilie Charlisse Caga-Anan,NCI DAC,,Christopher Haiman,Released
Genomic Analysis of Paired Endometrial Cancer Primaries and Metastases,phs001127.v1.p1,Sharna Tingle,NHGRI,,Rameen Beroukhim,Released
Physician's Health Study (PHS),phs001128.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Andrew Chan,Released
Nurses' Health Study (NHS),phs001129.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Andrew Chan,Released
FOCI Affymetrix Exome Chip,phs001131.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Thomas Sellers,Released
FOCI GWAS Meta-Analysis,phs001132.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Thomas Sellers,Released
�Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI),phs001133.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Thomas Sellers,Released
Radiation-related genomic profile of papillary thyroid cancer after the Chernobyl accident,phs001134.v3.p1,Geoffrey Tobias,NCI DAC,Yes,Stephen Chanock,Released
PROstate cancer Medically Optimized genome enhanced ThErapy (PROMOTE),phs001141.v2.p1,Joseph Flores-Toro,NCI DAC,,Manish Kohli,Released
FOCI Mayo OmniExpress,phs001142.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Thomas Sellers,Released
FOCI Mayo 2.5M,phs001150.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Thomas Sellers,Released
Genetic Analysis to interrogate tumor heterogeneity in lung adenocarcinoma,phs001159.v1.p1,Kathleen Calzone,NCI DAC,,Udayan Guha,Released
Kids First: Genomic Studies of Orofacial Cleft Birth Defects,phs001168.v2.p2,Freddie Pruitt,Kids First DAC,Yes,Mary Marazita,Released
Integrative analysis of lung adenocarcinoma in EAGLE,phs001169.v2.p1,Geoffrey Tobias,NCI DAC,,Maria Teresa Landi,Released
Hawaii Colorectal Cancer Studies 2&3 (Colo2&3),phs001170.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Loic Le Marchand,Released
Multiethnic Cohort Study (MEC),phs001171.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Loic Le Marchand,Released
Head and Neck Cancer Genome-wide Association Study,phs001173.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Sanjay Shete,Released
Rare germline variations in familial melanoma,phs001177.v2.p1,Geoffrey Tobias,NCI DAC,,Xiaohong Yang,Released
Kids First Pediatric Research Project on the Genetic Basis of Disorders/Differences of Sex Development (DSD),phs001178.v1.p1,Freddie Pruitt,Kids First DAC,Yes,Eric Vilain,Released
FoundationOne Data Release 1.0,phs001179.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,Yes,Doron Lipson,Released
Single-cell DNA and RNA sequencing over a 29 year period of a CLL patient demonstrating evolution of multiple cell clones,phs001181.v1.p1,Geoffrey Tobias,NCI DAC,,Michael Dean,Released
Genome-Wide Scan for Genetic Variants Associated with Early Onset Prostate Cancer,phs001185.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Kathleen Cooney,Released
Thoracic patient-derived xenografts,phs001192.v1.p1,Freddie Pruitt,NCI DAC,,Mark Kris,Released
Hispanic Colorectal Cancer Study,phs001193.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Jane Figueiredo,Released
The Thailand Initiative in Genomics and Expression Research for Liver Cancer (TIGER-LC),phs001199.v2.p1,Kathleen Calzone,NCI DAC,,Xin Wang,Released
Differences in the Fecal Microbiome associated with Adenomous Polyps,phs001204.v1.p1,Ian Fingerman,NCI DAC,,Nicholas Chia,Released
NCI Lung Cancer and Smoking Phenotypes in African-American Subjects,phs001210.v1.p1,Geoffrey Tobias,NCI DAC,,Stephen Chanock,Released
Familial Blood and Lymph Node Cancers,phs001219.v1.p1,Geoffrey Tobias,NCI DAC,,Neil Caporaso,Released
Genome-wide Association Study of Prostate Cancer,phs001221.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,John Witte,Released
Analysis of AR Gene Rearrangements in Prostate Cancer,phs001223.v1.p1,Ian Fingerman,NCI DAC,,Scott Dehm,Released
Kids First Pediatric Research Program in Susceptibility to Ewing Sarcoma Based on Germline Risk and Familial History of Cancer,phs001228.v2.p2,Freddie Pruitt,Kids First DAC,Yes,Joshua Schiffman,Released
Targeted sequencing of primary ER-positive breast tumors treated with 5 years of Tamoxifen,phs001234.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Elaine Mardis,Released
Integrative analysis of lung adenocarcinoma in EAGLE (phase 2),phs001239.v1.p1,Geoffrey Tobias,NCI DAC,Yes,Maria Teresa Landi,Released
"H. Lee Moffitt Cancer Center, Washington University St. Louis and Translational Genomics (TGen) Collaborative Melanoma Genome Project Protocol and Analysis Plan",phs001241.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Jeffrey Weber,Released
Small Genomic Insertions Form Enhancers that Misregulate Oncogenes,phs001242.v1.p1,Sharna Tingle,NHGRI,,Richard Young,Released
Genetic Basis of Breast Cancer Resistance in BRCA1+ Carrier,phs001243.v1.p1,Ian Fingerman,NCI DAC,,San Ming Wang,Released
Kids First Pediatric Research Program in Cranial Dysinnervation Disorders,phs001247.v1.p1,Freddie Pruitt,Kids First DAC,Yes,Elizabeth Engle,Released
Chemosensitive relapse in small cell lung cancer patient-derived xenografts,phs001249.v1.p1,Freddie Pruitt,NCI DAC,,Charles Rudin,Released
Sequencing of Coding and Non-coding Regions in Primary Breast Cancers and Patient-Matched Controls,phs001250.v1.p1,Sharna Tingle,NHGRI,,Todd Golub,Released
Molecular Evolution of Cancer,phs001255.v1.p1,Ian Fingerman,NCI DAC,,Arend Sidow,Released
Loss of IFN-g signaling in tumor cells associates with primary resistance to anti-CTLA-4 therapy,phs001257.v2.p1,Ian Fingerman,NCI DAC,,Andrew Futreal,Released
DNA Inverted Repeats as an At-risk Motif for Palindromic Gene Amplification,phs001261.v1.p1,Ian Fingerman,NCI DAC,,Hisashi Tanaka,Released
"Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE): Genome-wide Association Study Meta-analysis",phs001263.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,David Hunter,Released
A Super-enhancer Associated with CD47 Links Pro-inflammatory Signaling in CD47 Upregulation in Breast Cancer,phs001264.v1.p1,Ian Fingerman,NCI DAC,,Michael Clarke,Released
Pooled Genome-wide Analysis of Kidney Cancer Risk,phs001271.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Ghislaine Scelo,Released
OncoArray: Lung Cancer,phs001273.v4.p2,Emilie Charlisse Caga-Anan,NCI DAC,,Christopher Amos,Released
Exome sequencing of chordoma families and sporadic cases,phs001280.v1.p1,Geoffrey Tobias,NCI DAC,,Xiaohong Yang,Released
Expression and Mutational Analysis of Endemic Burkitt Lymphoma,phs001282.v4.p1,Ian Fingerman,NCI DAC,,Ann Moormann,Released
Familial Blood and Lymph Node Cancers - Waldenstrom macroglobulinemia,phs001284.v1.p1,Geoffrey Tobias,NCI DAC,,Neil Caporaso,Released
Clinical Proteomic Tumor Analysis Consortium (CPTAC),phs001287.v21.p6,Sean Hanlon,NCI DAC,Yes,Jasminkumar Bavarva,Released
CIDR: NCI Genome Wide Predictors of Survival in Colorectal Cancer,phs001290.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Ulrike Peters,Released
Genome-Wide Association Study of Testicular Germ Cell Tumors,phs001303.v1.p1,Geoffrey Tobias,NCI DAC,,Katherine McGlynn,Released
Inherited Genetic Variation and Predisposition to Testicular Germ Cell Tumor,phs001307.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Katherine Nathanson,Released
CIDR: Detecting Common and Rare Genetic Loci and GxE Interactions in Colorectal Cancer,phs001315.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Ulrike Peters,Released
International Glioma Case-Control Study,phs001319.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Melissa Bondy,Released
OncoArray: Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA),phs001321.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Antonis Antoniou,Released
Multiple Myeloma Genomic Study (MMGS),phs001323.v3.p1,Ian Fingerman,NCI DAC,,Irene Ghobrial,Released
Childhood Cancer Survivor Study (CCSS),phs001327.v2.p1,Geoffrey Tobias,NCI DAC,,Lindsay Morton,Released
Longitudinal Study of Immune Mediated Disorders after Allogeneic HCT Protocol (Immune Mediated Disorders after Allo-HCT) - cGVHD 6501,phs001331.v2.p1,Elaine Collier,NCATS,,Stephanie Lee,Released
Post Genome-wide Association Studies in Testicular Germ Cell Tumors,phs001349.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Katherine Nathanson,Released
Integrated single cell genetic and transcriptional analysis suggests novel private drivers of chronic lymphocytic leukemia.,phs001372.v1.p1,Ian Fingerman,NCI DAC,,Catherine Wu,Released
APOLLO Network Project - Applied Proteogenomics OrganizationaL Learning and Outcomes Network,phs001374.v2.p1,Sean Hanlon,NCI DAC,Yes,Nhan Do,Released
Gut microbiome and types of colorectal polyps,phs001381.v1.p1,Claire Zhu,NCI DAC,,Jiyoung Ahn,Released
Time Lapse to Cancer-Defining the transistion from polyp to cancer,phs001384.v1.p1,Grace Mishkin,NCI DAC,,Lisa Boardman,Released
Evaluation of Ancestry Admixture among Chileans,phs001385.v1.p1,Geoffrey Tobias,NCI DAC,,Jill Koshiol,Released
Histone modification and gene expression profiling in primary glioblastoma multiforme tumors,phs001389.v1.p1,Ian Fingerman,NCI DAC,,Vishwanath Iyer,Released
OncoArray: Prostate Cancer,phs001391.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Christopher Haiman,Released
Genetics of Pigmentation in Eastern and Southern African Populations Study,phs001396.v1.p1,Geoffrey Tobias,NCI DAC,,Stephen Chanock,Released
Development of Precision Neoadjuvant-Adjuvant Therapies,phs001399.v1.p1,Kathleen Calzone,NCI DAC,,Adam Sowalsky,Released
WES and CNV analysis of NF1-associated plexiform neurofibromas,phs001403.v1.p1,Geoffrey Tobias,NCI DAC,,Douglas Stewart,Released
Molecular Profiling of Gallbladder Cancer (MPOG),phs001404.v1.p1,Geoffrey Tobias,NCI DAC,,Jill Koshiol,Released
Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212,phs001405.v1.p1,Grace Mishkin,NCI DAC,,Lisa Carey,Released
HNPCC-Sys: Molecular Characterization of Lynch Syndromes,phs001407.v1.p1,Ian Fingerman,NCI DAC,,Markus Loeffler,Released
Kids First Pediatric Research Project on Adolescent Idiopathic Scoliosis,phs001410.v2.p2,Freddie Pruitt,Kids First DAC,Yes,Jonathan Rios,Released
CIDR: Uncovering the genetic architecture of colorectal cancer with focus of rare and less frequent variants,phs001415.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Ulrike Peters,Released
Whole exome sequencing and methylation profiling of uveal melanoma,phs001421.v1.p1,Shannon Hughes,NCI DAC,,James Harbour,Released
Genomic analysis of pre-treatment and treatment-resistant autopsy glioblastoma specimens,phs001424.v1.p1,Ian Fingerman,NCI DAC,,Priscilla Brastianos,Released
Melanoma Sequential Immune Checkpoint Blockade Treatment Sequencing Study,phs001425.v1.p1,Shannon Hughes,NCI DAC,,Andrew Futreal,Released
Genome-wide predictors of treatment-related toxicities,phs001428.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Christine Ambrosone,Released
Genome-wide Methylation Profiling in MBL and from Early to Advanced CLL,phs001431.v2.p1,Ian Fingerman,NCI DAC,,Catherine Wu,Released
A Pilot Study of Rapid Autopsy and Procurement of Tissue in Thoracic Malignancy Cancer Patients to Investigate Tumor Heterogeneity,phs001432.v1.p1,Kathleen Calzone,NCI DAC,,Udayan Guha,Released
Non-coding RNAs Activated by the Wnt/Beta-catenin Signaling Pathway in Hepatoblastoma,phs001433.v1.p1,Ian Fingerman,NCI DAC,,Piero Carninci,Released
Kids First Pediatric Research Program in Neuroblastoma,phs001436.v1.p1,Freddie Pruitt,Kids First DAC,Yes,John Maris,Released
Genomic Variation in Diffuse Large B Cell Lymphomas,phs001444.v2.p1,Kathleen Calzone,NCI DAC,Yes,Louis Staudt,Released
Genomic resistance patterns to second generation androgen blockade in paired tumor biopsies of metastatic castrate-resistant prostate cancer,phs001447.v1.p1,Mariam Eljanne,NCI DAC,,Eliezer Van Allen,Released
Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis,phs001448.v1.p1,Sean Hanlon,NCI DAC,,Norman Sharpless,Released
Personal Neoantigen Cancer Vaccines,phs001451.v5.p1,Ian Fingerman,NCI DAC,,Catherine Wu,Released
Genomic Regions Associated With Susceptibility To Barrett�s Esophagus And Esophageal Adenocarcinoma In African Americans: The Cross BETRNet Admixture Study,phs001454.v1.p1,Natalie Abrams,NCI DAC,,Amitabh Chak,Released
Temporal and Clonal Progression in Pediatric Ependymoma,phs001461.v1.p1,Ian Fingerman,NCI DAC,,Joshua Rubin,Released
Impaired HLA Class 1 Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer,phs001464.v1.p1,Ian Fingerman,NCI DAC,,Katerina Politi,Released
Multiregion Sequencing of Localized Prostate Cancer,phs001465.v1.p1,Kathleen Calzone,NCI DAC,,David Vanderweele,Released
High response rate to anti PD-1 therapy in desmoplastic melanoma,phs001469.v1.p1,Grace Mishkin,NCI DAC,,Antoni Ribas,Released
The landscape of dynamic genetic changes in ibrutinib-treated CLL,phs001473.v2.p2,Ian Fingerman,NCI DAC,,Catherine Wu,Released
Single cell RNA-seq reveals malignant and stromal programs associated with invasion and metastasis in head and neck cancer,phs001474.v2.p1,Ian Fingerman,NCI DAC,,Bradley Bernstein,Released
Inherited Bone Marrow Failure Syndromes,phs001481.v1.p1,Geoffrey Tobias,NCI DAC,,Sharon Savage,Released
DRIVE: Breast Cancer WGS,phs001483.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,David Hunter,Released
NCI Cancer Model Development for the Human Cancer Models Initiative (HCMI),phs001486.v5.p4,Freddie Pruitt,NCI DAC,Yes,Jean Zenklusen,Released
Whole Exome Predictors of Immune Checkpoint Therapy Response in Renal Cell Carcinoma,phs001493.v2.p1,Ian Fingerman,NCI DAC,,Eliezer Van Allen,Released
DAXX Suppression of ALT,phs001495.v2.p1,Kathleen Calzone,NCI DAC,,Paul Meltzer,Released
The Adult Glioma Study,phs001497.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Margaret Wrensch,Released
Transdisciplinary Studies of Genetic Variation in Colorectal Cancer (CORECT): Meta-analysis,phs001499.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Stephen Gruber,Released
NCI Primary Human Melanocyte QTL Study,phs001500.v2.p1,Geoffrey Tobias,NCI DAC,,Kevin Brown,Released
Mechanisms of Chemotherapy Resistance in T-ALL,phs001513.v1.p1,Ian Fingerman,NCI DAC,,Alejandro Gutierrez,Released
Personalized NeoAntigen Cancer Vaccine with RT for Newly Diagnosed Glioblastoma,phs001519.v2.p1,Ian Fingerman,NCI DAC,,Catherine Wu,Released
CIDR: The Genetic Basis of Aggressive Prostate Cancer: The Role of Rare Variation,phs001524.v3.p2,Emilie Charlisse Caga-Anan,NCI DAC,Yes,Christopher Haiman,Released
Oral microbiome in esophageal adenocarcinoma,phs001527.v1.p1,Claire Zhu,NCI DAC,,Zhiheng Pei,Released
"Gene Expression of Small Cell Carcinoma of the Ovary, Hypercalcemic Type",phs001528.v2.p1,Ian Fingerman,NCI DAC,,Jeffrey Trent,Released
CIDR: Genome-wide Association Studies of Breast Cancer Prognosis and Treatment Outcomes,phs001534.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Lawrence Kushi,Released
Genome-wide association study and meta-analysis of Ewing sarcoma,phs001549.v1.p1,Geoffrey Tobias,NCI DAC,,Stephen Chanock,Released
Genomic analysis of melanocytic neoplasms,phs001550.v3.p1,Grace Mishkin,NCI DAC,,Boris Bastian,Released
Detection of Colorectal Cancer Susceptibility Loci Using Genome-Wide Sequencing,phs001554.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,Yes,Ulrike Peters,Released
Genomic Correlates of Response and Resistance to Immune Checkpoint Blockade in Solid Tumors,phs001565.v1.p1,Ian Fingerman,NCI DAC,,Eliezer Van Allen,Released
Metaplastic breast cancer in a patient with neurofibromatosis type 1 and somatic loss of heterozygosity,phs001566.v1.p1,Ian Fingerman,NCI DAC,,Sameek Roychowdhury,Released
Genetic Epidemiology of Chronic Lymphocytic Leukemia,phs001568.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Nicola Camp,Released
"CALGB 40601: Randomized Phase 3 Trial of Paclitaxel Combined with Trastuzumab, Lapatinib, or Both as Neoadjuvant Treatment of HER2-Positive Breast Cancer",phs001570.v4.p1,Grace Mishkin,NCI DAC,,Lisa Carey,Released
Pan-tumor genomic biomarkers for personalization of PD-1 checkpoint blockade based immunotherapy,phs001572.v1.p1,Ian Fingerman,NCI DAC,,Razvan Cristescu,Released
Intra-tumor heterogeneity and clonal evolution of papillary renal cell carcinoma,phs001573.v1.p1,Geoffrey Tobias,NCI DAC,,Maria Teresa Landi,Released
Widespread chromosomal losses and mitochondrial-encoded alterations in electron transport in metastatic Hurthle cell carcinoma of the thyroid,phs001580.v1.p1,Ian Fingerman,NCI DAC,,David McFadden,Released
Establishment and characterization of prostate cancer organoids,phs001587.v3.p1,Kathleen Calzone,NCI DAC,,Kathleen Siebenlist,Released
Breast Cancer Family Registry Early-onset Breast Cancer GWAS,phs001589.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Habibul Ahsan,Released
Molecular characterization of mucosal melanomas,phs001594.v1.p1,Freddie Pruitt,NCI DAC,,Boris Bastian,Released
Molecular characterization of acral melanoma,phs001596.v1.p1,Freddie Pruitt,NCI DAC,,Boris Bastian,Released
Genomic Analysis of Bevacizumab-induced Hypertension,phs001597.v1.p1,Grace Mishkin,NCI DAC,Yes,Deanna Kroetz,Released
Organoid profiling identifies common responders to chemotherapy in pancreatic cancer,phs001611.v1.p1,Ian Fingerman,NCI DAC,Yes,David Tuveson,Released
eMERGE Netword Phase III Clinical Sequencing : eMERGEseq Panel,phs001616.v2.p2,Sharna Tingle,NHGRI,,Rex Chisholm,Released
A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers,phs001618.v1.p1,Freddie Pruitt,NCI DAC,,Kurt Schalper,Released
Clinical Resistance to Crenolanib in Acute Myeloid Leukemia Due to Diverse Molecular Mechanisms,phs001628.v1.p1,Freddie Pruitt,NCI DAC,Yes,Jeffrey Tyner,Released
A secondary mutation in BRAF confers resistance to RAF inhibition in a BRAF V600E-mutant brain tumor,phs001629.v1.p1,Mariam Eljanne,NCI DAC,,Christine Pratilas,Released
African American Multiple Myeloma GWAS,phs001632.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Wendy Cozen,Released
Genomic and Transcriptomic characterization of chordoma,phs001643.v1.p1,Ian Fingerman,NCI DAC,,Winnie Liang,Released
Genomic Landscape of Cutaneous Diffuse Large B Cell Lymphoma,phs001645.v1.p1,Ian Fingerman,NCI DAC,,Jaehyuk Choi,Released
Whole Exome Characterization of Squamous Cell Lung Cancers (Lung SQCC) from Appalachian Kentucky (APPKY),phs001651.v1.p1,Elaine Collier,NCATS,,Susanne Arnold,Released
"Aspirin and Inflammation: Mutations, Genes, Pathways and Prevention",phs001654.v1.p1,Claire Zhu,NCI DAC,,Brian Reid,Released
Functional Genomic Landscape of Acute Myeloid Leukemia,phs001657.v3.p1,Freddie Pruitt,NCI DAC,Yes,Jeffrey Tyner,Released
Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors,phs001658.v1.p1,Kathleen Calzone,NCI DAC,,Electron Kebebew,Released
Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer (Paclitaxel Cohort),phs001660.v1.p1,Kathleen Calzone,NCI DAC,,William Figg,Released
A phase II trial of the aurora kinase A inhibitor alisertib for patients with castration resistant and neuroendocrine prostate cancer,phs001666.v1.p1,Freddie Pruitt,NCI DAC,,Himisha Beltran,Released
Genomic Profiling in Cancer Patients (Breast Cancer Paired Tumor Samples),phs001674.v1.p1,Freddie Pruitt,NCI DAC,,Jose Baselga,Released
High-throughput determination of the antigen specificities of T cell receptors in single cells,phs001678.v1.p1,Freddie Pruitt,NCI DAC,,Ning Jiang,Released
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma,phs001680.v1.p1,Ian Fingerman,NCI DAC,,Nir Hacohen,Released
Transdisciplinary Research Into Cancer of the Lung (TRICL): Affymetrix Axiom Array,phs001681.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Christopher Amos,Released
Prediction of DNA Repair Inhibitor Response in Short Term Patient-Derived Ovarian Cancer Organoids,phs001685.v1.p1,Hiromi Ono,NHLBI,,Alan D'Andrea,Released
Using Genomics to Reduce Breast Cancer Disparities in the African Diaspora,phs001687.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,Yes,Olufunmilayo Olopade,Released
"Obesity, Body Fat Distribution, and Cancer Risk in the Multiethnic Cohort",phs001689.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Loic Le Marchand,Released
Genomic studies for understanding etiology of esophageal adenocarcinoma,phs001696.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,James Dai,Released
Integrative analyses of lung cancer in never smokers,phs001697.v1.p1,Geoffrey Tobias,NCI DAC,,Maria Teresa Landi,Released
Enhancer mapping in chronic lymphocytic leukemia,phs001704.v1.p1,Freddie Pruitt,NCI DAC,,Jennifer Brown,Released
Count Me In: The Metastatic Breast Cancer Project,phs001709.v2.p2,Freddie Pruitt,NCI DAC,Yes,Diane Diehl,Released
Transplant Outcomes in Aplastic Anemia (TOAA),phs001710.v2.p1,Geoffrey Tobias,NCI DAC,,Shahinaz Gadalla,Released
LCCC 1108: Development of A Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions,phs001713.v1.p1,Sean Hanlon,NCI DAC,Yes,Shelton Earp,Released
Kids First Pediatric Research Study in Osteosarcoma,phs001714.v1.p1,Freddie Pruitt,Kids First DAC,Yes,Kenan Onel,Released
Understanding the progression of metastatic colorectal cancer,phs001722.v1.p1,Ian Fingerman,NCI DAC,,Ha Dang,Released
Kids First Pediatric Research Study in Familial Predisposition to Hematopoietic Malignancies (SJFAMILY-HM),phs001738.v1.p1,Freddie Pruitt,Kids First DAC,Yes,Charles Mullighan,Released
High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer,phs001742.v2.p1,Ian Fingerman,NCI DAC,,Helen Piwnica-Worms,Released
Contribution of systemic and somatic factors to clinical response and resistance in urothelial cancer: an exploratory multi-omic analysis,phs001743.v1.p1,Ian Fingerman,NCI DAC,,Dean Bajorin,Released
CIDR: Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC),phs001744.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Manal Hassan,Released
Molecular Genetics of Histiocytic Sarcomas,phs001748.v1.p1,Kathleen Calzone,NCI DAC,,Elaine Jaffe,Released
Whole exome sequencing (WES) and whole genome bisulfite sequencing (WGBS) of circulating tumor DNA in patients with castration resistant and neuroendocrine prostate cancer,phs001752.v2.p1,Freddie Pruitt,NCI DAC,,Himisha Beltran,Released
A Strategy to Search for Genes Predisposing to Papillary Carcinoma of the Thyroid When Mutated,phs001758.v1.p1,Ian Fingerman,NCI DAC,,Albert De La Chapelle,Released
Genomic Characteristics of Myeloproliferative Neoplasms in Patients Exposed to Ionizing Radiation following the Chernobyl Nuclear Accident,phs001761.v1.p1,Ian Fingerman,NCI DAC,,Steven Balk,Released
Comprehensive Genomic Characterization of Parathyroid Cancer Identifies Novel Candidate Drive Mutations and Core Pathways.,phs001765.v1.p1,Mariam Eljanne,NCI DAC,,Nancy Perrier,Released
A Genomic Approach to Improved Diagnosis and Treatment of Neuroendocrine Tumors,phs001772.v3.p2,Freddie Pruitt,NCI DAC,,James Howe,Released
NCI Laboratory of Translational Genomics (LTG) Human Pancreas QTL study,phs001776.v1.p1,Geoffrey Tobias,NCI DAC,,Laufey Amundadottir,Released
Proteogenomic Landscape of Squamous Cell Lung Cancer,phs001781.v1.p1,Freddie Pruitt,NCI DAC,,Eric Haura,Released
Exome Recapture and Sequencing of Prospectively-Characterized Clinical Specimens,phs001783.v8.p1,Ian Fingerman,NCI DAC,,David Solit,Released
Genomic and Imaging Study for Patients Undergoing Surgery for Liver Cancer,phs001784.v1.p1,Freddie Pruitt,NCI DAC,,Sandi Kwee,Released
Kids First Genomic Analysis of a Cohort with Infantile Hemangiomas Associated with Multi-Organ Structural Birth Defects,phs001785.v1.p1,Freddie Pruitt,Kids First DAC,Yes,Dawn Siegel,Released
SU2C Genomics-Enabled Medicine for Melanoma (GEMM) Trial,phs001786.v1.p1,Ian Fingerman,NCI DAC,,Jeffrey Trent,Released
Discovery�of�colorectal�cancer�susceptibility�genes�in�high-risk�families,phs001787.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,Yes,Sean Tavtigian,Released
Pharmacogenomic interactions in Glioblastoma cell line models,phs001793.v1.p1,Freddie Pruitt,NCI DAC,,Keith Ligon,Released
Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy,phs001797.v1.p1,Ian Fingerman,NCI DAC,,Andrew Hsieh,Released
African American Sequencing Study,phs001798.v2.p2,Sharna Tingle,NHGRI,Yes,Adam Auton,Released
Genomic landscape of Neutrophilic Leukemias of Ambiguous Diagnosis,phs001799.v1.p1,Freddie Pruitt,NCI DAC,Yes,Jeffrey Tyner,Released
Genomics of pediatric renal medullary carcinomas,phs001800.v2.p1,Freddie Pruitt,NCI DAC,,Andrew Hong,Released
Endogenous CD4+ T cells recognize neoantigens in lung cancer patients including KRAS and ERBB2.,phs001805.v1.p1,Ian Fingerman,NCI DAC,,Stanley Riddell,Released
Molecular determinants of tumor behavior in early lung adenocarcinoma,phs001811.v1.p1,Freddie Pruitt,NCI DAC,,Pierre Massion,Released
Integrative tissue analysis of men with prostate cancer,phs001813.v3.p1,Kathleen Calzone,NCI DAC,,Adam Sowalsky,Released
MH-GRID Consortium,phs001815.v1.p1,Sharna Tingle,NHGRI,,Rakale Quarells,Released
Single-cell genomic analysis of gastrointestinal cancer,phs001818.v5.p1,Freddie Pruitt,NCI DAC,,Hanlee Ji,Released
Whole Genome Sequencing to Discover Familial Myeloma Risk Genes,phs001819.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,Yes,Steven Lipkin,Released
Genome and transcriptome analysis of lung cancer cell lines,phs001823.v1.p1,Freddie Pruitt,NCI DAC,,John Minna,Released
RNASeq of plasmacytoid dendritic cells in head and neck squamous cell cancer patients,phs001824.v1.p1,Ian Fingerman,NCI DAC,,Bin Zhang,Released
Parallel functional analysis of 5' UTR mutations in prostate cancer reveal dynamic regulation of clinically relevant gene networks,phs001825.v1.p1,Ian Fingerman,NCI DAC,,Andrew Hsieh,Released
Molecular characterization of response to rectal chemoradiation,phs001829.v1.p1,Freddie Pruitt,NCI DAC,,Eliezer Van Allen,Released
Tumor heterogeneity and acquired drug resistance in FGFR2 fusion-positive cholangiocarcinoma through rapid research autopsy,phs001830.v1.p1,Freddie Pruitt,NCI DAC,,Sameek Roychowdhury,Released
Elucidating transcription regulation by epigenetics in neuroblastoma,phs001831.v1.p1,Mariam Eljanne,NCI DAC,,Mark Applebaum,Released
Whole-exome sequencing and targeted DNA sequencing of matched ocular melanocytosis and uveal melanoma,phs001835.v1.p1,Freddie Pruitt,NCI DAC,,James Harbour,Released
Deep sequencing of 3 cancer cell lines on 2 sequencing platforms,phs001839.v1.p1,Ian Fingerman,NCI DAC,,Nicolas Robine,Released
Cross-species Single Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-presenting Cancer-associated Fibroblasts,phs001840.v1.p1,Ian Fingerman,NCI DAC,,David Tuveson,Released
Kids First Pediatric Research Project on the Intersection of Childhood Cancers and Structural Birth Defects,phs001846.v1.p1,Freddie Pruitt,Kids First DAC,Yes,Hakon Hakonarson,Released
Understanding RNA Biology and Therapeutics in Hematopoiesis and Leukemia,phs001847.v1.p1,Ian Fingerman,NCI DAC,,Melissa Fullwood,Released
MGH Gastrointestinal Malignancies Resistance Initiative,phs001853.v1.p1,Ian Fingerman,NCI DAC,,Ryan Corcoran,Released
Single cell RNA-seq of BRAF-rearranged pilocytic astrocytomas,phs001854.v1.p1,Ian Fingerman,NCI DAC,,Rameen Beroukhim,Released
Genetics of Mammographic Density in Ashkenazi Jewish Women,phs001857.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Elad Ziv,Released
Anonymized germline variants of prospectively characterized clinical cancer specimens,phs001858.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Michael Berger,Released
Genomic Characterization CS-MATCH-0007 Arm Z1D,phs001859.v1.p1,Grace Mishkin,NCI DAC,Yes,Lyndsay Harris,Released
Cellular and genomic landscape of uveal melanoma at single cell resolution,phs001861.v1.p1,Freddie Pruitt,NCI DAC,,James Harbour,Released
Origins of BRAF-mutant hematologic malignancies and their therapeutic resistance,phs001864.v1.p1,Ian Fingerman,NCI DAC,,Omar Abdel-Wahab,Released
GEICAM 2009-03 (ConvertHER) Study,phs001866.v1.p1,Ian Fingerman,NCI DAC,,Charles Perou,Released
Detection of Somatic Mutations in vitro Aging Cells,phs001867.v1.p1,Sharna Tingle,NHGRI,,Michael Erdos,Released
Genetic architecture of susceptibility to melanoma,phs001868.v1.p1,Geoffrey Tobias,NCI DAC,,Maria Teresa Landi,Released
Center for Common Disease Genomics (CCDG) - Cardiovascular: Cleveland Clinic Cohort,phs001871.v1.p1,Sharna Tingle,NHGRI,Yes,Ira Hall,Released
Determinants of venetoclax resistance,phs001875.v1.p1,Ian Fingerman,NCI DAC,,Catherine Wu,Released
Clonotypic heterogeneity in cutaneous T-cell lymphoma (mycosis fungoides) revealed by comprehensive whole exome sequencing,phs001877.v1.p1,Ian Fingerman,NCI DAC,,Robert Gniadecki,Released
OncoArray: Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI),phs001882.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Thomas Sellers,Released
Whole Exome Sequencing of DNA from Pre-Chemotherapy Needle Biopsies of Triple Negative and Inflammatory Breast Cancers Enrolled on the S0800 Trial,phs001883.v1.p1,Grace Mishkin,NCI DAC,,Lajos Pusztai,Released
OncoArray: Endometrial Cancer Association Consortium,phs001885.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Thomas Sellers,Released
Genomic Characterization CS-MATCH-0007 Arm H,phs001888.v1.p1,Grace Mishkin,NCI DAC,Yes,Lyndsay Harris,Released
Single Molecule Molecular Inversion Probe Capture Developed Using the CIViC Database,phs001890.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Obi Griffith,Released
Genome sequencing of lung cancer in European Americans and African Americans,phs001895.v2.p1,Kathleen Calzone,NCI DAC,,Brid Ryan,Released
OncoArray: Colorectal Cancer,phs001903.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Stephen Gruber,Released
Genomic Characterization CS-MATCH 0007 Arm Y,phs001904.v1.p1,Grace Mishkin,NCI DAC,Yes,Lyndsay Harris,Released
CIDR: Molecular Pathological Epidemiology of Colorectal Cancer,phs001905.v2.p2,Emilie Charlisse Caga-Anan,NCI DAC,,Ulrike Peters,Released
Epigenetic activation of the FGF4 and KIT oncogenes in gastrointestinal stromal tumors,phs001906.v1.p1,Ian Fingerman,NCI DAC,,Bradley Bernstein,Released
CPTAC: Microscaled Proteogenomic Methods for Precision Oncology,phs001907.v1.p1,Sean Hanlon,NCI DAC,,Matthew Ellis,Released
Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors,phs001910.v1.p1,Freddie Pruitt,NCI DAC,,Bradley Bernstein,Released
Evolution of Whole Genomes in nonprogressing and progressing Barrett's Esophagus,phs001912.v1.p1,Claire Zhu,NCI DAC,,Brian Reid,Released
Improved Detection and Identification of Microsatellite Instability Features in Colorectal Cancer,phs001914.v1.p1,Sharna Tingle,NHGRI,,Hanlee Ji,Released
Prospective immune profiling using methylation markers and pancreatic cancer risk,phs001917.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Dominique Michaud,Released
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma,phs001919.v1.p1,Freddie Pruitt,NCI DAC,,Antoni Ribas,Released
Genomic Characterization of Brain Metastases,phs001920.v1.p1,Freddie Pruitt,NCI DAC,,Priscilla Brastianos,Released
DNA methylation and prostate cancer,phs001921.v1.p1,Ian Fingerman,NCI DAC,,Janet Stanford,Released
Case Study of Acquired Resistance to FGFR Inhibition in Cholangiocarcinoma using Targeted DNA and RNA Sequencing,phs001924.v1.p1,Freddie Pruitt,NCI DAC,,Sameek Roychowdhury,Released
Characterization of Clonal Evolution in Three MSI-H Cancers through Multi-regional Exome Sequencing,phs001925.v1.p1,Freddie Pruitt,NCI DAC,,Sameek Roychowdhury,Released
Genomic Characterization CS-MATCH-0007 Arm Q,phs001926.v1.p1,Grace Mishkin,NCI DAC,Yes,Lyndsay Harris,Released
A comprehensive genomic study of pediatric malignancy,phs001928.v2.p2,Kathleen Calzone,NCI DAC,,Javed Khan,Released
Count Me In: The Angiosarcoma Project,phs001931.v1.p1,Freddie Pruitt,NCI DAC,Yes,Diane Diehl,Released
Clinical and Laboratory Analysis of Familial Cancer,phs001935.v1.p1,Kathleen Calzone,NCI DAC,,Kathleen Calzone,Released
"Genome, Exome, and Transcriptome Sequencing of Gastric Cancer",phs001936.v1.p1,Ian Fingerman,NCI DAC,,Julie Hotopp,Released
Neoadjuvant Intense ADT for High Risk Prostate Cancer,phs001938.v3.p1,Kathleen Calzone,NCI DAC,,William Dahut,Released
Count Me In: The Metastatic Prostate Cancer Project,phs001939.v3.p1,Freddie Pruitt,NCI DAC,Yes,Diane Diehl,Released
Multimodal Genomic Features Predict Outcome of Immune Checkpoint Blockade in Non-small Cell Lung Cancer,phs001940.v2.p1,Freddie Pruitt,NCI DAC,,Valsamo Anagnostou,Released
Molecular Genetics of Secondary Histiocytic/Dendritic Sarcoma,phs001942.v1.p1,Kathleen Calzone,NCI DAC,,Elaine Jaffe,Released
Hereditary Cancer Predisposition Syndromes and Uveal Melanoma,phs001943.v1.p1,Ian Fingerman,NCI DAC,,Mohamed Abdel-Rahman,Released
African Collaborative Center for Microbiome and Genomics Research (ACCME) - CIDR,phs001945.v1.p1,Barbara Thomas,NHGRI,,Clement Adebamowo,Released
Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated After Starting Hu14.18-IL2 Predicts Outcome,phs001947.v1.p1,Kathleen Calzone,NCI DAC,,Javed Khan,Released
Genomic Characterization CS-MATCH-0007 Arm W,phs001948.v1.p1,Grace Mishkin,NCI DAC,Yes,Lyndsay Harris,Released
Relapsed Acute Lymphoblastic Leukemia (ALL): Mutational Landscape,phs001951.v2.p1,Ian Fingerman,NCI DAC,,Adolfo Ferrando,Released
Genomic Profiling of Metastatic Uveal Melanoma from a Phase I study of AEB071,phs001953.v1.p1,Ian Fingerman,NCI DAC,,Sophie Piperno-Neumann,Released
Women's Health Study Accelerometer Data,phs001964.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,I-Min Lee,Released
MP2PRT: Identification of genetic changes associated with relapse and/or adaptive resistance in patients registered as Favorable Histology Wilms Tumor on AREN03B2,phs001965.v1.p1,Grace Mishkin,NCI DAC,Yes,Elizabeth Perlman,Released
Molecular Biomarkers in Glioma (Mechanisms and therapeutic implications of hypermutation in gliomas),phs001967.v1.p1,Freddie Pruitt,NCI DAC,,Keith Ligon,Released
Cellular Origins and Genetic Landscape of Cutaneous Gamma Delta T Cell Lymphoma,phs001969.v1.p1,Mariam Eljanne,NCI DAC,,Jaehyuk Choi,Released
DNA methylation of rhabdomyosarcoma,phs001970.v1.p1,Kathleen Calzone,NCI DAC,,Frederic Barr,Released
Two hit gene mapping in renal cell carcinoma,phs001971.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,James McKay,Released
Genomic Characterization CS-MATCH-0007 Arm Z1A,phs001973.v1.p1,Grace Mishkin,NCI DAC,Yes,Lyndsay Harris,Released
Large cancer fingerprint screening for detection of MRD,phs001977.v1.p1,Ian Fingerman,NCI DAC,,Viktor Adalsteinsson,Released
Genomic landscape of human skin at a single-cell resolution,phs001979.v1.p1,Mariam Eljanne,NCI DAC,,Alan Shain,Released
University of Texas PDX Development and Trial Center Grant,phs001980.v2.p1,Grace Mishkin,NCI DAC,Yes,Jack Roth,Released
Copy Number Alteration Profiling of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma,phs001982.v1.p1,Freddie Pruitt,NCI DAC,,Samuel Singer,Released
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors,phs001983.v1.p1,Freddie Pruitt,NCI DAC,Yes,Aviv Regev,Released
Gabriella Miller Kids First Pediatric Research Program in Enchondromatoses and Related Malignant Tumors,phs001987.v3.p1,Marcia Fournier,Kids First DAC,Yes,Nara Sobreira,Released
Molecular characterization of bulk and single cell prostate cancer,phs001988.v2.p1,Freddie Pruitt,NCI DAC,,Eliezer Van Allen,Released
"Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define pre-malignant neurofibromatosis type 1-associated atypical neurofibromas",phs001993.v1.p1,Kathleen Calzone,NCI DAC,,Douglas Stewart,Released
Effects of tobacco smoking on the tumor immune microenvironment in head and neck squamous cell carcinoma,phs001994.v1.p1,Ian Fingerman,NCI DAC,,Christine Chung,Released
Kids First: Whole Genome Sequencing of African and Asian Orofacial Clefts Case-Parent Triads,phs001997.v1.p1,Freddie Pruitt,Kids First DAC,Yes,Azeez Butali,Released
CLL relapse after allo-HSCT,phs001998.v2.p1,Ian Fingerman,NCI DAC,,Catherine Wu,Released
Advanced Genetic and Molecular Analysis of Solid Tumors,phs001999.v1.p1,Ian Fingerman,NCI DAC,,Yuliya Pylayeva-Gupta,Released
The genomic landscape of Mongolian hepatocellular carcinoma,phs002000.v1.p1,Kathleen Calzone,NCI DAC,,Xin Wang,Released
Acquired Resistance Mechanisms to Osimertinib in EGFR Mutant Lung Cancer,phs002001.v1.p1,Kathleen Calzone,NCI DAC,,Udayan Guha,Released
Intratumoral NK Cell and ILC Landscape,phs002002.v1.p1,Claire Zhu,NCI DAC,,John Sunwoo,Released
MP2PRT: Comprehensive Genomic Profiling to Identity Alterations Associated with Relapse for NCI Stand Risk B-lineage ALL for NCI High Risk (HR) B-lineage ALL with Favorable Genetic Features,phs002005.v1.p1,Grace Mishkin,NCI DAC,Yes,Mignon Loh,Released
Genomic landscape of pediatric germ cell tumors,phs002009.v1.p1,Ian Fingerman,NCI DAC,,James Amatruda,Released
PLCO - Limited Use Pilot Test Data,phs002011.v1.p1,Freddie Pruitt,NCI DAC,Yes,Paul Pinsky,Released
SEER Remote Access Pilot Test Data (2018),phs002012.v1.p1,Freddie Pruitt,NCI DAC,Yes,Lynne Penberthy,Released
Whole exome and transcriptome analysis of UV-exposed epidermis and carcinoma in situ,phs002019.v1.p1,Ian Fingerman,NCI DAC,,John Seykora,Released
Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System,phs002021.v1.p1,Kathleen Calzone,NCI DAC,,Steven Pavletic,Released
Genomic Analysis of Primary Plasma Cell Leukemia reveals complex Structural Alterations and High Risk Mutational Patterns,phs002022.v1.p1,Ian Fingerman,NCI DAC,,Carolina Schinke,Released
Medium-throughput drug screening of patient-derived organoids from colorectal peritoneal metastases can be used to guide therapy,phs002023.v1.p1,Ian Fingerman,NCI DAC,,Susan Woods,Released
Genomic Characterization CS-MATCH-0007 Arm B,phs002028.v1.p1,Grace Mishkin,NCI DAC,Yes,Lyndsay Harris,Released
Genomic Characterization CS-MATCH-0007 Arm R,phs002029.v1.p1,Grace Mishkin,NCI DAC,Yes,Lyndsay Harris,Released
Genomic evolution of low and high grade glioma,phs002034.v1.p1,Freddie Pruitt,NCI DAC,,Joseph Costello,Released
Methylomic biomarkers for magnesium deficiency and colon neoplasia prevention,phs002037.v1.p1,Natalie Abrams,NCI DAC,,Qi Dai,Released
Intraductal transplantation models of human pancreatic ductal adenocarcinoma reveal progressive transition of molecular subtypes,phs002045.v1.p1,Ian Fingerman,NCI DAC,,David Tuveson,Released
Genomic Profiling of Hematologic Disorders,phs002049.v1.p1,Ian Fingerman,NCI DAC,,Ross Levine,Released
Molecular Pathological Epidemiology of Colorectal Cancer,phs002050.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,Yes,Ulrike Peters,Released
DNA methylation in rhabdomyosarcoma PDX and PDX-derived primary cells,phs002051.v1.p1,Kathleen Calzone,NCI DAC,,Frederic Barr,Released
Neoadjuvant Pazopanib and Molecular Analysis of Tissue Response in Renal Cell Carcinoma,phs002053.v1.p1,Mariam Eljanne,NCI DAC,,Wendy Rathmell,Released
CIDR: Impact of Genetic Variants on Failure of Active Surveillance for Prostate Cancer,phs002056.v1.p1,Freddie Pruitt,NCI DAC,,William Catalona,Released
Genomic Characterization CS-MATCH-0007 Arm Z1I,phs002058.v1.p1,Grace Mishkin,NCI DAC,Yes,Lyndsay Harris,Released
Pharmacogenomic Analysis of Microtubule Targeting Agent Response and Toxicity,phs002060.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Deanna Kroetz,Released
Markers of genomic damage in HIV-uninfected children exposed to zidovudine in utero,phs002061.v1.p1,Geoffrey Tobias,NCI DAC,,Eric Engels,Released
Polygenic risk score for the prediction of breast cancer and terminal duct lobular unit involution of the breast,phs002062.v1.p1,Geoffrey Tobias,NCI DAC,,Gretchen Gierach,Released
Identification of novel viruses in anaplastic large cell lymphoma,phs002064.v1.p1,Geoffrey Tobias,NCI DAC,,Eric Engels,Released
Mechanisms of extreme genomic instability at large transcribed genes,phs002066.v2.p1,Ian Fingerman,NCI DAC,,Thomas Wilson,Released
Comprehensive Sequencing of High Grade Neuroendocrine Neoplasms,phs002070.v1.p1,Ian Fingerman,NCI DAC,,Pamela Kunz,Released
Multimodal Mapping of the Immune Landscape in Human Pancreatic Cancer,phs002071.v1.p1,Ian Fingerman,NCI DAC,,Marina Pasca Di Magliano,Released
Role of tobacco smoke in clear cell renal cell carcinoma,phs002083.v1.p1,Ian Fingerman,NCI DAC,,Maria Czyzyk-Krzeska,Released
Dynamics of genomic and immune responses during primary immunotherapy resistance in mismatch repair deficient tumors,phs002089.v1.p1,Kathleen Calzone,NCI DAC,,Anish Thomas,Released
�Refractory Cancer (RC) Program,phs002097.v1.p1,Freddie Pruitt,NCI DAC,Yes,Jean Zenklusen,Released
Refractory Cancers (RC) HOPE-CARE,phs002098.v1.p1,Freddie Pruitt,NCI DAC,,Jean Zenklusen,Released
Kids First Study in Craniofacial Microsomia: Genetic Causes and Pathway Discovery,phs002130.v1.p1,Freddie Pruitt,Kids First DAC,Yes,Daniela Luquetti,Released
Evolution of Chromatin Architecture and Transcriptional Regulation in Mammals,phs002146.v1.p1,Sharna Tingle,NHGRI,,Charles Danko,Released
Genomic Characterization CS-MATCH-0007 Arm N,phs002151.v1.p1,Grace Mishkin,NCI DAC,Yes,Lyndsay Harris,Released
Genomic Characterization CS-MATCH-0007 Arm P,phs002152.v1.p1,Grace Mishkin,NCI DAC,Yes,Lyndsay Harris,Released
Genomic Characterization CS-MATCH-0007 Arm S1,phs002153.v1.p1,Grace Mishkin,NCI DAC,Yes,Lyndsay Harris,Released
Translating Gene-Calcium Interactions to Precision Medicine for Colorectal Cancer,phs002164.v1.p1,Claire Zhu,NCI DAC,,Todd Edwards,Released
Serrated Colorectal Cancer: An Emerging Disease Subtype,phs002171.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Polly Newcomb,Released
Gabriella Miller Kids First Pediatric Research Project in Microtia in Hispanic Populations,phs002172.v1.p1,Marcia Fournier,Kids First DAC,Yes,Jonathan Seidman,Released
"Gabriella Miller Kids First Pediatric Research Program in Bladder Exstrophy, Epispadias, Complex (BEEC)",phs002173.v2.p2,Marcia Fournier,Kids First DAC,Yes,Angie Jelin,Released
"Gabriella Miller Kids First Pediatric Research Project in Cornelia de Lange Syndrome, Related Diagnosis and Structural Birth Defects",phs002174.v2.p1,Marcia Fournier,Kids First DAC,Yes,Ian Krantz,Released
Genomic Predictors of Response to PD-1/PD-L1 Blockade in Small Cell Lung Cancer,phs002176.v2.p1,Kathleen Calzone,NCI DAC,,Anish Thomas,Released
Genomic Characterization CS-MATCH-0007 Arm C1,phs002177.v1.p1,Grace Mishkin,NCI DAC,Yes,Lyndsay Harris,Released
Genomic Characterization CS-MATCH-0007 Arm S2,phs002178.v1.p1,Grace Mishkin,NCI DAC,Yes,Lyndsay Harris,Released
Genomic Characterization CS-MATCH-0007 Arm U,phs002179.v1.p1,Grace Mishkin,NCI DAC,Yes,Lyndsay Harris,Released
Genomic Characterization CS-MATCH-0007 Arm Z1B,phs002180.v1.p1,Grace Mishkin,NCI DAC,Yes,Lyndsay Harris,Released
Genomic Characterization CS-MATCH-0007 Arm I,phs002181.v1.p1,Grace Mishkin,NCI DAC,Yes,Lyndsay Harris,Released
CIDR: Genetics of Graft-vs-Host Disease,phs002185.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Vahid Afshar-Kharghan,Released
Merkel cell carcinoma Tissue and Data Repository,phs002189.v1.p1,Ian Fingerman,NCI DAC,,James Decaprio,Released
Cancer Moonshot Biobank,phs002192.v5.p2,Freddie Pruitt,NCI DAC,Yes,Helen Moore,Released
Tissue Procurement and Natural History Study of Patients with Malignant Mesothelioma and Other Mesothelin Expressing Cancers,phs002207.v2.p1,Kathleen Calzone,NCI DAC,,Raffit Hassan,Released
Comprehensive analysis of structural variants in breast cancer genomes using single molecule sequencing,phs002210.v1.p1,Brandon Wright,NCI DAC,,William McCombie,Released
HTAN_MCL_PCAPP_Breast_CA,phs002225.v3.p1,Natalie Abrams,NCI DAC,,Christopher Amos,Released
"Innate Immune Deamination in Aged, Pre-leukemia and Leukemia Stem cells",phs002228.v2.p1,Ludmila Pawlikowska,NIDDK,,Catriona Jamieson,Released
Germ cell tumor molecular heterogeneity revealed through analysis of primary and metastasis pairs,phs002229.v1.p1,Sean Hanlon,NCI DAC,,Darren Feldman,Released
Germ cell tumor and associated hematologic malignancies,phs002231.v1.p1,Anil Wali,NCI DAC,,Omar Abdel-Wahab,Released
Genomic profiling of relapsed and refractory childhood cancers,phs002238.v1.p1,Ian Fingerman,NCI DAC,,Giselle Sholler,Released
A model for predicting response to PD-1 inhibitors in NSCLC,phs002244.v1.p1,Brandon Wright,NCI DAC,,Edward Garon,Released
Refractory Cancer - Peripheral T-Cell Lymphoma (RC-PTCL),phs002247.v1.p1,Freddie Pruitt,NCI DAC,,Jean Zenklusen,Released
"CIDR: Discovery, Biology, and Risk of Inherited Variants in Glioma",phs002250.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,Yes,Melissa Bondy,Released
Cellular and molecular characterization of renal cell carcinoma,phs002252.v1.p1,Freddie Pruitt,NCI DAC,,Catherine Wu,Released
CCG Multicentric Italian Lung Detection,phs002253.v1.p1,Freddie Pruitt,NCI DAC,Yes,Jean Claude Zenklusen,Released
Characterization of immune evasion in Merkel cell carcinoma,phs002260.v2.p1,Ian Fingerman,NCI DAC,,Catherine Wu,Released
A New Pipeline to Predict and Confirm Tumor Neoantigens Predicts Better Response to Checkpoint Blockade,phs002269.v1.p1,Ian Fingerman,NCI DAC,,Nicholas Durham,Released
Very low tumor mutation burden identifies inflamed recurrent glioblastomas responsive to cancer immunotherapy,phs002270.v1.p1,Ran Zhang,NINDS,,David Ashley,Released
Analysis of recurrently protected genomic regions in urine cell-free DNA,phs002273.v1.p1,Freddie Pruitt,NCI DAC,,Muhammed Murtaza,Released
Selenium Chemoprevention: Benefits and Harms,phs002283.v2.p1,Claire Zhu,NCI DAC,,Elizabeth Jacobs,Released
A Phase I/II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers,phs002286.v1.p1,Kathleen Calzone,NCI DAC,,Christian Hinrichs,Released
Evolution of resistance in ER+ Breast Cancer,phs002287.v1.p1,Shannon Hughes,NCI DAC,,Andrea Bild,Released
Analysis of epigenomes and genome topology in colorectal cancer,phs002288.v1.p1,Ian Fingerman,NCI DAC,,Bradley Bernstein,Released
Yale SPORE in Skin Cancer Project 2,phs002289.v2.p1,Freddie Pruitt,NCI DAC,,Marcus Bosenberg,Released
Tumor fraction guided cell-free DNA profiling in metastatic cancer patients,phs002290.v1.p1,Freddie Pruitt,NCI DAC,,David Solit,Released
"MP2PRT: Genomic and molecular characterization of biomarkers associated with tumor angiogenesis, DNA repair, and immunologic tolerance using samples from the NRG Oncology Phase 3 Randomized Trial, GOG-0240 (NCT00803062)",phs002293.v1.p1,Grace Mishkin,NCI DAC,Yes,Krishnansu Tewari,Released
Chemoresistance in high grade serous ovarian cancer,phs002294.v1.p1,Shannon Hughes,NCI DAC,,Andrea Bild,Released
Cross-site concordance evaluation of tumor DNA and RNA sequencing platforms of CIMAC-CIDC network,phs002295.v1.p1,Freddie Pruitt,NCI DAC,,Catherine Wu,Released
Whole genome sequencing of skull-based chordoma,phs002301.v1.p1,Geoffrey Tobias,NCI DAC,,Xiaohong Yang,Released
PEDS-PLAN � Pediatric Precision Laboratory Advanced Neuroblastoma Therapy,phs002303.v2.p1,Ian Fingerman,NCI DAC,,Giselle Sholler,Released
Germline and Somatic Genetic Landscape of Pediatric Rhabdomyosarcoma,phs002304.v1.p1,Ian Fingerman,NCI DAC,,Philip Lupo,Released
Washington University PDX Development and Trial Center,phs002305.v1.p1,Grace Mishkin,NCI DAC,Yes,Li Ding,Released
Identification and characterization of skin-resident memory T cells in patients with melanoma-associated vitiligo,phs002309.v2.p1,Ian Fingerman,NCI DAC,,Mary Jo Turk,Released
GATA2 Deficiency,phs002311.v1.p1,Kathleen Calzone,NCI DAC,,Dennis Hickstein,Released
Copy-number analysis of understudied black women ovarian cancers,phs002313.v1.p1,Freddie Pruitt,NCI DAC,,Joe Delaney,Released
Genetic underpinnings of ethnic disparities in bone toxicities between Hispanic and non-Hispanic children treated for acute lymphoblastic leukemia,phs002317.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Song Yao,Released
Characterizing Advanced Breast Cancer Heterogeneity and Treatment Resistance through Serial Biopsies and Comprehensive Analytics,phs002321.v1.p1,Freddie Pruitt,NCI DAC,,Zahi Mitri,Released
Kids First: Genetics of Pediatric Germ Cell Tumors,phs002322.v1.p1,Marcia Fournier,Kids First DAC,Yes,Jenny Poynter,Released
Defining and overcoming intrinsic T cell dysfunction to enable pediatric immunotherapy,phs002323.v2.p1,Ian Fingerman,NCI DAC,,David Barrett,Released
Therapeutic targeting of ATR yields durable regressions in high replication stress tumors,phs002327.v1.p1,Kathleen Calzone,NCI DAC,,Anish Thomas,Released
Genetic determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo,phs002334.v1.p1,Freddie Pruitt,NCI DAC,,Katerina Politi,Released
Dana-Farber Cancer Institute (DFCI) Wu Lab/Avicenne CLL RNA-seq Study,phs002335.v1.p1,Freddie Pruitt,NCI DAC,,Catherine Wu,Released
A multi-omic single-cell atlas of human gynecologic malignancies,phs002340.v1.p1,Freddie Pruitt,NCI DAC,,Hector Franco,Released
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation,phs002342.v1.p1,Freddie Pruitt,NCI DAC,,William Gillanders,Released
Structure of the Mucosal and Stool Microbiome in Lynch Syndrome,phs002343.v1.p1,Ian Fingerman,NCI DAC,,Curtis Huttenhower,Released
Study of tumor recurrence related to the expression of the PAX3-FOXO1 oncogenic transcription factor in fusion-positive rhabdomyosarcoma,phs002344.v1.p1,Kathleen Calzone,NCI DAC,,Frederic Barr,Released
Characterization of immune-related gene expression in lung cancer,phs002346.v1.p1,Geoffrey Tobias,NCI DAC,,Maria Teresa Landi,Released
PDAC prognosis biomarker in genomic and transcriptomic molecular data,phs002347.v1.p1,Ian Fingerman,NCI DAC,,Taesung Park,Released
Lineage plasticity and immune cell heterogeneity are coordinately dysregulated through changes in FOXA1 expression in bladder cancers with squamous differentiation,phs002357.v1.p1,Freddie Pruitt,NCI DAC,,Hikmat Al-Ahmadie,Released
Derivation and investigation of the first human cell-based model of Beckwith-Wiedemann syndrome,phs002365.v1.p1,Mariam Eljanne,NCI DAC,,Jennifer Kalish,Released
Lung Cancer Genetic Study among Asian Never Smokers,phs002366.v2.p2,Emilie Charlisse Caga-Anan,NCI DAC,Yes,Qiuyin Cai,Released
Human Tumor Atlas Network (HTAN),phs002371.v7.p2,Sean Hanlon,NCI DAC,Yes,Ethan Cerami,Released
Novel Approach to High-Throughput Identification and characterization of Neoantigens,phs002372.v1.p1,Freddie Pruitt,NCI DAC,,Magali Soumillon,Released
A Phase I/IB Study of Ipilimumab or Nivolumab in Patients With Relapsed Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation,phs002377.v1.p1,Grace Mishkin,NCI DAC,,Catherine Wu,Released
Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine Gliomas,phs002380.v1.p1,Freddie Pruitt,NCI DAC,,Rameen Beroukhim,Released
Genomic and transcriptomic markers associated with response to immune checkpoint blockade,phs002388.v1.p1,Ian Fingerman,NCI DAC,,Richard Chen,Released
Chromatin accessibility landscape of human pancreatic ductal adenocarcinoma (PDAC),phs002394.v1.p1,Freddie Pruitt,NCI DAC,,Steven Leach,Released
Integrated Metabolic Profiling and Gene Expression Analysis Reveals Therapeutic Modalities in Breast Cancer,phs002396.v1.p1,Freddie Pruitt,NCI DAC,,Charles Perou,Released
Genomics of Prostate Cancer,phs002398.v1.p1,Ian Fingerman,NCI DAC,,David Einstein,Released
Gene Variants in Pheochromocytoma and Paraganglioma,phs002405.v2.p1,John Ilekis,NICHD,,Karel Pacak,Released
A single cell atlas of MMRd and MMRp colorectal cancer,phs002407.v1.p1,Ian Fingerman,NCI DAC,,Nir Hacohen,Released
Integrative molecular characterization of breast cancer,phs002419.v2.p1,Freddie Pruitt,NCI DAC,,Eliezer Van Allen,Released
ALT Neuroblastoma Chemoresistance due to ATM Activation by Telomere Dysfunction is Reversible with the ATM Inhibitor AZD0156,phs002421.v1.p1,Ian Fingerman,NCI DAC,,Patrick Reynolds,Released
UNC Tumor Donation Program Set 2021,phs002429.v1.p1,Freddie Pruitt,NCI DAC,,Charles Perou,Released
Childhood Cancer Data Initiative (CCDI): Integration of genomic and clinical data from unique rare solid tumor datasets to facilitate data sharing (Funded to UCSF),phs002430.v1.p1,Freddie Pruitt,NCI DAC,Yes,Alejandro Sweet-Cordero,Released
"Childhood Cancer Data Initiative (CCDI): Enhancement of Data Sharing in Pediatric, Adolescent and Young Adult Cancers (Funded to UMICH)",phs002431.v1.p1,Joseph Flores-Toro,NCI DAC,Yes,Rajen Mody,Released
Wistar PDX Development and Trial Center SPORE in Skin Cancer,phs002432.v1.p1,Grace Mishkin,NCI DAC,Yes,Meenhard Herlyn,Released
Mentored Patient Oriented Research in Lymphoma,phs002434.v1.p1,Mariam Eljanne,NCI DAC,,Christopher Flowers,Released
Development and validation of Patient-Derived Xenografts from Fibrolamellar Carcinoma human tissue,phs002435.v1.p1,Freddie Pruitt,NCI DAC,,Sanford Simon,Released
Transcriptome and Epigenome of TIL infusion for cancer immunotherapy,phs002436.v1.p1,Kathleen Calzone,NCI DAC,,Steven Rosenberg,Released
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion,phs002437.v1.p1,Natalie Abrams,NCI DAC,,Scott Lippman,Released
Development and validation of Organoids from Fibrolamellar Carcinoma human cells,phs002439.v1.p1,Freddie Pruitt,NCI DAC,,Sanford Simon,Released
High-Throughput and High-Dimensional Single Cell Analysis of Antigen-Specific CD8+ T cells,phs002441.v1.p1,Freddie Pruitt,NCI DAC,,Ning Jiang,Released
Molecular signatures of DCIS to invasive progression for basal-like breast cancers: An integrated mouse model and human tumor study,phs002443.v1.p1,Freddie Pruitt,NCI DAC,,Charles Perou,Released
Germline Genetic Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma,phs002444.v1.p1,Geoffrey Tobias,NCI DAC,,Lisa Mirabello,Released
Comprehensive Analysis of the Immunogenomics of Triple Negative Breast Cancer Brain Metastases from LCCC1419,phs002457.v1.p1,Sean Hanlon,NCI DAC,,Benjamin Vincent,Released
Evolution of Chronic Lymphocytic Leukemia to Richter's Syndrome (RS),phs002458.v2.p1,Ian Fingerman,NCI DAC,,Catherine Wu,Released
Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis,phs002462.v1.p1,Freddie Pruitt,NCI DAC,,Himisha Beltran,Released
A Polygenic Score for Acute Vaso-Occlusive Pain in Pediatric Sickle Cell Disease,phs002470.v1.p1,Hiromi Ono,NHLBI,,Gang Wu,Released
Single-cell RNA-sequencing identifies immune biomarkers of response to immunotherapy in patients with high-risk Smoldering Myeloma,phs002476.v3.p1,Ian Fingerman,NCI DAC,,Irene Ghobrial,Released
HCI-PDX Trial Center for Breast Cancer Therapy,phs002479.v1.p1,Grace Mishkin,NCI DAC,Yes,Alana Welm,Released
Combined targeting CDK4/6 and HER2 signaling in orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases,phs002482.v1.p1,Freddie Pruitt,NCI DAC,,Jean Zhao,Released
Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer,phs002486.v2.p1,Joseph Flores-Toro,NCI DAC,,John Cleveland,Released
Germline whole-exome sequencing of lung cancer in EAGLE,phs002496.v1.p1,Geoffrey Tobias,NCI DAC,,Maria Teresa Landi,Released
Integrative Genomic and Transcriptomic Analyses of Refractory Multiple Myeloma,phs002498.v1.p1,Ian Fingerman,NCI DAC,,Arul Chinnaiyan,Released
"GWA Study of Oral Cavity, Pharynx and Larynx Cancers in European, and North and South American Populations - CIDR",phs002503.v1.p1,Alicia Chou,NIDCR,,Shama Virani,Released
CPTAC: Molecular dissection of chemotherapy response in triple negative breast cancer,phs002505.v1.p1,Sean Hanlon,NCI DAC,,Matthew Ellis,Released
Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas,phs002515.v1.p1,Ian Fingerman,NCI DAC,,Jaehyuk Choi,Released
Rapid Acceleration of Diagnostics - Digital Health (RADx-DH): NIH Digital Health Solutions for COVID-19,phs002516.v1.p1,Shu Hui Chen,RADx,Yes,Teresa Gibson,Released
Childhood Cancer Data Initiative (CCDI): Integration of genomic and clinical data from unique rare cancer datasets to facilitate data sharing (Funded to UPenn/CHOP),phs002517.v4.p2,Joseph Flores-Toro,NCI DAC,Yes,Adam Resnick,Released
"Childhood Cancer Data Initiative (CCDI): Administrative Supplements for the NCI P30 Cancer Center Support Grants to Enhance Data Sharing in Pediatric, Adolescent, and Young Adult Cancers (Funded to USC)",phs002518.v1.p1,Joseph Flores-Toro,NCI DAC,Yes,Amie Hwang,Released
Rapid Acceleration of Diagnostics - Digital Health (RADx-DH): Covidseeker and COVID-19 Citizen Science: Leveraging Citizen Science and Real-Time Geospatial Temporal Mobile Data for Digital Contact Tracing and SARS-CoV-2 Hotspotting,phs002519.v1.p1,Shu Hui Chen,RADx,Yes,Yulin Hswen,Released
Rapid Acceleration of Diagnostics - Digital Health (RADX-DH): Digital Health Solutions for COVID-19: COVID Community Action and Research Engagement (COVID-CARE),phs002533.v1.p1,Shu Hui Chen,RADx,Yes,Praduman Jain,Released
Rapid Acceleration of Diagnostics - Digital Health (RADx-DH): Digital Health Solution for COVID-19,phs002534.v1.p1,Shu Hui Chen,RADx,Yes,Robert Walton,Released
Rapid Acceleration of Diagnostics - Digital Health (RADx-DH): COVID-19 Experience Study (C19EX) Survey,phs002537.v1.p1,Shu Hui Chen,RADx,Yes,Ernesto Ramirez,Released
Rapid Acceleration of Diagnostics - Digital Health (RADx-DH): ILI Labels and Longitudinal Novel Engagement with Symptom Surveillance (ILLNESS) Study,phs002538.v1.p1,Shu Hui Chen,RADx,Yes,Ernesto Ramirez,Released
Rapid Acceleration of Diagnostics - Digital Health (RADx-DH): Large Scale Flu Surveillance Study (LSFS),phs002539.v1.p1,Shu Hui Chen,RADx,Yes,Ernesto Ramirez,Released
Rapid Acceleration of Diagnostics - Digital Health (RADx-DH): SAFER-COVID,phs002540.v1.p1,Shu Hui Chen,RADx,Yes,Vik Kheterpal,Released
Integrated genomic and transcriptomic analysis of small cell lung cancer reveals inter- and intratumoral heterogeneity and a novel chemotherapy-refractory subtype,phs002541.v1.p1,Kathleen Calzone,NCI DAC,,Anish Thomas,Released
Nivolumab and Ipilimumab and Radiation Therapy in Microsatellite Stable (MSS) and Microsatellite Instable (MSI) High Colorectal and Pancreatic Cancer,phs002545.v1.p1,Freddie Pruitt,NCI DAC,,David Ting,Released
Genomic Analysis of Low Grade B Cell Lymphoma,phs002552.v2.p1,Freddie Pruitt,NCI DAC,,Anne Novak,Released
Genomic Features of Lung Adenocarcinoma from Individuals with ?10 Pack-Year Smoking History,phs002556.v1.p1,Freddie Pruitt,NCI DAC,,Frederick Wilson,Released
Transcriptional profiling of macrophages in situ in metastatic melanoma reveals localization dependent phenotypes and function,phs002564.v1.p1,Ian Fingerman,NCI DAC,,Karolina Palucka,Released
"Foregut Microbiome and Risk of Gastric Intestinal Metaplasia, and Gastric Cancer Risk",phs002566.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Yu Chen,Released
International Cancer Proteogenome Consortium (ICPC): Proteogenomics of Oral Squamous Cell Carcinoma in Taiwan,phs002580.v1.p1,Sean Hanlon,NCI DAC,,Jau-Song Yu,Released
Preclinical modeling of leiomyosarcoma identifies susceptibility to transcriptional CDK inhibitors through antagonism of E2F-driven oncogenic gene expression.,phs002587.v1.p1,Freddie Pruitt,NCI DAC,,Matthew Hemming,Released
Kids First: Congenital Heart Defects and Laterality Birth Defects,phs002589.v1.p1,Marcia Fournier,Kids First DAC,Yes,Stephanie Ware,Released
Kids First: Whole Genome Sequencing in Recessive Structural Brain Defects,phs002590.v1.p1,Marcia Fournier,Kids First DAC,Yes,Joseph Gleeson,Released
"Kids First: CHARGE Syndrome, Related Conditions and Structural Anomalies",phs002592.v1.p1,Marcia Fournier,Kids First DAC,Yes,Donna Martin,Released
Kids First: Genetic Basis of Fetal Alcohol Spectrum Disorders,phs002594.v1.p1,Marcia Fournier,Kids First DAC,Yes,Christina Chambers,Released
Kids First: Genomics of Orofacial Clefts in the Philippines,phs002595.v1.p1,Marcia Fournier,Kids First DAC,Yes,Elizabeth Leslie,Released
Childhood Cancer Data Initiative (CCDI): NCI CCSG CCDI Supplement Additional Genomic Submission (Funded to OHSU),phs002599.v1.p1,Freddie Pruitt,NCI DAC,Yes,Jeffrey Tyner,Released
Immunogenomics of Malignant Brain Tumors,phs002612.v1.p1,Freddie Pruitt,NCI DAC,,Malachi Griffith,Released
Multi-omic Investigation of Beckwith-Wiedemann Syndrome Hepatoblasto,phs002614.v2.p1,Mariam Eljanne,NCI DAC,,Jennifer Kalish,Released
Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP): Rapid Acceleration of Acceptable COVID Testing and Care Options for NYC Public Housing Residents (RADx NYCHA),phs002618.v1.p1,Shu Hui Chen,RADx,Yes,Lorna Thorpe,Released
Childhood Cancer Data Initiative (CCDI): Feasibility and clinical utility of whole genome profiling in pediatric and young adult cancers (Funded to MSKCC),phs002620.v1.p1,Joseph Flores-Toro,NCI DAC,Yes,Elli Papaemmanuil,Released
Aurora US Metastatic Breast Cancer Retrospective Project,phs002622.v1.p1,Freddie Pruitt,NCI DAC,,Charles Perou,Released
Kids First: The genomic basis of structural birth defects associated with chromosome 18 copy number changes,phs002627.v1.p1,Marcia Fournier,Kids First DAC,Yes,Jannine Cody,Released
Rapid Acceleration of Diagnostics - Digital Health (RADx-DH): Digital Health Solutions for COVID-19: Clear2G,phs002628.v1.p1,Shu Hui Chen,RADx,Yes,Adarbad Master,Released
Myelofibrosis etiology and transplant outcomes,phs002635.v1.p1,Geoffrey Tobias,NCI DAC,,Shahinaz Gadalla,Released
CIDR: The Role of Rare Coding Variation in Prostate Cancer in Men of African Ancestry (RESPOND),phs002637.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,Yes,Christopher Haiman,Released
Genomic analysis of metastatic brain cancer,phs002639.v1.p1,Freddie Pruitt,NCI DAC,,Analiz Rodriguez,Released
Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP): Communities Fighting COVID,phs002649.v1.p1,Shu Hui Chen,RADx,Yes,Susan Kiene,Released
Identification of somatic changes in tumors from Fanconi anemia patients,phs002652.v1.p1,Ian Fingerman,NCI DAC,Yes,Agata Smogorzewska,Released
"Tumor mutation burden, expressed neoantigen and immune microenvironment in diffuse gliomas",phs002653.v1.p1,Kathleen Calzone,NCI DAC,,Jing Wu,Released
Genomics from LCCC1525: A Priming Dose of Cyclophosphamide Prior to Pembrolizumab to Treat mTNBC,phs002659.v1.p1,Freddie Pruitt,NCI DAC,,Mark Woodcock,Released
"Childhood Cancer Data Initiative (CCDI): Integrating Longitudinal Clinical, Sociodemographic and Genomic Data into the NCCR (Funded to DFCI)",phs002677.v1.p1,Joseph Flores-Toro,NCI DAC,Yes,Katherine Janeway,Released
Natural Killer Cell Therapies for Hematologic Malignancies,phs002681.v2.p1,Freddie Pruitt,NCI DAC,,Todd Fehniger,Released
Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma,phs002683.v1.p1,Grace Mishkin,NCI DAC,,Nir Hacohen,Released
RNA-seq of whole blood from pediatric Sickle Cell Anemia (SCA) patients,phs002687.v1.p1,Hiromi Ono,NHLBI,,Robert Meller,Released
"CIDR Estrogen Receptor Negative Breast Cancer in African American Women: DNA Methylation, Reproductive Events, and Mammary Epithelial Cell Populations",phs002688.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Christine Ambrosone,Released
The MD Anderson Colorectal Cancer Case Control Study,phs002691.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Chad Huff,Released
Single Cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib,phs002705.v1.p1,Freddie Pruitt,NCI DAC,,Catherine Wu,Released
Rapid Acceleration of Diagnostics - Underserved Populations (RADx): Using Health Communication to Increase COVID-19 Testing and Vaccination in Underserved Populations,phs002713.v1.p1,Shu Hui Chen,RADx,Yes,Matthew Kreuter,Released
Genetics of Prostate Cancer in Africa,phs002718.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Timothy Rebbeck,Released
Patient-derived breast cancer organoid study,phs002722.v1.p1,Brandon Wright,NCI DAC,,David Spector,Released
Colon Cancer Family Registry (Colon CFR),phs002733.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Mark Jenkins,Released
Rapid Idiosyncratic Mechanisms of Clinical Resistance to KRAS G12C Inhibition,phs002734.v1.p1,Ian Fingerman,NCI DAC,,Chad Pecot,Released
Tumor Infiltrating Lymphocytes (TIL) recognize unique somatic mutations and mediate objective clinical responses in metastatic breast cancer,phs002735.v1.p1,Kathleen Calzone,NCI DAC,,Steven Rosenberg,Released
Transcriptome and TCR sequencing of T cells from metastectomies,phs002748.v1.p1,Kathleen Calzone,NCI DAC,,Steven Rosenberg,Released
Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers,phs002765.v1.p1,Freddie Pruitt,NCI DAC,,Eric Tran,Released
Multi-omic Investigation of Beckwith-Wiedemann Syndrome Wilms Tumor,phs002769.v1.p1,Mariam Eljanne,NCI DAC,,Jennifer Kalish,Released
Pan cancer investigation of human leukocyte antigen loss of heterozygosity,phs002783.v1.p1,Freddie Pruitt,NCI DAC,,Charles Abbott,Released
Personalized Breast Cancer Vaccines Based on Genome Sequencing,phs002787.v2.p1,Freddie Pruitt,NCI DAC,,William Gillanders,Released
Childhood Cancer Data Initiative (CCDI): Molecular Characterization Initiative,phs002790.v8.p2,Joseph Flores-Toro,NCI DAC,Yes,Malcolm Smith,Released
Chromatin accessibility alterations in KDM6A-mutant bladder cancers,phs002801.v1.p1,Mariam Eljanne,NCI DAC,,Byron Lee,Released
A phase Ib/II Study of Palbociclib in Combination with Bazedoxifene in Hormone Receptor Breast Cancer,phs002802.v1.p1,Freddie Pruitt,NCI DAC,,Rinath Jeselsohn,Released
A Phase II clinical trial of the PARP inhibitor talazoparib in BRCA1 and BRCA2 wild-type patients,phs002803.v1.p1,Freddie Pruitt,NCI DAC,,Melinda Telli,Released
DNA double strand breaks in KMT2A-rearranged AML patients,phs002804.v1.p1,Freddie Pruitt,NCI DAC,,Yuh-Hwa Wang,Released
Genome-wide Pleiotropy Scan across Multiple Cancers,phs002809.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,John Witte,Released
Genetic analysis of Latin American Cervical Cancer,phs002810.v1.p1,Geoffrey Tobias,NCI DAC,,Michael Dean,Released
Transcriptome-wide association study to identify susceptibility genes for colorectal cancer,phs002813.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Xingyi Guo,Released
Esophageal Squamous Cell Carcinoma Precursor Study,phs002814.v1.p1,Geoffrey Tobias,NCI DAC,,Philip Taylor,Released
Intercepting progression from pre-invasive to invasive lung adenocarcinoma,phs002818.v1.p1,Natalie Abrams,NCI DAC,,Nasser Altorki,Released
Cancer Risk Estimates Related to Susceptibility Genes (CARRIERS),phs002820.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Fergus Couch,Released
Stand Up To Cancer (SUC2) Lung Cancer Checkpoint Blockade Project - MGH,phs002822.v1.p1,Freddie Pruitt,NCI DAC,,Justin Gainor,Released
A Phase 2 Study of Lamivudine in patients with p53 mutant metastatic colorectal cancer,phs002833.v1.p1,Ian Fingerman,NCI DAC,,David Ting,Released
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer,phs002834.v1.p1,Freddie Pruitt,NCI DAC,,Matthew Hellmann,Released
Breast Cancer Family Registry,phs002835.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Mary Beth Terry,Released
Evolutionary resistance of metastatic breast cancer,phs002840.v1.p1,Mariam Eljanne,NCI DAC,,Erik Ladewig,Released
Expression of Activation Induced Cytidine Deaminase and Risk of Transformation in Follicular Lymphoma,phs002845.v1.p1,Freddie Pruitt,NCI DAC,,Grzegorz Nowakowski,Released
"Circulating Tumor DNA as a Biomarker in Patients with Stage III and IV Wilms Tumor: Analysis from a Children's Oncology Group Trial, AREN0533",phs002847.v1.p1,Joseph Flores-Toro,NCI DAC,,Brian Crompton,Released
Refractory Cancer (RC) Burkitt�s Lymphoma (BL),phs002851.v1.p1,Freddie Pruitt,NCI DAC,,Jean Zenklusen,Released
A Pilot Study of NKTR-214 and Nivolumab in Selected Patients with Locally Advanced/Metastatic Sarcoma,phs002852.v1.p1,Freddie Pruitt,NCI DAC,,Sandra D'Angelo,Released
MSK SPECTRUM - SPatiotemporal Evolution of Cancer TRaced Using Multimodalities,phs002857.v2.p1,Joseph Flores-Toro,NCI DAC,,Britta Weigelt,Released
RB1 loss triggers dependence on ESRRG in retinoblastoma,phs002859.v1.p1,Freddie Pruitt,NCI DAC,,James Harbour,Released
Collection of Tissue and Blood Specimens and Clinical Data from Patients with Suspected Gynecological Neoplasms and Patients with Gynecological Cancers,phs002862.v1.p1,Freddie Pruitt,NCI DAC,,Catherine Wu,Released
Accurate genome-wide germline DNA profiling from decade-old archival tissue specimen,phs002865.v1.p1,Joseph Flores-Toro,NCI DAC,,Olivier Harismendy,Released
Circulating Tumor DNA in Intermediate Risk Rhabdomyosarcoma,phs002866.v1.p1,Joseph Flores-Toro,NCI DAC,,Brian Crompton,Released
Blood somatic mutations in TCGA donors suffering from solid tumors,phs002867.v1.p1,Brandon Wright,NCI DAC,,Nuria Lopez-Bigas,Released
Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP): COVID-19 Testing in Underserved and Vulnerable Populations Receiving Care in San Diego Community Health,phs002869.v1.p1,Shu Hui Chen,RADx,Yes,Martinez Maria,Released
Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP): Implementation Science Center in Cancer Control Equity: A Competitive Revision to Accelerate COVID Testing in Vulnerable Communities - Project 08,phs002872.v1.p1,Shu Hui Chen,RADx,Yes,Karen Emmons,Released
Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy,phs002877.v1.p1,Freddie Pruitt,NCI DAC,,Catherine Wu,Released
The role of CDX2 in controlling ABCB1 expression and chemosensitivity in human colon cancer.,phs002903.v1.p1,Joseph Flores-Toro,NCI DAC,,Piero Dalerba,Released
California Teachers Study (CTS): Whole Genome Sequences from Under-represented Populations - CIDR,phs002918.v1.p1,Barbara Thomas,NCI DAC,,James Lacey,Released
Cancer Patients Receiving Immune Therapy,phs002922.v2.p1,Joseph Flores-Toro,NCI DAC,,Gad Getz,Released
Genomic analysis of Extra-nodal Natural Killer/T-cell lymphoma (ENKTCL),phs002925.v1.p1,Brandon Wright,NCI DAC,,Wing Chan,Released
Adoptive cell therapy of autologous T cell receptor-engineered T cells targeting the p53 R175H neoantigen in human breast cancer,phs002928.v1.p1,Kathleen Calzone,NCI DAC,,Steven Rosenberg,Released
Decade-long leukemia remissions with persistence of CD4+ CAR T-cells,phs002931.v1.p1,Freddie Pruitt,NCI DAC,,Jan Melenhorst,Released
Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome,phs002933.v1.p1,Grace Mishkin,NCI DAC,,Youn Kim,Released
Molecular Biomarkers of Obesity and Metformin Response in Endometrial Cancer: Analysis of GOG-0286B,phs002934.v1.p1,Grace Mishkin,NCI DAC,,Victoria Bae-Jump,Released
Transcriptomic Profiling of Oropharyngeal Squamous Cell Carcinoma,phs002935.v1.p1,Grace Mishkin,NCI DAC,,Travis Schrank,Released
NCI-Maryland Prostate Cancer Case-Control Study,phs002939.v1.p1,Kathleen Calzone,NCI DAC,,Stefan Ambs,Released
CALGB/SWOG 80405 ct DNA Biomarker Evaluation,phs002941.v1.p1,Grace Mishkin,NCI DAC,Yes,Xueping Qu,Released
Melanoma brain metastasis single-cell RNA sequencing atlas,phs002944.v1.p1,Freddie Pruitt,NCI DAC,,Benjamin Izar,Released
Methylation profiles of cell-free DNA using nanopore sequencing,phs002950.v1.p1,Freddie Pruitt,NCI DAC,,Hanlee Ji,Released
Predictors of Myelodysplastic Syndrome in Minnesota,phs002962.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Jenny Poynter,Released
Single-cell analysis of CD19-specific CAR T cell treatment of relapsed/refractory CD19+ acute lymphoblastic leukemia,phs002966.v1.p1,Joseph Flores-Toro,NCI DAC,,Stephen Gottschalk,Released
Functional analysis of genetic variants in African Americans with breast cancer.,phs002977.v1.p1,Ian Fingerman,NCI DAC,,Luisel Ricks-Santi,Released
AC-ICAM: An Atlas and Compass of Immune-Colon-cancer-Microbiome interactions,phs002978.v1.p1,Brandon Wright,NCI DAC,,Wouter Hendrickx,Released
A Randomized Multi-Institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck,phs002986.v1.p1,Freddie Pruitt,NCI DAC,,Siddharth Sheth,Released
Genomic Analysis of Follicular Lymphoma,phs002989.v1.p1,Freddie Pruitt,NCI DAC,,Anne Novak,Released
BRCA Mutation Status Shapes the Microenvironment of Pancreatic Adenocarcinoma,phs002994.v1.p1,Freddie Pruitt,NCI DAC,,David Kelsen,Released
Immune Profiles Study,phs002998.v1.p1,Freddie Pruitt,NCI DAC,,John Wiencke,Released
ALLELE Consortium GBM Project,phs003000.v1.p1,Freddie Pruitt,NCI DAC,,Keith Ligon,Released
A Platform Study of Combination Immunotherapy for the Neoadjuvant and Adjuvant Treatment of Patients with Surgically Resectable Adenocarcinoma of the Pancreas,phs003002.v2.p1,Freddie Pruitt,NCI DAC,,Lei Zheng,Released
Transcriptional and Epigenetic Profiles of Male Breast Cancer at Single-Cell Resolution Nominate Salient Cancer Specific Enhancers,phs003006.v1.p1,Freddie Pruitt,NCI DAC,,Philip Spanheimer,Released
Comprehensive genomic characterization of translocation renal cell carcinoma.,phs003008.v1.p1,Heather Basehore,NCI DAC,,Srinivas Viswanathan,Released
Genomic Characterization of Duke Melanoma Brain Metastases,phs003009.v1.p1,Freddie Pruitt,NCI DAC,,April Salama,Released
APOLLO1: Proteogenomic analysis of lung adenocarcinoma,phs003011.v1.p1,Sean Hanlon,NCI DAC,Yes,Christopher Moskaluk,Released
NCI's Datasets for General Research Use,phs003014.v1.p1,Freddie Pruitt,NCI DAC,,Freddie Pruitt,Released
Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer,phs003019.v1.p1,Freddie Pruitt,NCI DAC,,Ursula Matulonis,Released
Molecular Analysis of Short- Versus Long-term Survivors of High-Grade Serous Ovarian Carcinoma,phs003020.v1.p1,Freddie Pruitt,NCI DAC,,Anil Sood,Released
Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors,phs003022.v1.p1,Freddie Pruitt,NCI DAC,,Paul Williams,Released
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failure in lymphoma,phs003023.v1.p1,Freddie Pruitt,NCI DAC,,Michael Jain,Released
Genomic analysis of nucleic acid sequences from pancreatic cancer,phs003035.v1.p1,Ian Fingerman,NCI DAC,,Subhajyoti De,Released
Single cell genome variation induced by mutational processes in cancer - HGSOC Trios study,phs003036.v1.p1,Heather Basehore,NCI DAC,,Sohrab Shah,Released
Exploiting New Patterns of Genome Damage in Triple Negative Breast Cancer,phs003038.v1.p1,Ying Huang,NCI DAC,,Sohrab Shah,Released
Novel Strategies to Eliminate Resistance to B-cell Receptor Inhibitor Therapy in Lymphoid Malignancies,phs003042.v1.p1,Mariam Eljanne,NCI DAC,,Deborah Stephens,Released
A Pilot Study to Evaluate Tissue- and Plasma-based DNA Driver Mutations in a Cohort of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms,phs003043.v1.p1,Freddie Pruitt,NCI DAC,,Jennifer Permuth,Released
"NCI's collection of datasets for Health, Medical, and Biomedical research purposes",phs003044.v1.p1,Freddie Pruitt,NCI DAC,,Freddie Pruitt,Released
"Extracellular RNA profiling of serum, plasma, and urine of healthy subjects",phs003054.v1.p1,Kathleen Calzone,NCI DAC,,Jennifer Jones,Released
"Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP): Evidence-based Interventions Individual, Community, and Structural Factors That Predict Lower Rates of Covid-19 Screening Testing in Underserved and Vulnerable Populations",phs003057.v1.p1,Shu Hui Chen,RADx,Yes,Jan Carney,Released
Metastatic colorectal adenocarcinoma tumor purity assessment from whole exome sequencing data,phs003059.v1.p1,Joseph Flores-Toro,NCI DAC,,Robert Warren,Released
Whole exome sequencing of Calcitonin producing pancreatic neuroendocrine neoplasms (CT-pNENs) indicates a unique molecular signature,phs003060.v1.p1,Freddie Pruitt,NCI DAC,,Detlef Bartsch,Released
Phenotypic Signatures of Circulating Neoantigen-Reactive CD8+ T Cells in Patients with Metastatic Cancers,phs003064.v1.p1,Kathleen Calzone,NCI DAC,,Steven Rosenberg,Released
Urothelial Cancer - Genomic Analysis to Improve Patient Outcomes and Research (UC-GENOME): a Bladder Cancer Advocacy Network (BCAN)-led Collaborative Research Pilot Study,phs003066.v1.p1,Freddie Pruitt,NCI DAC,,Matthew Milowsky,Released
Single cell RNA-sequencing in adenoid cystic carcinoma,phs003070.v1.p1,Mariam Eljanne,NCI DAC,,Sidharth Puram,Released
A National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer (PLC),phs003074.v1.p1,Kathleen Calzone,NCI DAC,,Tim Greten,Released
Retinoblastoma Aqueous Humor Liquid Biopsy Repository,phs003077.v1.p1,Mariam Eljanne,NCI DAC,,Jesse Berry,Released
Spatiotemporal evolution of the ccRCC microenvironment links intra-tumoral heterogeneity to immune escape CINOMA,phs003079.v1.p1,Sean Hanlon,NCI DAC,,Abraham Hakimi,Released
Genome sequencing of circulating tumor cells for minimally invasive molecular characterization of multiple myeloma pathology,phs003084.v1.p1,Ian Fingerman,NCI DAC,,Irene Ghobrial,Released
RNA-sequencing of B-lymphoblastic leukemia with glucocorticoids and PI3K delta inhibition,phs003085.v1.p1,Freddie Pruitt,NCI DAC,,Miles Pufall,Released
"Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model",phs003090.v1.p1,Ian Fingerman,NCI DAC,,Ryan Fields,Released
The Genomic Landscape of Interval Colorectal Cancers,phs003093.v1.p1,Claire Zhu,NCI DAC,,Andrew Chan,Released
Urothelial Cancer - Genomic Analysis to Improve Patient Outcomes and Research (UC-GENOME): a Bladder Cancer Advocacy Network (BCAN)-led Collaborative Research Pilot Study-for sample collected at Johns Hopkins,phs003094.v1.p1,Freddie Pruitt,NCI DAC,,Matthew Milowsky,Released
"Multi-modal single-cell and whole-genome sequencing of small, frozen clinical specimens",phs003097.v1.p1,Freddie Pruitt,NCI DAC,,Benjamin Izar,Released
Integration of Clinical and Molecular Biomarkers for Melanoma Survival (Berwick),phs003099.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Marianne Berwick,Released
Whole-genome sequencing analysis of extrachromosomal DNA with Amplicon Architect,phs003100.v1.p1,Freddie Pruitt,NCI DAC,,Michalina Janiszewska,Released
Multivalent state transitions shape the intratumoral composition of small cell lung carcinoma,phs003102.v1.p1,Ian Fingerman,NCI DAC,,Mohamed Abazeed,Released
Single cell analysis of sporadic human basal cell carcinomas,phs003103.v1.p1,Freddie Pruitt,NCI DAC,,Anthony Oro,Released
Childhood Cancer Data Initiative (CCDI): Clonal Evolution during Metastatic Spread in HighRrisk Neuroblastoma,phs003111.v1.p1,Freddie Pruitt,NCI DAC,Yes,Elli Papaemmanuil,Released
CIDR: Detroit Research on Cancer Survivors (ROCS) and Disparities and Cancer Epidemiology- Colorectal Cancer (DANCE),phs003116.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Ann Schwartz,Released
Multiregional single-cell transcriptomic analysis of liver cancer,phs003117.v1.p1,Kathleen Calzone,NCI DAC,,Xin Wang,Released
Targeted genomic sequencing in large human genes to detect induced structural variants,phs003121.v2.p1,Ian Fingerman,NCI DAC,,Thomas Wilson,Released
Genetic Progression of Head and Neck Squamous Cell Carcinoma,phs003139.v1.p1,Alicia Chou,NIDCR,,Gad Getz,Released
Genetic Epidemiology of Ovarian Cancer Histotypes,phs003140.v1.p1,Mariam Eljanne,NCI DAC,,Mollie Barnard,Released
Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors,phs003141.v1.p1,Freddie Pruitt,NCI DAC,,Eliezer Van Allen,Released
My Pediatric and Adult Rare Tumor (MyPART) Natural History Study of Rare Solid Tumors,phs003143.v1.p1,Kathleen Calzone,NCI DAC,Yes,Mary Wedekind Malone,Released
Tissue Sampling and Biorepository to improve Cancer Cell Therapy,phs003145.v1.p1,Freddie Pruitt,NCI DAC,,Ash Alizadeh,Released
A Phase II Neoadjuvant Study of Palbociclib in Combination with Letrozole and Trastuzumab as Neoadjuvant Treatment of Stage II-III ER+ HER2+ Breast Cancer (PALTAN),phs003147.v1.p1,Nathaniel Boyd,NCI DAC,,Foluso Ademuyiwa,Released
NCT03343197: Clinical Biomarker Data,phs003148.v1.p1,Nathaniel Boyd,NCI DAC,,Sung Choe,Released
Bladder Cancer Organoids as a Functional System to Model Different Disease Stages and Therapy Response,phs003149.v1.p1,Nathaniel Boyd,NCI DAC,,Francesca Demichelis,Released
International Cancer Proteogenomics Consortium (ICPC): Proteogenomics of East-Asian Breast Cancer,phs003150.v1.p1,Sean Hanlon,NCI DAC,,Hsuan-Yu Chen,Released
CPTAC: Proteogenomic studies of ovarian tumor responses to agents targeting the DNA damage response,phs003152.v1.p1,Sean Hanlon,NCI DAC,,Amanda Paulovich,Released
Neoantigen-targeted CD8+ T-cell responses 1 with PD-1 blockade therapy,phs003153.v1.p1,Freddie Pruitt,NCI DAC,,Antoni Ribas,Released
"An Advanced Molecular Medicine Case Report of a Rare Human Tumor Using Genomics, Pathomics, and Radiomics",phs003154.v1.p1,Nathaniel Boyd,NCI DAC,,Donald Johann,Released
S�zary syndrome originates from heavily mutated hematopoietic progenitors,phs003158.v1.p1,Ian Fingerman,NCI DAC,,Jose Conejo-Garcia,Released
Targeted long-read sequencing of the Ewing sarcoma 6p25.1 susceptibility locus,phs003159.v1.p1,Geoffrey Tobias,NCI DAC,,Mitchell Machiela,Released
Childhood Cancer Data Initiative (CCDI): Pediatric In Vivo Testing Program � Neuroblastoma,phs003163.v1.p1,Freddie Pruitt,NCI DAC,Yes,John Maris,Released
Childhood Cancer Data Initiative (CCDI): PIVOT Children's Cancer Institute Australia,phs003164.v2.p1,Freddie Pruitt,NCI DAC,Yes,Richard Lock,Released
Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases,phs003165.v1.p1,Kathleen Calzone,NCI DAC,,Stanley Lipkowitz,Released
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer,phs003170.v1.p1,Freddie Pruitt,NCI DAC,,Muhammed Murtaza,Released
Comparison between qPCR and RNAseq reveals challenges of quantifying HLA expression,phs003177.v1.p1,Kathleen Calzone,NCI DAC,,Mary Carrington,Released
"Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial",phs003178.v1.p1,Freddie Pruitt,NCI DAC,,Gad Getz,Released
The Ultrasound Study of Tamoxifen,phs003183.v1.p1,Geoffrey Tobias,NCI DAC,,Gretchen Benson,Released
Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions,phs003185.v1.p1,Nathaniel Boyd,NCI DAC,,Avrum Spira,Released
Tamoxifen Response at Single Cell Resolution in Estrogen Receptor Positive Primary Human Breast Tumors,phs003186.v1.p1,Freddie Pruitt,NCI DAC,,Philip Spanheimer,Released
Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy,phs003188.v1.p1,Ian Fingerman,NCI DAC,,Alex Kentsis,Released
Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and is Associated with Worse Outcomes,phs003190.v1.p1,Kathleen Calzone,NCI DAC,,Anish Thomas,Released
RNA splicing dysregulation in the pathogenesis of chronic lymphocytic leukemia,phs003191.v1.p1,Ian Fingerman,NCI DAC,,Lili Wang,Released
ARST17B2-Q Germline and Somatic Genetic Landscape of Pediatric Rhabdomyosarcoma,phs003192.v1.p1,Geoffrey Tobias,NCI DAC,,Philip Lupo,Released
Detection and Targeting of Splicing Deregulation in Pediatric Acute Myeloid Leukemia Stem Cells,phs003196.v1.p1,Ludmila Pawlikowska,NIDDK,,Catriona Jamieson,Released
Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer,phs003198.v1.p1,Nathaniel Boyd,NCI DAC,,Susan Neuhausen,Released
RNAseq data from early stage triple negative breast cancer tumors treated with TVEC and chemotherapy (MCC18621),phs003199.v1.p1,Freddie Pruitt,NCI DAC,,Hatem Soliman,Released
E5103 correlative studies,phs003201.v1.p1,Grace Mishkin,NCI DAC,,Bryan Schneider,Released
Single cell colony whole genome sequencing data from individuals with telomere syndromes,phs003207.v1.p1,Ian Fingerman,NCI DAC,,Mary Armanios,Released
Structurally complex osteosarcoma genomes exhibit limited heterogeneity within individual tumors and across evolutionary time,phs003209.v1.p1,Ian Fingerman,NCI DAC,,Ryan Roberts,Released
Melbourne Collaborative Cohort Study DNA methylation studies,phs003213.v1.p1,Freddie Pruitt,NCI DAC,,Roger Milne,Released
Molecular Determinants of Esophageal Cancer in Tanzania,phs003217.v1.p1,Freddie Pruitt,NCI DAC,,Elia Mmbaga,Released
Single cell sequencing reveals distinct microenvironment cell types associated with response to high dose melphalan and autologous stem cell transplant in multiple myeloma,phs003219.v1.p1,Nathaniel Boyd,NCI DAC,,Brian Walker,Released
Identification of high-risk PHF19 expressing cells in myeloma single cell multiomics,phs003220.v2.p1,Nathaniel Boyd,NCI DAC,,Brian Walker,Released
Genomic profiling of pediatric B-cell Acute Lymphoblastic Leukemia,phs003226.v1.p1,Ian Fingerman,NCI DAC,,Jesse Dixon,Released
Hi-C profiling of solid tumor samples,phs003227.v1.p1,Ian Fingerman,NCI DAC,,Jesse Dixon,Released
Genomics of blastic plasmacytoid dendritic cell neoplasm,phs003228.v1.p1,Ian Fingerman,NCI DAC,,Andrew Lane,Released
Analysis of donor pancreata defines the transcriptomic signature and microenvironment of early neoplastic pancreatic lesions.,phs003229.v1.p1,Ian Fingerman,NCI DAC,,Marina Pasca Di Magliano,Released
Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation,phs003230.v2.p1,Ian Fingerman,NCI DAC,,Thomas Graeber,Released
Single Cell Genotypic and Phenotypic Analysis of Measurable Residual Disease in Acute Myeloid Leukemia,phs003233.v1.p1,Freddie Pruitt,NCI DAC,,Wenbin Xiao,Released
Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biologic Studies (10C0086),phs003243.v1.p1,Kathleen Calzone,NCI DAC,,Rosandra Kaplan,Released
Deterministic evolution and stringent selection during pre-neoplasia,phs003249.v1.p1,Ian Fingerman,NCI DAC,,Christina Curtis,Released
Genetic studies of homologous recombination deficiency in hispanic gastric cancer,phs003251.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Luis Carvajal,Released
Single-cell ATAC and RNA sequencing of human breast cancer reveals salient cancer-specific enhancers,phs003253.v1.p1,Freddie Pruitt,NCI DAC,,Hector Franco,Released
Single duplex DNA sequencing with CODEC detects mutations with high sensitivity,phs003255.v1.p1,Nathaniel Boyd,NCI DAC,,Viktor Adalsteinsson,Released
Therapy-induced APOBEC3A drives evolution of resistance to targeted therapies in non-small cell lung cancer,phs003256.v1.p1,Freddie Pruitt,NCI DAC,,Aaron Hata,Released
Investigating the role of neddylation in the repair of topoisomerase I-mediated DNA damage in colorectal cancer,phs003257.v1.p1,Kathleen Calzone,NCI DAC,,Yves Pommier,Released
GATA2 Deficiency and the MonoMAC Syndrome,phs003269.v1.p1,Kathleen Calzone,NCI DAC,,Dennis Hickstein,Released
Supraphysiologic MDM2 expression impacts P53-independent chromatin networks and therapeutic responses in sarcoma,phs003272.v1.p1,Ian Fingerman,NCI DAC,,Bradley Bernstein,Released
Association of Oxidative Stress Pathway Alterations with Risk of Treatment Failure in RTOG9512: A Randomized Trial of Hyperfractionation Versus Conventional Fractionation in T2 Squamous Cell Carcinoma of the Vocal Cord,phs003274.v1.p1,Freddie Pruitt,NCI DAC,,David Hayes,Released
Prediction of Resistance and Sensitivity to HER2 Targeted Therapy in the Neoadjuvant Setting,phs003275.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Lisa Carey,Released
MAITS in HCC,phs003279.v1.p1,Kathleen Calzone,NCI DAC,Yes,Tim Greten,Released
Spatiotemporal charting of human esophageal development for epidermolysis bullosa cell therapy,phs003281.v1.p1,Nathaniel Boyd,NCI DAC,,Anthony Oro,Released
Genetic analysis of skin cells,phs003282.v2.p1,Ian Fingerman,NCI DAC,,A. Hunter Shain,Released
Immune-related adverse events after immune checkpoint blockade-based therapy are associated with improved survival in advanced sarcoma,phs003284.v2.p1,Freddie Pruitt,NCI DAC,,Sandra D'Angelo,Released
CDKN2A remodels lipid metabolism to prime glioblastoma for ferroptosis,phs003286.v2.p1,Ian Fingerman,NCI DAC,,David Nathanson,Released
"Cell-free, methylated DNA in blood samples reveals tissue-specific, cellular damage from radiation treatment",phs003290.v1.p1,Freddie Pruitt,NCI DAC,,Anton Wellstein,Released
Ipilimumab plus decitabine for patients with MDS or AML in post-transplant or transplant na�ve settings,phs003292.v1.p1,Freddie Pruitt,NCI DAC,Yes,Jacqueline Garcia,Released
Whole Genome Sequencing for Metastatic Mutational Burden in Extraskeletal Myxoid Chondrosarcoma,phs003305.v1.p1,Freddie Pruitt,NCI DAC,,Kurt Weiss,Released
Characterization of Macrophage-Tropic HIV Infection of Central Nervous System Cells and the Influence of Inflammation,phs003306.v1.p1,Jonathan Pollock,JAAMH,,Ronald Swanstrom,Released
A microwell platform for high-throughput longitudinal phenotyping and selective retrieval of organoids,phs003315.v1.p1,Ian Fingerman,NCI DAC,,Christina Curtis,Released
"A pilot study of neoadjuvant nivolumab, ipilimumab and intralesional oncolytic virotherapy for HER2-negative breast cancer",phs003316.v1.p1,Freddie Pruitt,NCI DAC,,Antoni Ribas,Released
Single-cell multi-omic analysis of the vestibular schwannoma ecosystem uncovers a nerve injury-like state,phs003318.v1.p1,Freddie Pruitt,NCI DAC,,Albert Kim,Released
RNA sequencing of ECOG-E1308,phs003320.v1.p1,Grace Mishkin,NCI DAC,,Wendell Yarbrough,Released
Whole Exome and RNA Sequencing of 22 Patient-Derived Xenografts from Estrogen Receptor-Positive Breast Cancers,phs003324.v1.p1,Freddie Pruitt,NCI DAC,,Michael Ittmann,Released
DNA-sequencing of baseline plasma from the phase III Alliance A031201 trial,phs003325.v1.p1,Freddie Pruitt,NCI DAC,,Scott Dehm,Released
Uveal Melanoma Immunogenomics Predict Immunotherapy Resistance and Susceptibility,phs003330.v1.p1,Nathaniel Boyd,NCI DAC,,Udai Kammula,Released
BarcUVa-Seq (Biology of Colorectal Cancer Risk Enhancers),phs003338.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Graham Casey,Released
Meta-analysis of genome-wide association studies of bladder cancer risk,phs003342.v1.p1,Geoffrey Tobias,NCI DAC,,Nathaniel Rothman,Released
Targeted linked-read DNA-seq analysis of castration-resistant prostate cancers,phs003343.v1.p1,Ian Fingerman,NCI DAC,,Scott Dehm,Released
Patient-derived models of prostate cancer,phs003369.v3.p1,Freddie Pruitt,NCI DAC,,Renea Taylor,Released
"A Phase I Study of the Treatment of Recurrent Malignant Glioma with rQNestin34.5v.2, a Genetically Engineered HSV-1 Virus, and Immunomodulation with Cyclophosphamide",phs003378.v2.p1,Grace Mishkin,NCI DAC,,E. Chiocca,Released
Germline mutations and developmental mosaicism underlying EGFR-mutant lung cancer,phs003379.v1.p1,Nathaniel Boyd,NCI DAC,,Gad Getz,Released
Cryptic Splice Mutation in the Fumarate Hydratase Gene in Patients With Clinical Manifestations of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC).,phs003381.v1.p1,Abid Al Reza,NCI DAC,,Marston Linehan,Released
PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research,phs003382.v1.p1,Claire Zhu,NCI DAC,,Catherine Tangen,Released
Systematic identification of minor histocompatibility antigens informs outcomes after allogeneic stem cell transplantation,phs003394.v1.p1,Freddie Pruitt,NCI DAC,,Catherine Wu,Released
Genomic tumor correlates of clinical outcomes following organ-sparing chemoradiation therapy for bladder cancer,phs003402.v1.p1,Freddie Pruitt,NCI DAC,,David Miyamoto,Released
Genomic Analysis of Prostate Tumor Heterogeneity in Metastasis,phs003404.v1.p1,Freddie Pruitt,NCI DAC,,Carlos Moreno,Released
Tracking Therapy-Resistant Alterations in Childhood Acute Lymphoblastic Leukemia,phs003409.v1.p1,Joseph Flores-Toro,NCI DAC,,Xiaotu Ma,Released
A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment,phs003410.v1.p1,Freddie Pruitt,NCI DAC,,Ash Alizadeh,Released
Correlative study in Protocol S1400I; A PHASE III RANDOMIZED STUDY OF NIVOLUMAB PLUS IPILIMUMAB VERSUS NIVOLUMAB IN STAGE IV SQUAMOUS CELL LUNG CANCER (CIMAC-CIDC),phs003412.v1.p1,Freddie Pruitt,NCI DAC,Yes,Michael Leblanc,Released
"Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor",phs003413.v1.p1,Freddie Pruitt,NCI DAC,,Alexandra-Chloe Villani,Released
Transcriptomic and epigenetic profiling of SCLC patient samples.,phs003416.v1.p1,Freddie Pruitt,NCI DAC,,Lauren Shipley,Released
Altered interactions between circulating and tissue-resident CD8 T cells with the colonic mucosa define checkpoint inhibitor colitis,phs003418.v1.p1,Freddie Pruitt,NCI DAC,,Alexandra-Chloe Villani,Released
Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer,phs003422.v1.p1,Abid Al Reza,NCI DAC,,Jeremy Davis,Released
CALGB/SWOG 80405: Genome-Wide Association Study of Patients With Advanced or Metastatic Colorectal Cancer Treated with First-Line Chemotherapy Combined With Cetuximab and/or Bevacizumab,phs003428.v1.p1,Grace Mishkin,NCI DAC,,Kouros Owzar,Released
Children's Hospital of Philadelphia B- and T-cell Acute Leukemia and Lymphomas,phs003432.v1.p1,Freddie Pruitt,NCI DAC,Yes,David Teachey,Released
Circulating Genomic Determinants of Treatment Failure in Hodgkin Lymphoma,phs003435.v1.p1,Freddie Pruitt,NCI DAC,,Ash Alizadeh,Released
KRT17High/CXCL8+ tumor cells display both classical and basal features and regulate myeloid infiltration in the pancreatic cancer microenvironment.,phs003436.v1.p1,Justin Benavidez,NCI DAC,,Marina Pasca Di Magliano,Released
Integrated Somatic and Germline Molecular Properties Dictating Biological and Clinical Phenotypes in Cancer,phs003438.v1.p1,Freddie Pruitt,NCI DAC,,Eliezer Van Allen,Released
The Cancer Dependency Map (DepMap),phs003444.v2.p1,Sharna Tingle,NCI DAC,Yes,Francisca Vazquez,Released
Profiling RNA translation in pediatric medulloblastoma,phs003446.v1.p1,Freddie Pruitt,NCI DAC,,John Prensner,Released
MAESTRO-Pool enables highly parallel and specific mutation-enrichment sequencing for minimal residual disease detection in cohort studies,phs003447.v1.p1,Freddie Pruitt,NCI DAC,,Viktor Adalsteinsson,Released
The genetic evolution of acral melanoma,phs003451.v2.p1,Freddie Pruitt,NCI DAC,,Boris Bastian,Released
Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy,phs003452.v1.p1,Freddie Pruitt,NCI DAC,,Matthew Milowsky,Released
Assessing Individual Head and Neck Squamous Cell Carcinoma Patient Response to Therapy Through Integration of Functional and Genomic Data,phs003456.v1.p1,Freddie Pruitt,NCI DAC,,Molly Kulesz-Martin,Released
Sensitive and accurate tumor detection by methylation and hemi-methylation of plasma cell-free DNA,phs003462.v1.p1,Freddie Pruitt,NCI DAC,,Zhiguo Zhang,Released
Genomic Landscape of Colorectal Cancer in a Multi-Ancestry Cohort,phs003464.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Stephanie Schmit,Released
"Breast Cancer In Blacks: Impact of Genomics, Healthcare Use and Lifestyle on Outcomes (BRIGHT)",phs003466.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Tuya Pal,Released
A missense SNP in the tumor suppressor SETD2 reduces H3K36me3 and mitotic spindle integrity in Drosophila,phs003474.v1.p1,Freddie Pruitt,NCI DAC,,Rebecca Arnold,Released
CEBP-Beta/IL-1-Beta/ TNF-alpha Feedback Loop Drives Drug Resistance to BCL2 and MDM2 Inhibitors in Monocytic Leukemia Cells,phs003479.v1.p1,Freddie Pruitt,NCI DAC,,Haijiao Zhang,Released
Single-cell RNA-sequencing of human prostatectomy tissue,phs003480.v1.p1,Freddie Pruitt,NCI DAC,,Srinivasan Yegnasubramanian,Released
Epigenomics of Prostate Cancer from Cell Free Plasma,phs003482.v2.p1,Abid Al Reza,NCI DAC,,David Takeda,Released
Acquired Cross-Resistance in Small Cell Lung Cancer Patient-Derived Xenografts,phs003486.v1.p1,Freddie Pruitt,NCI DAC,,Benjamin Drapkin,Released
APOLLO2: Applied Proteogenomics of High Grade Serous Ovarian Carcinoma,phs003488.v1.p1,Sean Hanlon,NCI DAC,Yes,Thomas Conrads,Released
Impact of genetic variation on response to GO therapy in COG-AML Trials AAML03P1 and AAML0531,phs003490.v1.p1,Freddie Pruitt,NCI DAC,,Jatinder Lamba,Released
Systems analysis of single-cell heterogeneity underlying glioma drug resistance,phs003501.v1.p1,Freddie Pruitt,NCI DAC,,James Park,Released
ILyAD (Indolent Lymphoma And vitamin D),phs003503.v1.p1,Freddie Pruitt,NCI DAC,,Jonathan Friedberg,Released
National Cancer Institute Multi-Ancestry Genome-Wide Association Study of Kidney Cancer (NCI-3),phs003505.v1.p1,Geoffrey Tobias,NCI DAC,,Mark Purdue,Released
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS),phs003517.v1.p1,Freddie Pruitt,NCI DAC,,Vered Stearns,Released
Childhood Cancer Data Initiative (CCDI): Single-cell atlas of NF1 nerve sheath tumors,phs003519.v1.p1,Freddie Pruitt,NCI DAC,Yes,John Shern,Released
Epigenetic damage in women living in LA food-desert zip codes,phs003522.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Victoria Seewaldt,Released
Light at night and prostate cancer in the Health Professionals Follow up Study,phs003538.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Lorelei Mucci,Released
The role of E2F4 in controlling resistance to irinotecan (CPT-11) in human colon cancer,phs003560.v1.p1,Freddie Pruitt,NCI DAC,,Piero Dalerba,Released
Spatial transcriptomics reveals discrete tumour microenvironments and autocrine loops within ovarian cancer subclones,phs003561.v1.p1,Freddie Pruitt,NCI DAC,,Alistair Forrest,Released
Transfer learning associates CAFs with EMT and inflammation in tumor cells in human tumors and organoid co-culture in pancreatic ductal adenocarcinoma,phs003563.v1.p1,Freddie Pruitt,NCI DAC,,Elana Fertig,Released
Aberrant activation of wound healing programs within the metastatic niche facilitates lung colonization by osteosarcoma cells,phs003569.v1.p1,Justin Benavidez,NCI DAC,,Ryan Roberts,Released
Detecting and subtyping lung cancer through analysis of gene expression from circulating tumor DNA,phs003570.v1.p1,Freddie Pruitt,NCI DAC,,David Macpherson,Released
Phase II study of cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma,phs003579.v1.p1,Grace Mishkin,NCI DAC,,Nir Hacohen,Released
Luminal Androgen Receptor-Enriched tripple Negative Breast Cancer,phs003586.v1.p1,Freddie Pruitt,NCI DAC,,Jeffrey Chang,Released
FIGHT-207- Anonymized Genomic Alterations and Clinical Responses,phs003590.v1.p1,Freddie Pruitt,NCI DAC,,Aidan Gilmartin,Released
Genomics analysis reveals molecular patterns of tumorigenesis in HPV-associated and HPV-independent sinonasal squamous cell carcinoma,phs003591.v1.p1,Kathleen Calzone,NCI DAC,,Nyall London,Released
Ongoing Replication Stress Tolerance and Clonal T Cell Responses Distinguish Liver and Lung Recurrence and Patient Outcomes in Pancreatic Ductal Adenocarcinoma,phs003597.v1.p1,Freddie Pruitt,NCI DAC,,Rosalie Sears,Released
Comprehensive Genomic Data Deposition for Pancreatic Cancer Precision Medicine Studies: Clinical Trials NCT02451982 and NCT02648282,phs003600.v1.p1,Nathaniel Boyd,NCI DAC,,Lei Zheng,Released
BET inhibition reforms the immune microenvironment and alleviates T-cell dysfunction in chronic lymphocytic leukemia,phs003613.v1.p1,Freddie Pruitt,NCI DAC,,Dalia Elgamal,Released
Phase 2 study of Nivolumab and Entinostat in unresectable or metastatic cholangiocarcinoma and pancreatic adenocarcinoma,phs003615.v1.p1,Freddie Pruitt,NCI DAC,,Marina Baretti,Released
Immune determinants of resistance to PD-1 blockade in renal cell carcinoma,phs003618.v1.p1,Freddie Pruitt,NCI DAC,,Catherine Wu,Released
BIRC5 Upregulation Enhances DNMT3A-Mutant T-ALL Cell Survival and Pathogenesis,phs003623.v1.p1,Justin Benavidez,NCI DAC,,Grant Challen,Released
Pre-existing skin-resident CD8 and gd T cell circuits mediate immune response in Merkel cell carcinoma and predict immunotherapy efficacy,phs003629.v1.p1,Freddie Pruitt,NCI DAC,,Kenneth Tsai,Released
Elucidating mechanisms of the graft versus leukemia effect of hematopoietic stem cell transplant for acute myeloid leukemia,phs003630.v1.p1,Freddie Pruitt,NCI DAC,,Catherine Wu,Released
Whole exome sequencing and RNA sequencing of high grade serous ovarian cancer in black and white patients,phs003632.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Jennifer Doherty,Released
Genomic Analysis of Diffuse Large B Cell Lymphoma,phs003634.v1.p1,Freddie Pruitt,NCI DAC,,Anne Novak,Released
Long-read sequencing to identify inherited mutations predisposing to breast cancer,phs003638.v1.p1,Justin Benavidez,NCI DAC,,Mary-Claire King,Released
The somatic mutational landscape of thyroid cancer in patients with germline PTEN mutations,phs003640.v1.p1,Freddie Pruitt,NCI DAC,,Charis Eng,Released
Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification,phs003648.v1.p1,Claire Zhu,NCI DAC,,Hanlee Ji,Released
Methylation-based immune deconvolution in prostate cancer patients before and after radical prostatectomy,phs003660.v1.p1,Abid Al Reza,NCI DAC,,Peter Pinto,Released
Prostate Cancer Upgrading Reference Set,phs003670.v1.p1,Claire Zhu,NCI DAC,,Robin Leach,Released
Chromothripsis in small cell lung carcinoma associated with carcinoid transformation,phs003676.v1.p1,Freddie Pruitt,NCI DAC,,Charles Rudin,Released
EWS-WT1 fusion isoforms establish oncogenic programs and therapeutic vulnerabilities in Desmoplastic Small Round Cell Tumors,phs003682.v1.p1,Freddie Pruitt,NCI DAC,,Miguel Rivera,Released
Somatic mutations in individual skin cells,phs003683.v2.p1,Justin Benavidez,NCI DAC,,Alan Shain,Released
Genomic alterations and transcriptional phenotypes in circulating tumor DNA and matched metastatic tumor,phs003689.v1.p1,Kathleen Calzone,NCI DAC,,Anish Thomas,Released
Evolving cell states and oncogenic drivers during the progression of IDH-mutant gliomas,phs003697.v1.p1,Justin Benavidez,NCI DAC,,Bradley Bernstein,Released
"Botensilimab, an Fc-enhanced anti-CTLA-4 antibody, is effective against tumors poorly responsive to conventional immunotherapy",phs003704.v1.p1,Joseph Flores-Toro,NCI DAC,,Dhan Chand,Released
"Clinical outcomes and ctDNA correlates for CAPOX BETR: A phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma",phs003706.v1.p1,Nathaniel Boyd,NCI DAC,,Harshabad Singh,Released
A personalized neoantigen vaccine generates anti-tumor immunity in high-risk renal cell carcinoma,phs003710.v1.p1,Nathaniel Boyd,NCI DAC,,Catherine Wu,Released
Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics,phs003712.v1.p1,Abid Al Reza,NCI DAC,,Jack Shern,Released
Molecular Analysis of Alliance A031201 study,phs003717.v1.p1,Grace Mishkin,NCI DAC,,Matthew Milowsky,Released
Contextual and Health Behavior Effects on Epigenetic Aging Among Africans in the Family and Community Health Studies,phs003723.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Frederick Gibbons,Released
Epigenetic control of Topoisomerase 1 by macroH2A1.1,phs003729.v1.p1,Justin Benavidez,NCI DAC,,Philipp Oberdoerffer,Released
Single-cell analysis of the multiple myeloma microenvironment after g-secretase inhibition and CAR T-cell therapy,phs003741.v1.p1,Freddie Pruitt,NCI DAC,,David Coffey,Released
Whole exome sequencing of head and neck patients-derived tumor organoids and formalin fixed paraffin embedded tumor tissue,phs003755.v1.p1,Abid Al Reza,NCI DAC,,Senthil Muthuswamy,Released
A clone's genomic stability as a biomarker of its DNA-damage resilience,phs003762.v1.p1,Mariam Eljanne,NCI DAC,,Noemi Andor,Released
Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts (LEANORA),phs003770.v1.p1,Kathleen Calzone,NCI DAC,,Sandra Swain,Released
Identification of novel immunotherapy targets in myeloma,phs003772.v1.p1,Nathaniel Boyd,NCI DAC,,Brian Walker,Released
Rearrangements of viral and human genomes at human papillomavirus integration events and their allele-specific impacts on cancer genome regulation,phs003780.v1.p1,Freddie Pruitt,NCI DAC,,Marco Marra,Released
Mind Body Study: a sub-study on psychosocial factors and microbiomes of nurses in the Nurse�s Health Study II,phs003786.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Heather Eliassen,Released
Single-cell RNA-sequencing of tumor and immune cells from patients with Asymptomatic Waldenstrom's Macroglobulinemia,phs003787.v1.p1,Justin Benavidez,NCI DAC,,Irene Ghobrial,Released
Understanding determinants of racial disparities in lung cancer incidence,phs003789.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Melinda Aldrich,Released
Single-Cell Transcriptomic Analysis of Kaposi Sarcoma,phs003800.v1.p1,Freddie Pruitt,NCI DAC,,Lee Ratner,Released
CD4 T cell subsets in human metastatic melanoma,phs003816.v1.p1,Justin Benavidez,NCI DAC,,Mary Jo Turk,Released
Genomic alterations in normal breast tissues preceding breast cancer diagnosis,phs003822.v1.p1,Freddie Pruitt,NCI DAC,,Lajos Pusztai,Released
Evolutionary pressures shape undifferentiated pleomorphic sarcoma development and radiotherapy response,phs003830.v1.p1,Freddie Pruitt,NCI DAC,,Everett Moding,Released
"NRG-GY017: Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer",phs003833.v1.p1,Grace Mishkin,NCI DAC,,Jyoti Mayadev,Released
Addiction of primary cutaneous gamma-delta T-cell lymphomas to JAK-STAT signaling,phs003837.v1.p1,Justin Benavidez,NCI DAC,,Jaehyuk Choi,Released
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors,phs003845.v1.p1,Freddie Pruitt,NCI DAC,,Kanwal Raghav,Released
Uncovering Principles of Adaptive Regulation in Cancer Resistance Through Deep Evolutionary Profiling,phs003851.v1.p1,Mariam Eljanne,NCI DAC,,Arvind Ravi,Released
Spatial multi-omics of intratumoral humoral immunity niches associated with tertiary lymphoid structures in pancreatic cancer pathologic responders to immunotherapy.,phs003862.v1.p1,Freddie Pruitt,NCI DAC,,Lei Zheng,Released
"Multi-modal single-cell, spatial, and genomic analyses of human non-small cell lung cancer brain metastases",phs003865.v1.p1,Justin Benavidez,NCI DAC,,Benjamin Izar,Released
Metabolic Biomarkers in Thoracic Cancers,phs003880.v1.p1,Justin Benavidez,NCI DAC,,Ralph Deberardinis,Released
Developing targeted therapy for patients with Multiple Myeloma and Amp1q,phs003886.v1.p1,Justin Benavidez,NCI DAC,,Irene Ghobrial,Released
Cancer-restricted cryptic antigens are targets for T cell recognition,phs003887.v1.p1,Freddie Pruitt,NCI DAC,,William Freed-Pastor,Released
Evaluation of next-generation sequence compression strategies for cancer genomes,phs000427.v1.p1,Hora Salehziyabari,NCI DAC,,Stephen Sherry,Incomplete
Clinical Sequencing: Genome Sequencing of Craniopharyngiomas,phs000696.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Sandro Santagata,Incomplete
A Genome-Wide Association Study of Prostate Cancer in African Americans,,Emilie Charlisse Caga-Anan,,,Brian Henderson,Incomplete
Genome-Wide Association Study of Hematotoxicity Among Chinese Workers Exposed to Benzene,,Geoffrey Tobias,NCI DAC,,Nathaniel Rothman,Incomplete
Genetic Predictors of AML Treatment Response,,Emilie Charlisse Caga-Anan,NCI DAC,,Richard Aplenc,Incomplete
The Meningioma Consortium: Genome-Wide Association Study,,Emilie Charlisse Caga-Anan,,,Elizabeth Claus,Incomplete
Determinants of breast tissue composition in young women,,Emilie Charlisse Caga-Anan,,,Norman Boyd,Incomplete
Genome-wide Determinants of Prognosis and Treatment of Early-Onset Breast Cancer,,Emilie Charlisse Caga-Anan,,,Habibul Ahsan,Incomplete
Molecular and Genetic Analysis of Lung Cancer Survival,,Emilie Charlisse Caga-Anan,,,David Christiani,Incomplete
Cancer Susceptibility Alleles Using Genome-Wide Scan Data,,Emilie Charlisse Caga-Anan,,,Celeste Pearce,Incomplete
Longitudinal Whole Genome Sequencing of a Myeloma Case Study Patient,,Emilie Charlisse Caga-Anan,NCI DAC,,Alexander Stewart,Incomplete
Network Analysis Identifies Mitochondrial Regulation of Epidermal Differentiation by MPZL3 and FDXR,,Asur Srinath,,,Paul Khavari,Incomplete
Genetic Susceptibility to Obesity after Treatment for Childhood Leukemia,,Geoffrey Tobias,NCI DAC,,Lindsay Morton,Incomplete
Pre-cancer atlases of cutaneous and hematologic origin (PATCH Center),,Natalie Abrams,NCI DAC,,Peter Karl Sorger,Incomplete
Molecular mechanisms of SCLC initiation and detection in mice and humans,,Claire Zhu,,,Mark Krasnow,Incomplete
Inflammation Genes and Lung Cancer Risk,,Emilie Charlisse Caga-Anan,,,Margaret Spitz,Incomplete
Structural Variation in Neuroblastoma,,Emilie Charlisse Caga-Anan,,,Sharon Diskin,Incomplete
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study,,Emilie Charlisse Caga-Anan,,,Cornelia Ulrich,Incomplete
The Boston Lung Cancer Survival Cohort,,Emilie Charlisse Caga-Anan,,,David Christiani,Incomplete
Molecular pathoepidemiology of contralateral breast cancer,,Emilie Charlisse Caga-Anan,,,Kathleen Malone,Incomplete
Molecular Classification of High Grade Endometrial Cancers: Extending TCGA Findings to a Diverse Pop,,Emilie Charlisse Caga-Anan,,,Michele Cote,Incomplete
Genomic and Morphologic Predictor of High-Risk DCIS,,Emilie Charlisse Caga-Anan,,,Robert West,Incomplete
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes,,Emilie Charlisse Caga-Anan,,,Brock Christensen,Incomplete
Immune epigenetic biomarkers of survival in glioma epidemiology,,Emilie Charlisse Caga-Anan,NCI DAC,,John Wiencke,Incomplete
Comprehensive characterization of prostate stromal gene expression and association with lethal prostate cancer,,Emilie Charlisse Caga-Anan,,,Kathryn Penney,Incomplete
Research Into Visual Endpoints and RB Health Outcomes After Treatment: The RIVERBOAT Consortium,,Emilie Charlisse Caga-Anan,,,Debra Friedman,Incomplete
Molecular and clinical evaluation of the glioma patient experience to anticipate modern outcomes and guide patient care,,Emilie Charlisse Caga-Anan,,,Laila Poisson,Incomplete
WNY Center for Research on Flavored Tobacco Products (CRoFT),,Emilie Charlisse Caga-Anan,,,Richard O'Connor,Incomplete
Oral Microbiome and Lung Cancer Risk,,Emilie Charlisse Caga-Anan,,,Qiuyin Cai,Incomplete
Characterizing Molecular Subtypes of Ovarian Cancer in African-American Women,,Emilie Charlisse Caga-Anan,,,Jennifer Doherty,Incomplete
Genetic Risk Prediction of Breast Cancer for African Americans,,Emilie Charlisse Caga-Anan,,,Dezheng Huo,Incomplete
"Colorectal cancer risk loci: GWAS, fine-mapping, and functional analysis",,Emilie Charlisse Caga-Anan,,,Wei Zheng,Incomplete
Identifying causal variants and genes underlying breast cancer risk loci,,Emilie Charlisse Caga-Anan,,,Matthew Freedman,Incomplete
Epidemiology and biology of lncRNAs in ovarian cancer,,Emilie Charlisse Caga-Anan,,,Thomas Sellers,Incomplete
Genomic and Transcriptomic Analysis of Breast and Ovarian Cancers,,Emilie Charlisse Caga-Anan,,,Joellen Schildkraut,Incomplete
Functional Characterization of Glioma GWAS Variants,,Emilie Charlisse Caga-Anan,,,Rose Lai,Incomplete
Determinants of pancreatic cancer and malignant melanoma phenotypes in CDKN2A hereditary kindreds,,Emilie Charlisse Caga-Anan,,,Gloria Petersen,Incomplete
Understanding the interactions between germline and somatic alterations in the pathogenesis of gliomas,,Emilie Charlisse Caga-Anan,,,Robert Jenkins,Incomplete
Genomic Prediction of Doxorubicin-Induced Cardiotoxicity,,Emilie Charlisse Caga-Anan,,,Paul Burridge,Incomplete
Next Generation of HPV and Cervical Cancer Research in HIV+ Women,,Emilie Charlisse Caga-Anan,NCI DAC,,Howard Strickler,Incomplete
Mentoring and Research in Cancer Stem Cells,,Mariam Eljanne,,,William Matsui,Incomplete
The Role of Inflammation in the Racial Disparities in Ovarian Cancer Survival,,Mariam Eljanne,,,Lauren Peres,Incomplete
Single cell epigenomics in cancer immunity and immunotherapy,,Mariam Eljanne,,,Ansuman Satpathy,Incomplete
Noninvasive Risk Stratification of Prostate Cancer Using Cell-Free Nucleic Acids,,Mariam Eljanne,,,Wei Gu,Incomplete
The role of neutrophils in pancreatic cancer pre-metastatic and metastatic niche formation,,Mariam Eljanne,,,Samer Hanna,Incomplete
"Social Environmental Factors, DNA methylation, and breast cancer survival among African American women: a bio-socially integrated approach",,Mariam Eljanne,,,Jesse Plascak,Incomplete
Epigenomic and transcriptomic markers of aggressive prostate cancer among African American men,,Mariam Eljanne,,,Kathryn Barry,Incomplete
Role of ATM Germline Mutations in Clonal Hematopoiesis of Indeterminate Potential,,Mariam Eljanne,,,Thomas Slavin,Incomplete
TEST TEST,,Michael Feolo,,,,Incomplete
"A Phase I Single-Arm Study of the Combination of Durvalumab (MEDI4736) and Vicinium (oportuzumab monatox, VB4-845) in Subjects with High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated with BCG",,Kathleen Calzone,,,Piyush Agarwal,Incomplete
Care of the Urothelial Cancer Patient and Prospective Collection of Biospecimens from Healthy Volunteers and Urothelial Cancer Patients,,Kathleen Calzone,,,Piyush Agarwal,Incomplete
Vaccine and BCG for Bladder Cancer,,Kathleen Calzone,,,Piyush Agarwal,Incomplete
MB-100 + Abrx in PDA,,Kathleen Calzone,,,Christine Alewine,Incomplete
Bay/Bev Phase II,,Kathleen Calzone,,,Christina Annunziata,Incomplete
Phase I Trial of Dasatinib+Bev,,Kathleen Calzone,,,Christina Annunziata,Incomplete
Metformin in Li-Fraumeni,,Kathleen Calzone,,,Christina Annunziata,Incomplete
Tissue Acquisition and Genomics Analysis of Breast and Other Gynecologic Malignancies,,Kathleen Calzone,,,Christina Annunziata,Incomplete
"A Phase 1 Study of Intraperitoneal MCY-M11 Therapy for Women with Platinum Resistant High Grade Serous Adenocarcinoma of the Ovary, Primary Preitoneum, or Fallopian Tube, or Subjects with Peritoneal Mesothelioma with Recurrence After Prior Chemotherapy",,Kathleen Calzone,,,Christina Annunziata,Incomplete
"A Phase 1/2, Multicenter, Single-Arm, Open-Label, Dose-Escalation Study of Birinapant in Combination with Pembrolizumab (KEYTRUDA) with Relapsed or Refractory Solid Tumors",,Kathleen Calzone,,,Christina Annunziata,Incomplete
COXEN,,Kathleen Calzone,,,Andrea Apolo,Incomplete
Lenalidomide in solid tumors,,Kathleen Calzone,,,Andrea Apolo,Incomplete
Phase 2 cabazitaxel in UC,,Kathleen Calzone,,,Andrea Apolo,Incomplete
A Phase 1 Study of Cabozantinib plus Nivolumab (CaboNivo) Alone or in Combination with Ipilimumab (CaboNivoIpi) in Patients with Advanced/Metastatic Urothelial Carcinoma and other Genitourinary Tumors,,Kathleen Calzone,,,Andrea Apolo,Incomplete
XL184 in Urothelial Carcinoma,,Kathleen Calzone,,,Andrea Apolo,Incomplete
Ph 3 Adj Pembro in Bladder Ca,,Kathleen Calzone,,,Andrea Apolo,Incomplete
A Phase II Study of Olaparib in Patients with Metastatic/Advanced Urothelial Carcinoma with DNA-Repair Defects,,Kathleen Calzone,,,Andrea Apolo,Incomplete
Exploring Outcomes and Risk in Patients with Rare Central Nervous System Tumors,,Kathleen Calzone,,,Terri Armstrong,Incomplete
MSB0010718C in Merkel Cell Ca,,Kathleen Calzone,,,Isaac Brownell,Incomplete
Histopath of Merkel cell CA,,Kathleen Calzone,,,Isaac Brownell,Incomplete
Merkel Cell Specimens,,Kathleen Calzone,,,Isaac Brownell,Incomplete
Exploring the Genomic Landscape of Inducible Pluripotent Stem Cells from Racially Diverse Donors,,Kathleen Calzone,,,Jung Shin Byun,Incomplete
Lymphoma Profiling,,Kathleen Calzone,,,Katherine Calvo,Incomplete
COLL PERIPH BLOOD-URINE,,Kathleen Calzone,,,Kevin Camphausen,Incomplete
Longitudinal Sample Collection and Tracking for the Developmental Therapeutics Clinic,,Kathleen Calzone,,,Alice Chen,Incomplete
NCI MATCH,,Kathleen Calzone,,,Alice Chen,Incomplete
Ph II ABT-888 Cyclophosphamide,,Kathleen Calzone,,,Alice Chen,Incomplete
Ph I/II TRC102 Temozolomide,,Kathleen Calzone,,,Alice Chen,Incomplete
PhII Vorinostat ACC,,Kathleen Calzone,,,Alice Chen,Incomplete
PhII PF-03084014 Desmoids,,Kathleen Calzone,,,Alice Chen,Incomplete
PhII Cediranib Sunitinib/ASPS,,Kathleen Calzone,,,Alice Chen,Incomplete
Ph II AZD2171 in ASPS,,Kathleen Calzone,,,Alice Chen,Incomplete
Phase I Z-Endoxifen,,Kathleen Calzone,,,Alice Chen,Incomplete
Thyroid Hormone Nuclear Receptors in Health and Disease,,Kathleen Calzone,,,Sheue-Yann Cheng,Incomplete
Prostate Cancer Imaging,,Kathleen Calzone,,,Peter Choyke,Incomplete
18F-DCFPyL/18F NaF-PET-MetPCa,,Kathleen Calzone,NCI DAC,,Peter Choyke,Incomplete
MRI & Molecular signature,,Kathleen Calzone,,,Peter Choyke,Incomplete
"A Phase I Trial of Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy",,Kathleen Calzone,,,Deborah Citrin,Incomplete
SBRT for Recurrent Prostate CA,,Kathleen Calzone,,,Deborah Citrin,Incomplete
Ruxolitinib for ATL,,Kathleen Calzone,,,Kevin Conlon,Incomplete
Nivolumab for ATLL,,Kathleen Calzone,,,Kevin Conlon,Incomplete
Anakinra in Pustular Dermatoses,,Kathleen Calzone,,,Edward Cowen,Incomplete
ART-P for mCRPC,,Kathleen Calzone,,,William Dahut,Incomplete
Exceptional Responders,,Kathleen Calzone,,,William Dahut,Incomplete
Phase I/II XL184 in mCRPC,,Kathleen Calzone,,,William Dahut,Incomplete
AMG386 and abiraterone in CRPC,,Kathleen Calzone,,,William Dahut,Incomplete
Genome wide profiling of histone variants in tumors,,Kathleen Calzone,,,Yamini Dalal,Incomplete
HIGH RISK BRST DUCT EPITHELIUM,,Kathleen Calzone,,,David Danforth,Incomplete
Profiling of Gastric Tumors,,Kathleen Calzone,,,Jeremy Davis,Incomplete
Hereditary Gastric Cancer,,Kathleen Calzone,,,Jeremy Davis,Incomplete
ACC Natural History Study,,Kathleen Calzone,,,Jeremy Davis,Incomplete
Surg Onc Tissue Procurement,,Kathleen Calzone,,,Jeremy Davis,Incomplete
BRCA1 and BRCA2 Mutations and Triple Negative Disease in Hispanic/Latino Breast Cancer Subjects,,Kathleen Calzone,,,Michael Dean,Incomplete
Tissue Procurement Protocol - Doroshow,,Kathleen Calzone,,,James Doroshow,Incomplete
MDR Analysis on non-NCI Samples,,Kathleen Calzone,,,William Figg,Incomplete
Blood Prostate Cancer,,Kathleen Calzone,,,William Figg,Incomplete
Collection of Tissue Blocks or Slides from Patients with Cancer,,Kathleen Calzone,,,William Figg,Incomplete
DMET genotyping of cancer pts,,Kathleen Calzone,,,William Figg,Incomplete
Patient Samples - Figg,,Kathleen Calzone,,,William Figg,Incomplete
Molecular linkages between epigenetic regulation and metabolism in breast cancer,,Kathleen Calzone,,,Kevin Gardner,Incomplete
Mechanisms of Transcriptional Control by p300,,Kathleen Calzone,,,Kevin Gardner,Incomplete
Programming T Cell Fates for Therapeutic Use,,Kathleen Calzone,,,Luca Gattinoni,Incomplete
"Phase II Clinical Trial of Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial and Spinal Cord Ependymoma",,Kathleen Calzone,,,Mark Gilbert,Incomplete
Nivolumab Rare CNS Cancers,,Kathleen Calzone,,,Mark Gilbert,Incomplete
Natural History Banking,,Kathleen Calzone,,,Mark Gilbert,Incomplete
Lacosamide seizure prophylaxis,,Kathleen Calzone,,,Mark Gilbert,Incomplete
Ph II Recurrent Ependymoma,,Kathleen Calzone,,,Mark Gilbert,Incomplete
NOB Natural History Study,,Kathleen Calzone,,,Mark Gilbert,Incomplete
PH I/II Bev Vorinostat GBM,,Kathleen Calzone,,,Mark Gilbert,Incomplete
"A randomized, double blind phase II trial of Surgery, Radiation Therapy plus Temozolomide and Pembrolizumab with and without HSPPC-96 in newly diagnosed Glioblastoma (GBM)",,Kathleen Calzone,,,Mark Gilbert,Incomplete
"Phase 1 Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide or Irinotecan in Patients with Previously Treated, Incurable Ewing Sarcoma",,Kathleen Calzone,,,John Glod,Incomplete
PhII SGI110 in Peds & Adults,,Kathleen Calzone,,,John Glod,Incomplete
Ph2.5 Saracatinib in Osteosarcoma of Lung,,Kathleen Calzone,,,John Glod,Incomplete
PhI niraparib/temozolomide,,Kathleen Calzone,,,John Glod,Incomplete
A Multicenter Phase II Study of Enhancement of Immune Reconstitution and Vaccine Responses with Administration of Glyco-recombinant Human IL-7 in Older Subjects Following Chemotherapy,,Kathleen Calzone,,,Ronald Gress,Incomplete
Immune Checkpoint Inhibition,,Kathleen Calzone,,,Tim Greten,Incomplete
Pexa-Vec in Colorectal Cancer,,Kathleen Calzone,,,Tim Greten,Incomplete
Gene Expression Studies in HCC,,Kathleen Calzone,,,Tim Greten,Incomplete
AMP224 SBRT Met Colorectal Ca,,Kathleen Calzone,,,Tim Greten,Incomplete
Gut Microbiota in HCC,,Kathleen Calzone,,,Tim Greten,Incomplete
TRC105 in HCC,,Kathleen Calzone,,,Tim Greten,Incomplete
Acquisition of Blood and Tumor Tissue Samples from Patients with Gastrointestinal Cancer,,Kathleen Calzone,,,Tim Greten,Incomplete
"Belinostat, CDDP, VP-16 in SCLC",,Kathleen Calzone,,,Tim Greten,Incomplete
Sorafenib and TRC105 in HCC,,Kathleen Calzone,,,Tim Greten,Incomplete
"antiPDL1, antiCTLA4 & Radiation",,Kathleen Calzone,,,Tim Greten,Incomplete
CAPOX Pembrolizumab in BTC,,Kathleen Calzone,,,Tim Greten,Incomplete
MK-3475 MSI Tumors,,Kathleen Calzone,,,Tim Greten,Incomplete
A Natural History Study of Children and Adults with Fibrolamellar Hepatocellular Carcinoma,,Kathleen Calzone,,,Tim Greten,Incomplete
"Phase II Study of Nivolumab (anti-PD1), Tadalafil and Oral Vancomycin in Patients with Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer from Colorectal or Pancreatic Cancers",,Kathleen Calzone,,,Tim Greten,Incomplete
Phase I MGAH22,,Kathleen Calzone,,,Udayan Guha,Incomplete
Natural history of lung cancer,,Kathleen Calzone,,,Udayan Guha,Incomplete
Ph I/II Neoadj PIN Prostate CA,,Kathleen Calzone,,,James Gulley,Incomplete
Ph Ib Avelumab with NHS-IL12,,Kathleen Calzone,,,James Gulley,Incomplete
MSB0011359C in solid tumors,,Kathleen Calzone,,,James Gulley,Incomplete
Crolibulin & cisplatin in ATC,,Kathleen Calzone,,,James Gulley,Incomplete
Biospecimen Acquisition,,Kathleen Calzone,,,James Gulley,Incomplete
Avelumab in solid tumors,,Kathleen Calzone,,,James Gulley,Incomplete
Function of Steroid Receptors in Subcellular Compartments,,Kathleen Calzone,,,Gordon Hager,Incomplete
Chromatin Structure and Gene Expression,,Kathleen Calzone,,,Gordon Hager,Incomplete
"DNA repair, p53 and apoptosis in lung cancer",,Kathleen Calzone,,,Curtis Harris,Incomplete
Molecular characterization of Ulcerative Colitis and Crohn's disease,,Kathleen Calzone,,,Curtis Harris,Incomplete
A Phase 2 Single-arm Study to Evaluate Safety and Efficacy of CRS- 207 with Pembrolizumab in Adults with Previously-Treated Malignant Pleural Mesothelioma,,Kathleen Calzone,,,Raffit Hassan,Incomplete
LMB-100 in Mesothelioma,,Kathleen Calzone,,,Raffit Hassan,Incomplete
CRS-207 in mesothelioma pts,,Kathleen Calzone,,,Raffit Hassan,Incomplete
Phase 2 Amatuximab,,Kathleen Calzone,,,Raffit Hassan,Incomplete
Tissue Procurement Protocol - Hassan,,Kathleen Calzone,,,Raffit Hassan,Incomplete
Ph 2 Olaparib in Mesothelioma,,Kathleen Calzone,,,Raffit Hassan,Incomplete
"An open-label, first-in-human, multi-center study to evaluate the safety, tolerability, pharmacokinetics and anti-tumor activity of a thorium-227 labeled antibody-chelator conjugate, BAY 2287411/18795 Injection, in patients with solid tumor",,Kathleen Calzone,,,Raffit Hassan,Incomplete
Long term follow-up of mesothelioma patients and their family members with germline mutations in BAP1 and other genes,,Kathleen Calzone,,,Raffit Hassan,Incomplete
"Perioperative MVT-5873, a fully human monoclonal antibody against a CA 19-9 epitope, for operable CA 19-9 producing pancreatic cancers, cholangiocarcinomas, and metastatic colorectal cancers.",,Kathleen Calzone,,,Jonathan Hernandez,Incomplete
Hepatic Artery Infusion Pump,,Kathleen Calzone,,,Jonathan Hernandez,Incomplete
Tumor infiltrating lymphocyte therapy for human papillomavirus-positive cancers,,Kathleen Calzone,,,Christian Hinrichs,Incomplete
HPV-16 E6 TCR,,Kathleen Calzone,,,Christian Hinrichs,Incomplete
ETIB Tissue Procurement,,Kathleen Calzone,,,Christian Hinrichs,Incomplete
Role of IKK alpha in lung cancer development,,Kathleen Calzone,,,Yinling Hu,Incomplete
"DNA Methylation in Gray Zone Lymphoma compared to Hodgkin Lymphoma, Primary Mediastinal Large Cell Lymphoma and Diffuse Large B-Cell Lymphoma.",,Kathleen Calzone,,,Elaine Jaffe,Incomplete
Lymphoma Disease Discovery and Definition,,Kathleen Calzone,,,Elaine Jaffe,Incomplete
T Cells Expressing a Fully-human Anti- CD19 Chimeric Antigen Receptor for Treating B-cell Malignancies�,,Kathleen Calzone,NCI DAC,,James Kochenderfer,Incomplete
A Phase I Clinical Trial of T-cells Targeting B-cell Maturation Antigen for Previously Treated Multiple Myeloma�,,Kathleen Calzone,,,James Kochenderfer,Incomplete
Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation,,Kathleen Calzone,,,Jennifer Kanakry,Incomplete
BMT for Primary Immunodeficiency,,Kathleen Calzone,,,Jennifer Kanakry,Incomplete
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis,,Kathleen Calzone,,,Rosandra Kaplan,Incomplete
Tumor Microenvironment in Cancer Progression,,Kathleen Calzone,,,Rosandra Kaplan,Incomplete
PhI/II PLX3397,,Kathleen Calzone,,,Rosandra Kaplan,Incomplete
"Carfilzomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma: a Clinical and Correlative Study",,Kathleen Calzone,,,Dickran Kazandjian,Incomplete
A Phase II Pilot Study of Avelumab in Combination with Hypofractionated Radiotherapy in Patients with Relapsed Refractory Multiple Myeloma,,Kathleen Calzone,,,Dickran Kazandjian,Incomplete
HIV genetics in blood of babies in South Africa who were infected in utero,,Kathleen Calzone,,,Mary Kearney,Incomplete
Investigating HIV genetics and Expression in vivo,,Kathleen Calzone,,,Mary Kearney,Incomplete
HIV genetics in blood and tissues,,Kathleen Calzone,,,Mary Kearney,Incomplete
Niclosamide for ACC,,Kathleen Calzone,,,Electron Kebebew,Incomplete
CUDC-907 for Thyroid Cancer,,Kathleen Calzone,,,Electron Kebebew,Incomplete
PANCREATIC LESIONS IN VHL,,Kathleen Calzone,,,Electron Kebebew,Incomplete
Oncogenomics,,Kathleen Calzone,,,Javed Khan,Incomplete
Identification of Novel Mutations In Pediatric Cancers,,Kathleen Calzone,,,Javed Khan,Incomplete
Comprehensive genomic analysis of pediatric normal and tumor tissues,,Kathleen Calzone,,,Javed Khan,Incomplete
Non-medullary thyroid cancer,,Kathleen Calzone,,,Joanna Klubo-Gwiezdzinska,Incomplete
T Cells Expressing a Fully-human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-expressing Lymphomas,,Kathleen Calzone,,,James Kochenderfer,Incomplete
SLPI / PGRN in ovarian cancer,,Kathleen Calzone,,,Elise Kohn,Incomplete
Ovarian Cancer Proteomics,,Kathleen Calzone,,,Elise Kohn,Incomplete
Sequencing and Analysis of Human Skin Samples from Atopic Dermatitis Patients,,Kathleen Calzone,,,Heidi Kong,Incomplete
UVR/UVA Phototoxicity Testing,,Kathleen Calzone,,,Heidi Kong,Incomplete
Dermatology Biospecimens,,Kathleen Calzone,,,Heidi Kong,Incomplete
Treatment Effect on Microbiome,,Kathleen Calzone,,,Heidi Kong,Incomplete
DNA Repair in Human Cancer-Prone Genetic Diseases,,Kathleen Calzone,,,Kenneth Kraemer,Incomplete
Cancer In XP Heterozygotes,,Kathleen Calzone,,,Kenneth Kraemer,Incomplete
A Phase I study of Moxetumomab pasudotox (Lumoxiti�) and Rituximab (Rituxan�) for Relapsed Hairy Cell Leukemia,,Kathleen Calzone,,,Robert Kreitman,Incomplete
Development of Recombinant Toxins to Treat Hematologic Malignancies,,Kathleen Calzone,,,Robert Kreitman,Incomplete
Samples for HCL & toxin study,,Kathleen Calzone,,,Robert Kreitman,Incomplete
Long-Term Specimen Storage,,Kathleen Calzone,,,Jung-Min Lee,Incomplete
Phase I/II MEDI+O and MEDI+C,,Kathleen Calzone,,,Jung-Min Lee,Incomplete
LY Chk1/2 Inhibitor,,Kathleen Calzone,,,Jung-Min Lee,Incomplete
NRG-GY005 COCOS,,Kathleen Calzone,,,Jung-Min Lee,Incomplete
"BMN 673, PARPi after PARPi",,Kathleen Calzone,,,Jung-Min Lee,Incomplete
Cediranib & Olaparib combined,,Kathleen Calzone,,,Jung-Min Lee,Incomplete
Ph 1 PKPD 2281 and carboplatin,,Kathleen Calzone,,,Jung-Min Lee,Incomplete
Phase I AZD2281+carboplatin,,Kathleen Calzone,,,Jung-Min Lee,Incomplete
ETCTN 9825 Olaparib Cediranib,,Kathleen Calzone,,,Jung-Min Lee,Incomplete
"Phase IIB Study of Cediranib and Olaparib Combination in Women with Recurrent Platinum Resistant Epithelial Ovarian Cancer, Fallopian Tubal and/or Primary Peritoneal Cancer without Germline BRCA Mutation, who had Prior Bevacizumab",,Kathleen Calzone,,,Jung-Min Lee,Incomplete
BIRT HOGG-DUBE SYNDROME,,Kathleen Calzone,,,Jung-Min Lee,Incomplete
Inherited Urologic Cancer,,Kathleen Calzone,,,William Linehan,Incomplete
HLRCC,,Kathleen Calzone,,,William Linehan,Incomplete
VT-464 in prostate & breast ca,,Kathleen Calzone,,,Ravi Madan,Incomplete
Docetaxel & PROSTVAC in mCSPC,,Kathleen Calzone,,,Ravi Madan,Incomplete
Clinical Interventional Studies of HIV Reservoirs,,Kathleen Calzone,,,Frank Maldarelli,Incomplete
Oral cGVHD Natural History,,Kathleen Calzone,,,Jacqueline Mays,Incomplete
"Immunogenetics of HIV/AIDS, cancers and other diseases",,Kathleen Calzone,,,Daniel McVicar,Incomplete
Host genetic effects CMV LSOCA,,Kathleen Calzone,,,Daniel McVicar,Incomplete
Functional impact of long non-coding RNA expression on HIV control,,Kathleen Calzone,,,Daniel McVicar,Incomplete
Genetics of HLA/KIR and Dengue Fever,,Kathleen Calzone,,,Daniel McVicar,Incomplete
Pilot Study of Idiotype Vaccine and EPOCH-Rituximab Chemotherapy in Untreated Mantle Cell,,Kathleen Calzone,,,Christopher Melani,Incomplete
"Phase 1b Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma",,Kathleen Calzone,,,Christopher Melani,Incomplete
Assessment of Genomic Variation in Osteosarcoma,,Kathleen Calzone,,,Paul Meltzer,Incomplete
Genomic Variation in Osteosarcoma,,Kathleen Calzone,,,Paul Meltzer,Incomplete
A Phase 1 Study of Interleukin-15 in Combination with Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies,,Kathleen Calzone,,,Milos Miljkovic,Incomplete
Pilot Tral of Human IL-15 (rhIL-15) and obinutuzumab for refractory and relapsed chronic lymphocytic leukemia (CLL),,Kathleen Calzone,,,Milos Miljkovic,Incomplete
Relationship between DNA damage detection and signaling,,Kathleen Calzone,,,Andre Nussenzweig,Incomplete
DNA repair,,Kathleen Calzone,,,Andre Nussenzweig,Incomplete
Investigating the link between DNA damage (Commercial cell line),,Kathleen Calzone,,,Philipp Oberdoerffer,Incomplete
"Investigating the link between DNA damage, chromatin and nuclear dysfunction",,Kathleen Calzone,,,Philipp Oberdoerffer,Incomplete
Epigenetic regulation of alternative pre-mRNA splicing,,Kathleen Calzone,,,Shalini Oberdoerffer,Incomplete
LTFU Stem Cell Transplant,,Kathleen Calzone,,,Steven Pavletic,Incomplete
Palifermin dose escalation,,Kathleen Calzone,,,Steven Pavletic,Incomplete
Natural Hx of Chronic GVHD,,Kathleen Calzone,,,Steven Pavletic,Incomplete
"To identify susceptibility markers, genomic alterations, and mRNA and micro RNA expression profiles associated with pancreatic cancer development and progression",,Kathleen Calzone,,,Syed Perwez Hussain,Incomplete
Topical ruxolitinib in cGVHD,,Kathleen Calzone,,,Dominique Pichard,Incomplete
Prostate Ca Tissue Procurement,,Kathleen Calzone,,,Peter Pinto,Incomplete
Pilot Study of Avelumab in TET,,Kathleen Calzone,,,Arun Rajan,Incomplete
Ph 1 SNX-5422 + Everolimus,,Kathleen Calzone,,,Arun Rajan,Incomplete
PDX101 & chemo-thymoma/thymic,,Kathleen Calzone,,,Arun Rajan,Incomplete
A Phase I/II Hyperacute Lung,,Kathleen Calzone,,,Arun Rajan,Incomplete
Genotypes in lung cancer,,Kathleen Calzone,,,Arun Rajan,Incomplete
Pomalidomide doxorubicin in KS,,Kathleen Calzone,,,Ramya Ramaswami,Incomplete
"Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1",,Kathleen Calzone,,,Karlyne Reilly,Incomplete
iPSC derived T Cells,,Kathleen Calzone,,,Nicholas Restifo,Incomplete
Molecular alterations in inflammatory bowel disease associated intestinal tumorigenesis,,Kathleen Calzone,,,Thomas Ried,Incomplete
(1) Phenotypic and genomic characterization of newly established cell lines and corresponding primary tumors and (2) Tumor Heterogeneity in Response to Radiochemotherapy in Patients with Colorectal Cancer,,Kathleen Calzone,,,Thomas Ried,Incomplete
Genomic instability of recurring and non-recurring low-grade colorectal adneomas,,Kathleen Calzone,,,Thomas Ried,Incomplete
Detection of Genomic Aberrations in Breast Cancers with long-term follow-up using sequencing and Multiplex FISH,,Kathleen Calzone,,,Thomas Ried,Incomplete
gp120/gp140 comparative boost study,,Kathleen Calzone,,,Marjorie Guroff,Incomplete
Mucosal-Systemic Study,,Kathleen Calzone,,,Marjorie Guroff,Incomplete
A Phase 2 Study of Response-Adapted Therapy with Copanlisib and Rituxumab in Untreated Follicular Lymphoma,,Kathleen Calzone,,,Mark Roschewski,Incomplete
A Phase 1/2 Proof-of-Concept Study of the Combination of Acalabrutinib and Vistusertib in Subjects with Relapsed/Refractory B-cell Malignancies,,Kathleen Calzone,,,Mark Roschewski,Incomplete
Pembro in R/R GZL and DLBCL,,Kathleen Calzone,,,Mark Roschewski,Incomplete
Clonal evolution in FL,,Kathleen Calzone,,,Mark Roschewski,Incomplete
A Phase 1b/2 Trial of Hu5F9-G4 in Combination with Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma,,Kathleen Calzone,,,Mark Roschewski,Incomplete
Phase 2 Trial of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas,,Kathleen Calzone,,,Mark Roschewski,Incomplete
Natural History of MGUS/SMM,,Kathleen Calzone,,,Mark Roschewski,Incomplete
CRd in Newly Diagnosed MM,,Kathleen Calzone,,,Mark Roschewski,Incomplete
Revlimid maintenance for MM,,Kathleen Calzone,,,Mark Roschewski,Incomplete
Lymphoma Tissue,,Kathleen Calzone,,,Mark Roschewski,Incomplete
SHORT-COURSE THERAPY AIDS-NHL,,Kathleen Calzone,,,Mark Roschewski,Incomplete
DA-EPOCH-R in BL,,Kathleen Calzone,,,Mark Roschewski,Incomplete
A Phase 1/2 Proof-of-Concept Study of the Combination of ACP-196 and ACP-319 in Subjects with B-cell Malignancies,,Kathleen Calzone,,,Mark Roschewski,Incomplete
PRISM: A Platform Protocol for the Treatment of Relapsed/Refractory Agreessive non-Hodgkin's Lymphoma,,Kathleen Calzone,,,Mark Roschewski,Incomplete
Cell Harvest,,Kathleen Calzone,,,Mark Roschewski,Incomplete
A Phase 1B/II Single-arm Study of M7824 (MSB0011359C) in Combination with Gemcitabine in Adults with Previously Treated Advanced Adenocarcinoma of the Pancreas,,Kathleen Calzone,,,Mark Roschewski,Incomplete
A Phase II Study of Selumetinib (AZD6244) for the Treatment of Advanced Pancreas Cancer harboring KRAS G12R Mutations,,Kathleen Calzone,,,Udo Rudloff,Incomplete
A Phase I Study of Birinapant and Intensity Modulated Re-Irradiation Therapy (IMRRT) for Local-Regionally Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC),,Kathleen Calzone,,,Vassiliki Saloura,Incomplete
"A randomized Phase 2 Trial of Durvalumab (MEDI4736) With or without SBRT in Clinical Stage I, II, and IIIA Non-Small Cell Lung Cancer",,Kathleen Calzone,,,David Schrump,Incomplete
DECITABINE/DEPSIPEPTIDE,,Kathleen Calzone,,,David Schrump,Incomplete
Profiling Thoracic Cancers,,Kathleen Calzone,,,David Schrump,Incomplete
Moxetumomab pasudotox,,Kathleen Calzone,,,Nirali Shah,Incomplete
Genomic characterization and development of therapies for Rhabdomyosarcoma,,Kathleen Calzone,,,John Shern,Incomplete
Genomic dissection of tumor heterogeneity and progression,,Kathleen Calzone,,,John Shern,Incomplete
An Open-Label Phase 2 Study to Evaluate PT2977 for the Treatment of Von Hippel-Lindau Disease-Associated Renal cell Carcinoma,,Kathleen Calzone,,,Ramaprasad Srinivasan,Incomplete
Bev/Erlotinib in Papillary RCC,,Kathleen Calzone,,,Ramaprasad Srinivasan,Incomplete
PT2385-202,,Kathleen Calzone,,,Ramaprasad Srinivasan,Incomplete
Genome expression,,Kathleen Calzone,,,Louis Staudt,Incomplete
Gene Expression in NF1,,Kathleen Calzone,,,Douglas Stewart,Incomplete
Pleuropulmonary Blastoma,,Kathleen Calzone,,,Douglas Stewart,Incomplete
Are APOL 1 renal risk alleles associated with prematurity or low birth weight?,,Kathleen Calzone,,,Jeffrey Strathern,Incomplete
Genetics of Complex Disease,,Kathleen Calzone,,,Jeffrey Strathern,Incomplete
Identification of host germline and somatic variations contributing to the development of hepatocellular carcinoma (HCC} in Southern China,,Kathleen Calzone,,,Jeffrey Strathern,Incomplete
Phase II Trial of M7824 in Subjects with HPV Associated Malignancies,,Kathleen Calzone,,,Julius Strauss,Incomplete
A Randomized Phase II trial of Standard of Care Alone or in Combination with Ad-CEA vaccine and Avelumab in Patients with Previously Untreated Metastatic Colorectal Cancer,,Kathleen Calzone,,,Julius Strauss,Incomplete
Safety Run-In and Phase II Trial of M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers,,Kathleen Calzone,,,Anish Thomas,Incomplete
Ph1/2 PEN-866 Adv Solid Tumors,,Kathleen Calzone,,,Anish Thomas,Incomplete
Ph I MM-398 plus Veliparib,,Kathleen Calzone,,,Anish Thomas,Incomplete
Topotecan + VX-970 in SCLC,,Kathleen Calzone,,,Anish Thomas,Incomplete
CRLX101 in lung cancer,,Kathleen Calzone,,,Anish Thomas,Incomplete
"Murine Microbiome in relation to genotype, treatment, and vendor",,Kathleen Calzone,,,Giorgio Trinchieri,Incomplete
Microbiota of Crohn's disease,,Kathleen Calzone,,,Giorgio Trinchieri,Incomplete
Eovist® MRI of Prostate Cancer,,Kathleen Calzone,,,Ismail Turkbey,Incomplete
The Acquisition of Blood and Skin Samples from Patient Volunteers to Support Research Activities on Dermatologic and Other Diseases,,Kathleen Calzone,,,Mark Udey,Incomplete
Standard Care Dermatology,,Kathleen Calzone,,,Mark Udey,Incomplete
Pembrolizumab in HIV+ cancer,,Kathleen Calzone,,,Thomas Uldrick,Incomplete
Tocilizumab in KSHV-MCD,,Kathleen Calzone,,,Thomas Uldrick,Incomplete
Evolution of Prostate Cancer Genome - CTCs,,Kathleen Calzone,,,David Vanderweele,Incomplete
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine,,Kathleen Calzone,,,Thomas Waldmann,Incomplete
INVEST OF HUMAN IMMUNE RESPONSE,,Kathleen Calzone,,,Thomas Waldman,Incomplete
Biomarkers for Liver Cancer,,Kathleen Calzone,,,Xin Wang,Incomplete
Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy,,Kathleen Calzone,,,Kathy Warren,Incomplete
Phase 1 Panobinostat,,Kathleen Calzone,,,Kathy Warren,Incomplete
PBTC-029,,Kathleen Calzone,,,Kathy Warren,Incomplete
An Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy in Pediatric Patients with Central Nervous System Tumors,,Kathleen Calzone,,,Kathy Warren,Incomplete
Molecular Analysis of Medullary Thyroid Carcinoma Tissues,,Kathleen Calzone,,,Samuel Wells,Incomplete
"Phase II Trial of Vandetanuib (ZD6474, Caprelsa(R)) in Children and Adults with Wild-Type Gastrointestinal Stromal Tumors",,Kathleen Calzone,,,Brigitte Widemann,Incomplete
Ph II selumetinib in NF1 GIST,,Kathleen Calzone,,,Brigitte Widemann,Incomplete
Phase I/II Mithramycin,,Kathleen Calzone,,,Brigitte Widemann,Incomplete
Nat Hx of PNs in NF1,,Kathleen Calzone,,,Brigitte Widemann,Incomplete
Vandetanib in Hereditary MTC,,Kathleen Calzone,,,Brigitte Widemann,Incomplete
PhII Selumetinib Biopsy,,Kathleen Calzone,,,Brigitte Widemann,Incomplete
NF1 Natural History study,,Kathleen Calzone,,,Brigitte Widemann,Incomplete
NF1 Transformation Evaluation,,Kathleen Calzone,,,Brigitte Widemann,Incomplete
NatHx Endo Neoplasia MTC,,Kathleen Calzone,,,Brigitte Widemann,Incomplete
Selumetinib in NF1 and cNF,,Kathleen Calzone,,,Brigitte Widemann,Incomplete
SARC031,,Kathleen Calzone,,,Brigitte Widemann,Incomplete
Ph2 MPNST RAD001 - SARC016,,Kathleen Calzone,,,Brigitte Widemann,Incomplete
Phase 2 Btk Inhibitor in DLBCL,,Kathleen Calzone,,,Wyndham Wilson,Incomplete
Btk Inhibitor in DLBCL,,Kathleen Calzone,,,Wyndham Wilson,Incomplete
HU1D10 RITUXIMAB LYMPHOMA CLL,,Kathleen Calzone,,,Wyndham Wilson,Incomplete
UCN-01 for Relapsed T-cell Lym,,Kathleen Calzone,,,Wyndham Wilson,Incomplete
R-CHOP v EPOCH-R for Untx DLCL,,Kathleen Calzone,,,Wyndham Wilson,Incomplete
EPOCH-RC in recurrent lymphoma,,Kathleen Calzone,,,Wyndham Wilson,Incomplete
FLUDARABINE TREATMENT,,Kathleen Calzone,,,Wyndham Wilson,Incomplete
Randomized Phase II Study of Dose-Adjusted EPOCH-Rituximab-Bortezomib Induction Followed by Bortezomib Maintenance versus Observation in Untreated Mantle Cell Lymphoma with Microarray Profiling and Proteomics,,Kathleen Calzone,,,Wyndham Wilson,Incomplete
EPOCH-RIL for relapsed DLBCL,,Kathleen Calzone,,,Wyndham Wilson,Incomplete
Ruxolitinib for DLBCL and PTCL,,Kathleen Calzone,,,Wyndham Wilson,Incomplete
Ph I/II TMZ+TG02 astrocytoma,,Kathleen Calzone,,,Jing Wu,Incomplete
A Phase II trial evaluating Nivolumab in patients with recurrent IDH-mutant gliomas with and without hypermutator phenotype,,Kathleen Calzone,,,Jing Wu,Incomplete
Laboratory and Clinical studies on T-cells recognizing NSCLC,,Kathleen Calzone,,,James Yang,Incomplete
Genomic Sequencing,,Kathleen Calzone,,,Robert Yarchoan,Incomplete
Sequencing of HIV+ Lymphomas,,Kathleen Calzone,,,Robert Yarchoan,Incomplete
"Collection of Blood, Bone Marrow, Tumor, or Tissue Samples from Patients with HIV Infection, KSHV Infection, Viral-related Pre-malignant Lesions, and/or Cancer",,Kathleen Calzone,,,Robert Yarchoan,Incomplete
Pomalidomide in Kaposi sarcoma,,Kathleen Calzone,,,Robert Yarchoan,Incomplete
Castleman's Disease,,Kathleen Calzone,,,Robert Yarchoan,Incomplete
Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis,,Kathleen Calzone,,,Stuart Yuspa,Incomplete
Phase 2 Study of ONC201,,Kathleen Calzone,,,Alexandra Zimmer,Incomplete
TMZ in breast ca brain mets,,Kathleen Calzone,,,Alexandra Zimmer,Incomplete
Phase I/II study of T-DM1 alone versus T-DM1 and Metronomic Temozolomide in secondary prevention of HER2-positive breast cancer brain metastases following sterotactice radiosurgery,,Kathleen Calzone,,,Alexandra Zimmer,Incomplete
Natural History and Biospecimen Accrual Study for Children and Adults with Rare Solid Tumors,,Kathleen Calzone,,,Jaydira Del Rivero,Incomplete
Studying the biology of IDH-mutant gliomas via longitudinal observation of 2-hydroxyglutarate (2-HG) using MR spectroscopy,,Kathleen Calzone,,,Jing Wu,Incomplete
A Phase II Study of LMB-100 Followed by Pembrolizumab in the Treatment of Adults with Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC),,Kathleen Calzone,,,Azam Ghafoor,Incomplete
Clonal reconstruction and targeting of the correa sequence,,Natalie Abrams,NCI DAC,,Frank McKeon,Incomplete
Test test,,Michael Feolo,,,,Incomplete
testtest,,Michael Feolo,,,,Incomplete
Phase II Trial of Combination Immunotherapy in Biochemically Recurrent Prostate Cancer,,Kathleen Calzone,,,Ravi Madan,Incomplete
A Phase 1/1b Study of Enhancement of Immune Reconstitution and Vaccine Responses with Administration of Recombinant Human IL-7-hyFc (NT-I7) in Older Subjects Following Chemotherapy,,Kathleen Calzone,,,Ronald Gress,Incomplete
Phase I/II Study De-intensifying Exposure of Post-transplantation Cyclophosphamide as GVHD Prophylaxis after HLA-haploidentical Hematopoietic Cell Transplantation for Hematologic Malignancies,,Kathleen Calzone,,,Christopher Kanakry,Incomplete
A Phase II Multi-Institutional Trial to Evaluate Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer,,Kathleen Calzone,,,William Dahut,Incomplete
"A Phase II Study of Combined Treatment of Durvalumab, Bevacizumab and Transarterial Chemoembolization (TACE) in Subjects with Hepatocellular Carcinoma (HCC)",,Kathleen Calzone,,,Tim Greten,Incomplete
Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Peripheral T cell Lymphoma,,Kathleen Calzone,,,Jennifer Kanakry,Incomplete
Bicalutamide with or without metformin for biochemical recurrence in prostate cancer patients (BIMET-1),,Kathleen Calzone,,,Marijo Bilusic,Incomplete
"Fifteen years of immunological follow-up of women who received one, two, and three doses of the bivalent HPV vaccine in the CVT (Costa Rican HPV-16/18 vaccine trial): Generating durability data: The ESCUDDO-CVT study",,Kathleen Calzone,,,Aimee Kreimer,Incomplete
Interactive Diet and Activity Tracking in AARP (iDATA): Biomarker Based Validation Study of Internet-Based and Conventional Self-Report Instruments for Assessing Diet and Physical Activity within AARP,,Kathleen Calzone,,,Kevin Dodd,Incomplete
Premenopausal Hormone Concentrations in a Population of Women at Very Low Risk of Breast Cancer,,Kathleen Calzone,,,Robert Hoover,Incomplete
"PHASE II STUDY OF IPILIMUMAB, CABOZANTINIB, AND NIVOLUMAB IN RARE GENITOURINARY CANCERS (ICONIC)",,Kathleen Calzone,,,Andrea Apolo,Incomplete
Phase I/II Study of Lu-177-DOTATATE (Lutathera) in Combination with Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET),,Kathleen Calzone,,,Frank Lin,Incomplete
Evaluation of the Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors,,Kathleen Calzone,,,Naris Nilubol,Incomplete
A Phase I Clinical Trial of T cells expressing a novel fully-human anti-BCMA CAR for treating multiple myeloma,,Kathleen Calzone,NCI DAC,,James Kochenderfer,Incomplete
Biomarker Analysis of Central Nervous System Tumors,,Kathleen Calzone,,,Terri Armstrong,Incomplete
A Phase II Study of Neoadjuvant Androgen Deprivation Therapy Combined with Enzalutamide and Abiraterone Using Multiparametric MRI and 18F-DCFPyL-PET/CT in Newly Diagnosed Prostate Cancer,,Kathleen Calzone,,,William Dahut,Incomplete
A Phase 1/2 Single Arm Open-label Clinical Trial of TC-210 in Subjects with Advanced Mesothelin Expressing Cancer,,Kathleen Calzone,,,Raffit Hassan,Incomplete
Natural History of Maternal Neoplasia,,Kathleen Calzone,NCI DAC,,Christina Annunziata,Incomplete
"A Study of Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas with Secondary Involvement of the Central Nervous System (CNS)",,Kathleen Calzone,,,Mark Roschewski,Incomplete
A Phase 2 Study of Acalabrutinib with DA-EPOCH-R or R-CHOP for PAtients with Untreated Diffuse Large B-cell Lymphoma,,Kathleen Calzone,,,Mark Roschewski,Incomplete
Whole exome and transcriptome sequencing of SCLC tissue and cell free DNA samples to identify tumor heterogeneity,,Mariam Eljanne,,,Sameek Roychowdhury,Incomplete
test submission,,Emily Boja,,Yes,,Incomplete
Genetic Analysis of T-cell Differentiation,,Kathleen Calzone,,,Remy Bosselut,Incomplete
Immunological Landscape,,Kathleen Calzone,,,Christian Hinrichs,Incomplete
HSCT for VEXAS,,Kathleen Calzone,,,Dennis Hickstein,Incomplete
Biolen + Radiation,,Kathleen Calzone,,,Deborah Citrin,Incomplete
Ind Pt TCR-Transduced T-cells,,Kathleen Calzone,,,Steven Rosenberg,Incomplete
"A first-in-human phase I single-agent dose-escalation, food effect and dose expansion study of oral ONC206 in recurrent and rare primary central nervous system neoplasms",,Kathleen Calzone,,,Mark Gilbert,Incomplete
PROter,,Kathleen Calzone,,,Frank Lin,Incomplete
Targeted Rx in Advanced NETs,,Kathleen Calzone,,,Naris Nilubol,Incomplete
LAMPARA,,Kathleen Calzone,,,Jaydira Del Rivero,Incomplete
LOXO-292+Cabo or Vandetanib,,Kathleen Calzone,,,John Glod,Incomplete
Berzosertib + Topotecan SCLC,,Kathleen Calzone,,,Anish Thomas,Incomplete
Natural History ONB,,,,,Charalampos Floudas,Incomplete
"DAC-THU/Pembro: NSCLC, EsC, PM",,Kathleen Calzone,,,David Schrump,Incomplete
PCCT for BAP1 TPDS,,Kathleen Calzone,,,David Schrump,Incomplete
Apheresis Pts w/Immunodeficiency,,Kathleen Calzone,,,Dennis Hickstein,Incomplete
Alliance A021804,,Kathleen Calzone,,,Jaydira Del Rivero,Incomplete
ProAgio in solid malignancies,,Kathleen Calzone,,,Christine Alewine,Incomplete
ProAgio in solid malignancies,,Kathleen Calzone,,,Christine Alewine,Incomplete
IMMU132 + M6620,,Kathleen Calzone,,,Anish Thomas,Incomplete
CATCH Study,,Kathleen Calzone,,,Steven Pavletic,Incomplete
Allo Anti-CD19-CAR T cells,,Kathleen Calzone,,,James Kochenderfer,Incomplete
EDEN Study,,Kathleen Calzone,,,James Gulley,Incomplete
PLX038 and Rucaparib,,Kathleen Calzone,,,Anish Thomas,Incomplete
M7824 plus M9241 with SBRT,,Kathleen Calzone,,,Andrea Apolo,Incomplete
Phase 1 JNJ-63898081 Monotx,,Kathleen Calzone,,,James Gulley,Incomplete
PT-112 in TET,,Kathleen Calzone,,,Arun Rajan,Incomplete
BrEAsT Trial,,Kathleen Calzone,,,Fatima Karzai,Incomplete
IP and IV Paclitaxel for GC,,Kathleen Calzone,,,Jeremy Davis,Incomplete
M9241+HAIP,,Kathleen Calzone,,,Jonathan Hernandez,Incomplete
"PDL1 CAR-NK, plus N-803 & Pembro",,Kathleen Calzone,,,Jason Redman,Incomplete
Optimizing PTCy Dosing for Older or Unfit Patients,,Kathleen Calzone,,,Christopher Kanakry,Incomplete
Rare GU malignancies,,Kathleen Calzone,,,Andrea Apolo,Incomplete
ConQuEST,,Kathleen Calzone,,,James Gulley,Incomplete
RAdR for R/R TCM,,Kathleen Calzone,,,Milos Miljkovic,Incomplete
PII VR Primary Brain Tumors,,Kathleen Calzone,,,Terri Armstrong,Incomplete
GIST,,Kathleen Calzone,,,Andrew Blakely,Incomplete
PANTHERAS: Tazemetostat + Pembrolizumab in HNSCC,,Kathleen Calzone,,,Vassiliki Saloura,Incomplete
Neoadjuvant IO for HNSCC,,,,,Jason Redman,Incomplete
HCT for Heme Malig in HIV,,Kathleen Calzone,,,Jennifer Kanakry,Incomplete
Combo Immunotx in HPV Cancers,,Kathleen Calzone,,,Julius Strauss,Incomplete
Combo Immunotx in HPV Cancers,,Kathleen Calzone,,,Julius Strauss,Incomplete
CD19/CD22 CAR T-cell in Peds,,Kathleen Calzone,,,Nirali Shah,Incomplete
High Genetic Risk for CaP,,Kathleen Calzone,,,William Dahut,Incomplete
ViPOR-P in RR B-cell NHL,,Kathleen Calzone,,,Christopher Melani,Incomplete
Dabrafenib & Trametinib,,Kathleen Calzone,,,Robert Kreitman,Incomplete
RCT of CDH1 Surveillance,,Kathleen Calzone,,,Jeremy Davis,Incomplete
Lurbinectedin + berzosertib,,Kathleen Calzone,,,Anish Thomas,Incomplete
IL-15+Mogamulizumab,,Kathleen Calzone,,,Milos Miljkovic,Incomplete
VENOM in R/R B-Cell NHL,,Kathleen Calzone,,,Mark Roschewski,Incomplete
Abemaciclib in NF1-ANF,,Kathleen Calzone,,,Andrea Gross,Incomplete
Radium-223 in BRPC,,Kathleen Calzone,,,Ravi Madan,Incomplete
"M7824, M9241 and SBRT",,Kathleen Calzone,,,Udo Rudloff,Incomplete
Pembro and IL-2 in Melanoma and RCC,,Kathleen Calzone,,,Stephanie Goff,Incomplete
Anti-CD19 and anti-CD20 -CAR T cells,,Kathleen Calzone,,,James Kochenderfer,Incomplete
18F-DCFPyL in HCC,,Kathleen Calzone,,,Freddy Escorcia,Incomplete
Combo Immunotx in HPV OPSCC,,Kathleen Calzone,,,Charalampos Floudas,Incomplete
THREAD,,Kathleen Calzone,,,Christine Alewine,Incomplete
MRI + Genomics in Prostate AS,,Kathleen Calzone,,,Peter Pinto,Incomplete
Olaparib plus Durvalumab,,Kathleen Calzone,,,Anish Thomas,Incomplete
Natural History NENs,,Kathleen Calzone,,,Jaydira Del Rivero,Incomplete
BMS-986253 in MDS,,Kathleen Calzone,,,Steven Pavletic,Incomplete
QuICC Trial,,Kathleen Calzone,,,Julius Strauss,Incomplete
KSHV MCD,,Kathleen Calzone,,,Ramya Ramaswami,Incomplete
B and T immunity and COVID-19,,Kathleen Calzone,,,Robert Kreitman,Incomplete
BEST Trial,,Kathleen Calzone,,,Houssein Abdul Sater,Incomplete
Trametinib and HCQ in BTC,,Kathleen Calzone,,,Tim Greten,Incomplete
FHS computational analysis,,Kathleen Calzone,,,Alejandro Schaffer,Incomplete
Endocrine Tissue Analysis,,Kathleen Calzone,,,Naris Nilubol,Incomplete
Genomics in Prostate Cancer,,Kathleen Calzone,,,William Dahut,Incomplete
Copanlisib in BL,,Kathleen Calzone,,,Mark Roschewski,Incomplete
Taxol-Tasigna,,Kathleen Calzone,,,Andrew Blakely,Incomplete
COVID-19 NH study,,Kathleen Calzone,,,Fatima Karzai,Incomplete
Bintrafusp alpha in ONB,,Kathleen Calzone,,,Charalampos Floudas,Incomplete
test test 2,,Freddie Pruitt,NCI DAC,,Freddie Pruitt,Incomplete
Phase I/II Study De-identifying Exposure of Post-transplantation Cyclophosphamide as GVHD Prophylaxis after HLA-haploidentical Hematopoietic Cell Transplantation for Hematologic Malignancies,,Kathleen Calzone,,,Christopher Kanakry,Incomplete
Phase I of NT-17 (rhIL-7-hyFc) for the Treatment of Kaposi Sarcoma in Patients With or Without Infection with HIV,,Kathleen Calzone,,,Ramya Ramaswami,Incomplete
Natural History and Biospecimen Acquisition Protocol for Myelodysplastic Syndromes (MDS Natural History Protocol),,Kathleen Calzone,,,Kathy McGraw,Incomplete
A Dose-Escalation and Expansion Study of the Safety and Pharmacokinetics of XL092 as Single-Agent and Combination Therapy in Subjects with Inoperable Locally Advanced or Metastatic Solid Tumors,,Kathleen Calzone,,,Andrea Apolo,Incomplete
Imaging and Biopsy of HIV-Infected Individuals Undergoing Analytic Treatment Interruption,,Kathleen Calzone,,,Frank Maldarelli,Incomplete
Phase II Study of Olaparib in Subjects with Advanced Pancreatic Acinar Cell Carcinoma,,Kathleen Calzone,,,Christine Alewine,Incomplete
Phase I/II Trial to Determine the Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination with Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis after Reduced Intensity Conditioning and Peripheral Blood Ste,,Kathleen Calzone,,,Christopher Kanakry,Incomplete
"Phase 1/2 study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies",,Kathleen Calzone,,,Christopher Melani,Incomplete
"A Phase III, Multicenter, International Study with a Parallel, Randomized, Double-blind, Placebo-controlled, 2 Arm Design to Assess the Efficacy and Safety of Selumetinib in Adult Participants with NF1 who have Symptomatic, Inoperable Plexiform Neurofibro",,Kathleen Calzone,,,Geraldine O'Sullivan Coyne,Incomplete
Omics of Cancer: OncoGenomics,,Kathleen Calzone,,,Javed Khan,Incomplete
A Phase I/II Study of Sacituzumab Govitecan plus Berzosertib in Small Cell Lung Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors,,Kathleen Calzone,,,Anish Thomas,Incomplete
"A Phase I/II Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Bone Marrow Transplantation Followed by GVHD Prophylaxis with Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies in People Living with HIV (PLWH)",,Kathleen Calzone,,,Jennifer Kanakry,Incomplete
The Impact of Immune Checkpoint Inhibition on the Outcomes of Metastatic Urothelial Small Cell Carcinoma,,Kathleen Calzone,,,Andrea Apolo,Incomplete
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer,,Kathleen Calzone,,,Peter Choyke,Incomplete
A Phase 1 / 2 Single Arm Open-label Clinical Trial of Gavocabtagene Autoleucel (gavo-cel) in Patients with Advanced Mesothelin Expressing Cancer,,Kathleen Calzone,,,Raffit Hassan,Incomplete
Phase I/II Trial of HPV Vaccine PRGN-2009 Alone or in Combination with Anti-PD-L1/TGF-? trap (M7824) in Subjects with HPV Positive Cancers,,Kathleen Calzone,,,Charalampos Floudas,Incomplete
"Phase I/II Trial of the Combination of Bintrafusp Alfa (M7824), Entinostat and NHS-IL12 (M9241) in patients with advanced cancer (BEST Trial)",,Kathleen Calzone,,,Julius Strauss,Incomplete
Test Study NCI,,Grace Mishkin,,,,Incomplete
Learning features of optimal CAR T cells for LBCL from patient data,,Freddie Pruitt,,,Zinaida Good,Incomplete
AI-Powered Uncovering of Mechanisms in Cancer Through Causal Discovery Analysis and Generative Modeling of Heterogeneous Data,,Mariam Eljanne,NCI DAC,,Petar Stojanov,Incomplete
Longitudinal Profiling Reveals Intrinsic and Extrinsic Characteristics of Response to Tagraxofusp in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN),,Freddie Pruitt,,,,Incomplete
Field effect-informed urine liquid biopsy analysis for assessment of adjuvant BCG response in non-muscle invasive bladder cancer,,Freddie Pruitt,,,Maximilian Diehn,Incomplete
"Clonal hierarchy and immunophenotype of PTPN11 mutations in acute myeloid leukemia (CALGB-8461, CALGB-9665, and CALGB-20202)",,Grace Mishkin,NCI DAC,,John Byrd,Incomplete
Transcriptomic profiling of metastatic adrenocortical carcinoma (ACC) tumors,,Kathleen Calzone,,,Jaydira Del Rivero,Incomplete
Spatial transcriptomics analysis of pediatric rhabdomyosarcoma,,Kathleen Calzone,,Yes,Javed Khan,Incomplete
�Transdisciplinary Studies of Genetic Variation in Colorectal Cancer (CORECT),phs001051.v1.p1,Emilie Charlisse Caga-Anan,eNCI DAC,,Stephen Gruber,DELETED
Genome-wide Association Study of Neuroblastoma,phs000124.v3.p1,Emilie Charlisse Caga-Anan,NCI DAC,,John Maris,Completed by GPA
�TCGA - The Cancer Genome Atlas,phs000178.v12,Freddie Pruitt,NCI DAC,Yes,Eric Lander,Completed by GPA
Evolution of human BCR-ABL1 leukemia-initiating cells,phs000329.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Charles Mullighan,Completed by GPA
CIDR-GWAS of Breast Cancer in the African Diaspora,phs000383.v2,Emilie Charlisse Caga-Anan,NCI DAC,,Olufunmilayo Olopade,Completed by GPA
CIDR: Whole Exome Sequencing for Colorectal Cancer,phs000410.v2,Emilie Charlisse Caga-Anan,NCI DAC,,Ulrike Peters,Completed by GPA
Identification of recurrent NAB2-STAT6 gene fusions in hemangiopericytoma/solitary fibrous tumor by integrative sequencing,phs000567.v2,Claire Zhu,NCI DAC,,Arul Chinnaiyan,Completed by GPA
CIDR_Epidemiology of Breast Cancer Subtypes in African American Women,phs000669.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Christine Ambrosone,Completed by GPA
CSER: Exploring Precision Cancer Medicine for Sarcoma and Rare Cancers,phs000673.v6,Emilie Charlisse Caga-Anan,NCI DAC,,Arul Chinnaiyan,Completed by GPA
Exome Sequencing of Childhood Wilms Tumor,phs000780.v1.p1,Ludmila Pawlikowska,NIDDK,,James Amatruda,Completed by GPA
Genomic Sequencing of Ewing Sarcoma,phs000804.v2.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Todd Golub,Completed by GPA
Phase 1b Trial of RAD001 in Patients with Operable Non-Small Cell Lung Cancer (NSCLC); NCT00401778,phs000829.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Fadlo Khuri,Completed by GPA
African American Breast Cancer Consortium (AABC) Study,phs000851.v2,Emilie Charlisse Caga-Anan,NCI DAC,,Christopher Haiman,Completed by GPA
Genome-wide analysis of Noncoding Regulatory Mutations in Cancer,phs000854.v4,Freddie Pruitt,NCI DAC,,Eric Lander,Completed by GPA
CPTAC Proteogenomic Confirmatory Study,phs000892.v7.p1,Freddie Pruitt,NCI DAC,Yes,Christopher Kinsinger,Completed by GPA
Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability,phs000915.v3.p2,Emilie Charlisse Caga-Anan,NCI DAC,,Arul Chinnaiyan,Completed by GPA
Prospective Procurement of Solid Tumor Tissue to Identify Novel Therapeutic Targets,phs001003.v4,Kathleen Calzone,NCI DAC,,Steven Rosenberg,Completed by GPA
Whole Genome Sequencing of Newly Established Pancreatic Cancer Lines Identifies Novel Somatic Mutation (c.2587G>A) in Axon Guidance Receptor Plexin A1 as Enhancer of Proliferation and Invasion.,phs001042.v1.p1,Kathleen Calzone,NCI DAC,,Udo Rudloff,Completed by GPA
MYB-QKI rearrangements in Angiocentric Glioma drive tumorigenicity through a tripartite mechanism,phs001054.v2.p1,Freddie Pruitt,NCI DAC,,Keith Ligon,Completed by GPA
Kids First Pediatric Research Project on the Genomic Analysis of Congenital Diaphragmatic Hernia,phs001110.v4,Freddie Pruitt,Kids First DAC,Yes,Wendy Chung,Completed by GPA
Targeted Mutational Analysis of Enteropathy-Associated T-cell Lymphoma,phs001126.v1.p1,Kathleen Calzone,NCI DAC,,Elaine Jaffe,Completed by GPA
Kids First Pediatric Research Program in Congenital Heart Disease,phs001138.v5,Marcia Fournier,Kids First DAC,Yes,Christine Seidman,Completed by GPA
ALCHEMIST Study,phs001140.v2.p2,Freddie Pruitt,NCI DAC,Yes,David Kozono,Completed by GPA
NCI Exceptional Responders Initiative,phs001145.v2,Freddie Pruitt,NCI DAC,Yes,Susan Ivy,Completed by GPA
CRU-Ukrainian National Research Center for Radiation Medicine Trio Study,phs001163.v2,Geoffrey Tobias,NCI DAC,Yes,Stephen Chanock,Completed by GPA
�Clinical Trial Sequencing Project (CTSP),phs001175.v3.p2,Freddie Pruitt,NCI DAC,Yes,Jean Claude Zenklusen,Completed by GPA
CTSP Diffuse Large B-Cell Lymphoma (DLBCL) CALGB 50303,phs001184.v3.p2,Freddie Pruitt,NCI DAC,,Wyndham Wilson,Completed by GPA
"OncoArray: Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE)",phs001265.v2,Emilie Charlisse Caga-Anan,NCI DAC,,Peter Kraft,Completed by GPA
"The Prostate, Lung, Colon, Ovary Screening Trial (PLCO): Etiologic and Early Marker Study",phs001286.v4.p2,Geoffrey Tobias,NCI DAC,,Steven Moore,Completed by GPA
�Biospecimen Pre-analytical Variables (BPV),phs001304.v2,Grace Mishkin,NCI DAC,,Ping Guan,Completed by GPA
AACR Project Genomics Evidence Neoplasia Information Exchange (GENIE),phs001337.v2.p2,Freddie Pruitt,NCI DAC,Yes,Justin Guinney,Completed by GPA
Aberrant Oligoclonal Hematopoiesis in Remission AML and Relapse from Rare Cells Genomically Resembling Leukemic Blasts,phs001408.v1.p1,Ian Fingerman,NCI DAC,,Sami Malek,Completed by GPA
Kids First: Genomics of Orofacial Cleft Birth Defects in Latin American Families,phs001420.v2,Freddie Pruitt,Kids First DAC,Yes,Mary Marazita,Completed by GPA
Pediatric Preclinical Testing Consortium (PPTC),phs001437.v3,Freddie Pruitt,NCI DAC,Yes,John Maris,Completed by GPA
The Women's Interagency HIV Study (WIHS),phs001503.v2.p1,Jonathan Pollock,JAAMH,,Bradley Aouizerat,Completed by GPA
Next Generation Sequencing of Diffuse Intrinsic Pontine Glioma Samples,phs001526.v2.p1,Ian Fingerman,NCI DAC,,Charles Keller,Completed by GPA
Structural alterations driving castration-resistant prostate cancer revealed by linked-read genome sequencing,phs001577.v2,Ian Fingerman,NCI DAC,,Matthew Meyerson,Completed by GPA
Small cell carcinomas of the bladder and lung are characterized by a convergent but distinct pathogenesis,phs001613.v1.p1,Freddie Pruitt,NCI DAC,,Barry Taylor,Completed by GPA
Genetic Susceptibility and Biomarkers of Platinum-Related Toxicities,phs001621.v2,Emilie Charlisse Caga-Anan,NCI DAC,,Lois Travis,Completed by GPA
mRNA signature for stratification by cold ischemia time,phs001634.v2,Grace Mishkin,NCI DAC,,Fay Betsou,Completed by GPA
Preanalytical Impacts on Copy Number Variation Detection by aCGH Technology,phs001635.v2,Grace Mishkin,NCI DAC,,Habtom Ressom,Completed by GPA
Investigate the effect of the delay to fixation on the proteome and phosphoproteome,phs001636.v2,Grace Mishkin,NCI DAC,,Daniel Chelsky,Completed by GPA
Preanalytical Impacts on Global Metabolite Profiling,phs001637.v2,Grace Mishkin,NCI DAC,,Edward Karoly,Completed by GPA
Evaluation of frozen conditions on mRNA profiling by TaqMan assay,phs001638.v2,Grace Mishkin,NCI DAC,,Habtom Ressom,Completed by GPA
Preanalytic Impacts on Genomic Sequencing by NGS technology,phs001639.v2,Grace Mishkin,NCI DAC,,Wendell Jones,Completed by GPA
Investigate the effect of storage conditions of tumor specimens on the proteome and phosphoproteome profiling,phs001640.v2,Grace Mishkin,NCI DAC,,Daniel Chelsky,Completed by GPA
Genomic Characterization of Metastatic Castration Resistant Prostate Cancer,phs001648.v3.p1,Ian Fingerman,NCI DAC,Yes,Eric Small,Completed by GPA
Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine,phs001652.v1.p1,Freddie Pruitt,NCI DAC,,Brian Wolpin,Completed by GPA
NCI-Epidemiology of Burkitt Lymphoma in East African Children and Minors (EMBLEM),phs001705.v2.p1,Geoffrey Tobias,NCI DAC,,Sam Mbulaiteye,Completed by GPA
University of Pennsylvania CAR T cell Responding and Non-responding Patients,phs001707.v4,Freddie Pruitt,NCI DAC,,Carl June,Completed by GPA
Shared Genomic Segment Analysis and Tumor Subtyping in High-Risk BrCa Pedigrees,phs001708.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Nicola Camp,Completed by GPA
Pancreatic adenocarcinoma human organoids share structural and genetic features with primary tumors,phs001731.v1.p1,Ian Fingerman,NCI DAC,,Kevin Roggin,Completed by GPA
Linked-Read Sequencing to Resolve Complex Structural Variants,phs001773.v1.p1,Sharna Tingle,NHGRI,,Patrick Marks,Completed by GPA
Altered microRNA expression profiles in large offspring syndrome and Beckwith-Wiedemann syndrome,phs001794.v2,Freddie Pruitt,NCI DAC,,Jennifer Kalish,Completed by GPA
Cancers of Unknown Primary Project (CUPP),phs001801.v1.p1,Freddie Pruitt,NCI DAC,Yes,Jean Claude Zenklusen,Completed by GPA
Kids First: Whole Genome Sequencing of Nonsyndromic Craniosynostosis,phs001806.v2,Freddie Pruitt,Kids First DAC,Yes,Simeon Boyadjiev Boyd,Completed by GPA
The Institute for Genomic Medicine at Nationwide Children's Hospital Pediatric Cancer and Blood Disorder Project,phs001820.v4,Ian Fingerman,NCI DAC,,Peter White,Completed by GPA
Imaging Studies of Local Responses of Prostate Cancer to Radiation Therapy,phs001821.v1.p1,Kathleen Calzone,NCI DAC,,Deborah Citrin,Completed by GPA
Genome-wide cell-free DNA fragmentation in patients with cancer,phs001827.v1.p1,Freddie Pruitt,NCI DAC,,Victor Velculescu,Completed by GPA
Transdisciplinary Studies of Genetic Variation in Colorectal Cancer (CORECT): Axiom Colorectal Cancer,phs001856.v2,Emilie Charlisse Caga-Anan,NCI DAC,,Stephen Gruber,Completed by GPA
CALGB 40603: Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer,phs001863.v2,Grace Mishkin,NCI DAC,,William Sikov,Completed by GPA
Characterization of Genomic Profile of Breast Tumors In Hong Kong,phs001870.v2,Geoffrey Tobias,NCI DAC,,Xiaohong Yang,Completed by GPA
"Genome Sequencing of Large, Multigenerational CEPH/Utah Families",phs001872.v2,Barbara Thomas,NHGRI,,Deborah Neklason,Completed by GPA
CTSP Kidney Renal Clear Cell Carcinoma E2805T6,phs001893.v1.p2,Freddie Pruitt,NCI DAC,,Jean Claude Zenklusen,Completed by GPA
Clonally expanded T cells reveal immunogenicity of rhabdoid tumors,phs001915.v1.p1,Ian Fingerman,NCI DAC,,Joshua Waterfall,Completed by GPA
Early Onset Malignancies Initiative,phs001952.v1.p1,Freddie Pruitt,NCI DAC,Yes,Worta McCaskill-Stevens,Completed by GPA
International Cancer Proteogenome Consortium (ICPC): Proteogenomics of Early Stage Lung Adenocarcinoma in Taiwan,phs001954.v2,Sean Hanlon,NCI DAC,,Hsuan-Yu Chen,Completed by GPA
Genomic Profiling of Peripheral T-cell Lymphoma,phs001962.v2.p1,Ian Fingerman,NCI DAC,,Teresa Palomero,Completed by GPA
Diet and probiotics impact the microbiome and melanoma immunotherapy response,phs002026.v1.p1,Ian Fingerman,NCI DAC,,Jennifer Wargo,Completed by GPA
Integrative molecular characterization of genitourinary cancers,phs002065.v2,Freddie Pruitt,NCI DAC,,Eliezer Van Allen,Completed by GPA
CTSP Breast (PACT1T1),phs002100.v1.p2,Freddie Pruitt,NCI DAC,,Jean Claude Zenklusen,Completed by GPA
CTSP Breast (E5103),phs002101.v1.p2,Freddie Pruitt,NCI DAC,,Jean Claude Zenklusen,Completed by GPA
Kids First: Hear-'n-Seq Sequencing for Hearing,phs002115.v1.p1,Freddie Pruitt,Kids First DAC,Yes,Jun Shen,Completed by GPA
Analyzing cancer stem cells isolated from central nervous system tumors - Martuza Protocol #2005P001609,phs002117.v1.p1,Ian Fingerman,NCI DAC,,Bradley Bernstein,Completed by GPA
Dynamics of Tumor and Immune Responses During Immune Checkpoint Blockade in Non-Small Cell Lung Cancer,phs002131.v1.p1,Freddie Pruitt,NCI DAC,,Valsamo Anagnostou,Completed by GPA
Systematic Mapping and Prediction of Gene-Enhancer Connections,phs002134.v1.p1,Sharna Tingle,,,Jesse Engreitz,Completed by GPA
Evolution of New Regulatory Networks via Genetic Arms Races between KRAB Zinc Finger Proteins and Retrotransposons,phs002135.v1.p1,Sharna Tingle,,,Sofie Salama,Completed by GPA
Early noninvasive detection of response to targeted therapy in non-small cell lung cancer,phs002142.v1.p1,Freddie Pruitt,NCI DAC,,Victor Velculescu,Completed by GPA
Discovering New Targets for Chemoprevention in Familial Adenomatous Polyposis,phs002148.v1.p1,Claire Zhu,NCI DAC,,Eduardo Vilar-Sanchez,Completed by GPA
Integrated genomic profiling expands clinical options for cancer patients,phs002149.v1.p1,Ian Fingerman,NCI DAC,,Kevin White,Completed by GPA
Sequencing of sarcomatoid renal cell cancer,phs002150.v1.p1,Ian Fingerman,NCI DAC,,Kanishka Sircar,Completed by GPA
The Oral Microbiome for the Detection of Barrett's Esophagus,phs002154.v1.p1,Natalie Abrams,NCI DAC,,Julian Abrams,Completed by GPA
Kids First:Genomic Analysis of Esophageal Atresia and Tracheoesophageal Fistulas and Associated Congenital Anomalies,phs002161.v2,Freddie Pruitt,Kids First DAC,Yes,Wendy Chung,Completed by GPA
Kids First: Genetics of kidney and urinary tract malformations,phs002162.v3,Freddie Pruitt,Kids First DAC,Yes,Ali Gharavi,Completed by GPA
Scalable Engineered Membranes for the Production of Low-Cost Filter Devices for Single Cell Genomics,phs002167.v1.p1,Sharna Tingle,NHGRI,,Todd Gierahn,Completed by GPA
CIDR: Multiethnic GWAS of Cancer and related traits in the Multiethnic Cohort (MEC),phs002183.v2,Emilie Charlisse Caga-Anan,NCI DAC,,Loic Le Marchand,Completed by GPA
Gabriella Miller Kids First - Myeloid Malignancies in Children,phs002187.v2,Marcia Fournier,Kids First DAC,Yes,Soheil Meshinchi,Completed by GPA
Single Cell Genomic Analysis of Lymphoma,phs002188.v3,Freddie Pruitt,NCI DAC,,Ronald Levy,Completed by GPA
NCI MYCN amplified spinal cord ependymomas study,phs002209.v1.p1,Kathleen Calzone,NCI DAC,,Mark Gilbert,Completed by GPA
National Cancer Institute Familial Burkitt Lymphoma in Shirati (FBiS),phs002223.v1.p1,Geoffrey Tobias,NCI DAC,,Sam Mbulaiteye,Completed by GPA
Genetic analysis of Latin American Breast Cancer,phs002246.v1.p1,Geoffrey Tobias,NCI DAC,,Michael Dean,Completed by GPA
WES of HapMap cell lines and admixtures for assay validation,phs002248.v1.p1,Freddie Pruitt,NCI DAC,,Paul Williams,Completed by GPA
Characterization of high-grade serous ovarian cancer subtypes via single-cell profiling,phs002262.v3,Ian Fingerman,NCI DAC,,Casey Greene,Completed by GPA
Gabriella Miller Kids First Pediatric Research Program in Pediatric T-cell Acute Lymphoblastic Leukemia,phs002276.v3.p1,Marcia Fournier,Kids First DAC,Yes,David Teachey,Completed by GPA
New England Bladder Cancer Study (NEBCS),phs002318.v1.p1,Geoffrey Tobias,NCI DAC,,Stella Koutros,Completed by GPA
Single cell DNA sequencing reveals complex mechanisms of resistance to quizartinib,phs002320.v1.p1,Ian Fingerman,NCI DAC,,Catherine Smith,Completed by GPA
Identification of genetic risk factors for familial urinary bladder cancer (UBC): exome sequencing of three multiplex pedigrees and a group of unrelated familial UBC patients,phs002326.v1.p1,Geoffrey Tobias,NCI DAC,,Douglas Stewart,Completed by GPA
"Kids First & INCLUDE: Down Syndrome, Heart Defects, and Acute Lymphoblastic Leukemia",phs002330.v3,Valerie Cotton,Kids First DAC,Yes,Philip Lupo,Completed by GPA
Massively parallel single-cell RNA-sequencing of chronic rhinosinusitis nasal and sinus tissue,phs002333.v2,Reed Shabman,NIAID,,Joshua Boyce,Completed by GPA
Breast Cancer genetic study in African ancestry populations,phs002345.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,Yes,Wei Zheng,Completed by GPA
Impact of FFPE processing parameters on RNA in situ hybridization,phs002350.v1,Grace Mishkin,NCI DAC,,Emily Park,Completed by GPA
Preanalytical Impacts on Protein Detection by HumanMap assay,phs002351.v1,Grace Mishkin,NCI DAC,,Troy Tremaine,Completed by GPA
Preanalytical impacts on protein stability by IHC evaluation,phs002352.v1,Grace Mishkin,NCI DAC,,Scott Jewell,Completed by GPA
FFPE DEMOD,phs002353.v1,Grace Mishkin,NCI DAC,,Susan Hester,Completed by GPA
Genomic Architecture of LGL leukemia,phs002359.v1.p1,Ian Fingerman,NCI DAC,,Thomas Loughran,Completed by GPA
NHLBI TOPMed: Genomics of Myelodysplastic Syndromes (MDS),phs002360.v1.p1,Hiromi Ono,NHLBI,,Matthew Walter,Completed by GPA
Ghana Breast Health Study,phs002387.v2,Geoffrey Tobias,NCI DAC,,Jonine Figueroa,Completed by GPA
Count Me In - Esophageal and Stomach Cancer Project,phs002404.v1.p1,Freddie Pruitt,NCI DAC,Yes,Nikhil Wagle,Completed by GPA
The Role of CTCF in the Organization of the Centromeric 11p15 Imprinted Domain Interactome,phs002408.v2,Mariam Eljanne,NCI DAC,,Jennifer Kalish,Completed by GPA
Characterization of CNS Metastases,phs002416.v3,Freddie Pruitt,NCI DAC,,Priscilla Brastianos,Completed by GPA
LKB1/STK11 is a tumor suppressor in the leukemic transformation of myeloproliferative neoplasms,phs002418.v1.p1,Freddie Pruitt,NCI DAC,,Raajit Rampal,Completed by GPA
Whole exome sequencing study of melanoma-prone families in Mediterranean populations,phs002420.v1.p1,Geoffrey Tobias,NCI DAC,,Maria Teresa Landi,Completed by GPA
Cellular Maturity Shifts and Highly Recurrent Gene Expression Changes Underlying Relapse in Adult Acute Myelogenous Leukemia,phs002426.v1.p1,Freddie Pruitt,NCI DAC,,Sami Malek,Completed by GPA
Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age,phs002427.v1.p1,Natalie Abrams,NCI DAC,,Megan Hitchins,Completed by GPA
A Prospective Study of the Oral Microbiome and Pancreatic Cancer,phs002454.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Julie Palmer,Completed by GPA
Health Professional Follow-Up Study,phs002460.v2,Emilie Charlisse Caga-Anan,NCI DAC,,Lorelei Mucci,Completed by GPA
Massively Parallel Single-Cell RNA-Sequencing of Chronic Rhinosinusitis Polyp and Non-polyp Tissue,phs002466.v1.p1,Reed Shabman,NIAID,,Nora Barrett,Completed by GPA
Multiregional genetic evolution of metastatic uveal melanoma,phs002491.v1.p1,Freddie Pruitt,NCI DAC,,James Harbour,Completed by GPA
CIDR: Whole Exome Sequencing of Multiple Myeloma,phs002497.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Vijai Joseph,Completed by GPA
Childhood Cancer Data Initiative (CCDI): Integration of genomic and clinical data from unique rare hematopoietic caner datasets to facilitate data sharing (Funded to UCSF),phs002504.v3,Freddie Pruitt,NCI DAC,Yes,Elliot Stieglitz,Completed by GPA
Childhood Cancer Data Initiative (CCDI): Free the Data: Open Sharing of Comprehensive Genomic Childhood Cancer Datasets (Funded to Kansas),phs002529.v2,Freddie Pruitt,NCI DAC,Yes,Midhat Farooqi,Completed by GPA
"Childhood Cancer Data Initiative (CCDI): NCI P30 Cancer Center Support Grants to Enhance Data Sharing in Pediatric, Adolescent, and Young Adult Cancers (Funded to MSKCC)",phs002530.v1.p1,Freddie Pruitt,NCI DAC,Yes,Andrew Kung,Completed by GPA
NGS of archived tissue from men of African descent,phs002547.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Damali Martin,Completed by GPA
Parallel genomic alterations of antigen and payload targets mediate polyclonal acquired clinical resistance to the antibody drug conjugate sacituzumab govitecan,phs002555.v1.p1,Freddie Pruitt,NCI DAC,,Leif Ellisen,Completed by GPA
Kids First: Whole Genome Sequencing in Structural Defects of the Neural Tube,phs002591.v2,Marcia Fournier,Kids First DAC,Yes,Joseph Gleeson,Completed by GPA
Kids First: Valvar Pulmonary Stenosis,phs002593.v1.p1,Marcia Fournier,Kids First DAC,Yes,Kathryn Weaver,Completed by GPA
"Kids First: Genetic Spectrum of Vascular Anomalies, Overgrowth and Structural Birth Defects",phs002596.v1.p1,Marcia Fournier,Kids First DAC,Yes,Beth Drolet,Completed by GPA
Kids First: Whole genome sequencing studies of multiplex nonsyndromic cleft lip/palate families,phs002626.v1.p1,Marcia Fournier,Kids First DAC,Yes,Ariadne Letra,Completed by GPA
Kids First: Genetic Overlap Between Anomalies and Cancer in Kids in the Children�s Oncology Group: The COG GOBACK Study,phs002629.v1.p1,Marcia Fournier,Kids First DAC,Yes,Philip Lupo,Completed by GPA
Kids First: Genomic Analysis of Histiocytosis,phs002630.v1.p1,Marcia Fournier,Kids First DAC,Yes,Michael Scheurer,Completed by GPA
"Genomic, transcriptomic, and single-cell sequencing of pancreatic cancer",phs002712.v1.p1,Ian Fingerman,NCI DAC,,William Hahn,Completed by GPA
Pilot Study of Genetic Alterations and Clonal Evolution of Relapsed Refractory Adult ALL in Patients Receiving KTE-X19 CAR-T in ZUMA-3 (ZUMA3 sequencing),phs002721.v1.p1,Brandon Wright,NCI DAC,,Armin Ghobadi,Completed by GPA
Tennessee Colorectal Polyp Study,phs002730.v1.p1,Freddie Pruitt,NCI DAC,,Martha Shrubsole,Completed by GPA
Integrative genomic analysis reveals low T cell infiltration as the primary feature of tobacco use in HPV(+) oropharyngeal cancer,phs002768.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Jose Zevallos,Completed by GPA
Characterization of neoantigen-reactive T cells by Single-cell analysis,phs002792.v2,Kathleen Calzone,NCI DAC,,James Yang,Completed by GPA
The Discovery and Validation of AML Prognostic Biomarkers,phs002805.v1.p1,Freddie Pruitt,NCI DAC,,Derek Stirewalt,Completed by GPA
"Children's Cancer Data Initiative (CCDI): Cancer in Children, Adolescents, and Young Adults: Germline analyses and model systems.",phs002823.v1.p1,Freddie Pruitt,NCI DAC,Yes,Yidong Chen,Completed by GPA
KidsFirst - Childhood Cancer Data Initiative (CCDI) - Discovering the Timing and Origins of Bone and Soft Tissue Cancers,phs002827.v1.p1,Freddie Pruitt,NCI DAC,Yes,Adam Shlien,Completed by GPA
Pediatric MATCH,phs002883.v1.p1,Joseph Flores-Toro,NCI DAC,Yes,Nita Seibel,Completed by GPA
Proteogenomic characterization of human uterine cervical cancer,phs002916.v1.p1,Freddie Pruitt,NCI DAC,,Joo-Young Kim,Completed by GPA
Drivers of Cancer Therapy Resistance in Rapid Autopsy Cases,phs002923.v1.p1,Joseph Flores-Toro,NCI DAC,,Gad Getz,Completed by GPA
Whole transcriptome analysis of mucosal melanoma,phs002951.v1.p1,Freddie Pruitt,NCI DAC,,Kasey Couts,Completed by GPA
"MP2PRT Genomic and molecular characterization of biomarkers associated with self reported race/ethnicity in high risk endometrial cancers from NRG Oncology/GOG protocol 210, molecular staging of endometrial cancer",phs002965.v1.p1,Grace Mishkin,NCI DAC,,Casey Cosgrove,Completed by GPA
Biomarker Analysis of Lymphoma and Lymphoproliferative Diseases,phs002967.v1.p1,Kathleen Calzone,,,Elaine Jaffe,Completed by GPA
Defining the impact of mutant oncogene zygosity,phs002972.v1.p1,Ian Fingerman,NCI DAC,,Nikolaus Schultz,Completed by GPA
National Cancer Institute (NCI) Heavy-chain-only (FHVH33-CD8BBZ) CAR study for multiple myeloma,phs002987.v1.p1,Kathleen Calzone,NCI DAC,,James Kochenderfer,Completed by GPA
Multi-omics study of lung cancer in smokers from EAGLE,phs002992.v1.p1,Geoffrey Tobias,NCI DAC,,Maria Teresa Landi,Completed by GPA
Examination of genetic susceptibility in radiation-associated meningioma,phs002993.v1.p1,Geoffrey Tobias,NCI DAC,,Douglas Stewart,Completed by GPA
The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location,phs003007.v1.p1,Ying Huang,NCI DAC,,Mariella Filbin,Completed by GPA
Multi-omics of Bladder Cancers of Solid Organ Transplant Recipients,phs003012.v1.p1,Kathleen Calzone,NCI DAC,,Gabriel Starrett,Completed by GPA
Ivy Glioblastoma Atlas Project,phs003013.v1.p1,Freddie Pruitt,NCI DAC,,Ralph Puchalski,Completed by GPA
Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia,phs003015.v3,Grace Mishkin,NCI DAC,,Jacqueline Garcia,Completed by GPA
Characterization of PARP inhibitor-associated myeloid neoplasms,phs003034.v1.p1,Freddie Pruitt,NCI DAC,,Scott Kaufmann,Completed by GPA
Mayo Clinic Adult Diffuse Glioma Illumina Oncoarray SNP data,phs003041.v2,Emilie Charlisse Caga-Anan,NCI DAC,,Robert Jenkins,Completed by GPA
Distinct clonal identities of B-ALLs arising after Lenolidomide therapy for Multiple Myeloma,phs003069.v1.p1,Mariam Eljanne,NCI DAC,,Obi Griffith,Completed by GPA
"A Phase II Trial of the DNA Methyl Transferase Inhibitor, SGI-110 (Guadecitabine), in Children and Adults with Wild Type GIST, Pheochromocytoma and Paraganglioma Associated with Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer",phs003087.v1.p1,Kathleen Calzone,NCI DAC,,John Glod,Completed by GPA
MP2PRT: PI3K Pathway Activation and Its Associated Genomic Profile as Predictive Biomarkers of HPV-Related Oropharyngeal Cancer: Evaluation of NRG HN002 and RTOG 1016,phs003089.v1.p1,Grace Mishkin,NCI DAC,Yes,Christine Chung,Completed by GPA
MP2PRT: Discovering biomarkers of outcome: EBV DNA quantification and the relationship of EBV and LINE1 retrotransposon expression in pediatric patients with Nasopharyngeal Carcinoma (NPC) enrolled on ARAR0331,phs003092.v1.p1,Grace Mishkin,NCI DAC,,Robyn Gartrell,Completed by GPA
Genetic Alterations in patients with head and neck cancers,phs003098.v1.p1,Freddie Pruitt,NCI DAC,,Freddie Pruitt,Completed by GPA
Post Genome Wide Association Studies in TGCT WES,phs003107.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Katherine Nathanson,Completed by GPA
Germline Genomic Analyses of Breast Cancer in Latinas,phs003144.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Susan Neuhausen,Completed by GPA
TCGA WGS Variants Across 18 Cancer Types,phs003155.v2,Joseph Flores-Toro,NCI DAC,Yes,John Torcivia,Completed by GPA
Whole exome sequencing of biopsies of Kaposi sarcoma lesions,phs003157.v1.p1,Kathleen Calzone,NCI DAC,,Robert Yarchoan,Completed by GPA
Childhood Cancer Data Initiative (CCDI): PIVOT UT San Antonio,phs003160.v1.p1,Freddie Pruitt,NCI DAC,Yes,Subhashini Jagu,Completed by GPA
Childhood Cancer Data Initiative (CCDI): PIVOT MSKCC,phs003161.v1.p1,Freddie Pruitt,NCI DAC,Yes,Subhashini Jagu,Completed by GPA
Childhood Cancer Data Initiative (CCDI): PIVOT Children's Hospital of Chicago,phs003162.v1.p1,Freddie Pruitt,NCI DAC,Yes,Subhashini Jagu,Completed by GPA
NSD2 E1099K drives relapse in pediatric acute lymphoblastic leukemia by disrupting 3D chromatin organization,phs003195.v2,Freddie Pruitt,NCI DAC,,William Carroll,Completed by GPA
The Natural History of Lymph Node Metastases in Head and Neck Cancer,phs003211.v1.p1,Joseph Flores-Toro,NCI DAC,,Narayanan Gopalakrishna Iyer,Completed by GPA
Texas Pediatric Patient Derived Xenograft�,phs003215.v1.p1,Subhashini Jagu,NCI DAC,,Subhashini Jagu,Completed by GPA
Co-occurring Alterations in Multiple Tumor Suppressor Genes are Associated with Worse Outcomes in Patients with EGFR-mutant Lung Cancer,phs003232.v1.p1,Freddie Pruitt,NCI DAC,,Katerina Politi,Completed by GPA
"Correlative studies in Protocol #9204, which studied ipilimumab or nivolumab in hematologic malignancies after transplantation, including studies in collaboration with CIMAC-CIDC",phs003291.v1.p1,Freddie Pruitt,NCI DAC,Yes,Catherine Wu,Completed by GPA
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease,phs003293.v1.p1,Freddie Pruitt,NCI DAC,,Subhashini Jagu,Completed by GPA
A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer,phs003294.v1.p1,Freddie Pruitt,NCI DAC,Yes,Jonathan Schoenfeld,Completed by GPA
"Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial",phs003295.v1.p1,Freddie Pruitt,NCI DAC,Yes,Jonathan Schoenfeld,Completed by GPA
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013,phs003296.v1.p1,Freddie Pruitt,NCI DAC,Yes,Subhashini Jagu,Completed by GPA
Kids First Project on Congenital Clubfoot,phs003336.v1.p1,Marcia Fournier,Kids First DAC,Yes,Jonathan Rios,Completed by GPA
T Cells Expressing a Novel Fully-Human Anti-BCMA CAR for Treating Multiple Myeloma,phs003352.v1.p1,Abid Al Reza,NCI DAC,,James Kochenderfer,Completed by GPA
Evolution of Structural Rearrangements in Prostate Cancer Intracranial Metastases,phs003357.v1.p1,Freddie Pruitt,NCI DAC,,Himisha Beltran,Completed by GPA
Bulk ATAC and RNA sequencing of human breast cancer metastasis samples,phs003363.v1.p1,Freddie Pruitt,NCI DAC,,Hector Franco,Completed by GPA
A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy,phs003367.v1.p1,Ian Fingerman,NCI DAC,,Craig Jordan,Completed by GPA
"GU 16-257: Neoadjuvant gemcitabine, cisplatin, plus nivolumab in patients with muscle- invasive bladder cancer with selective bladder sparing: CIMACC-CIDC (Study 1)",phs003372.v1.p1,Freddie Pruitt,NCI DAC,Yes,Matthew Galsky,Completed by GPA
Subtyping of Small Cell Lung Cancer using plasma cell-free nucleosomes,phs003393.v1.p1,Abid Al Reza,NCI DAC,,Anish Thomas,Completed by GPA
A Phase 2 Study of MEDI4736(durvalumab) and Tremelimumab Alone or in Combination with High or Low-Dose Radiation in Metastatic Colorectal and NSCLC,phs003401.v1.p1,Grace Mishkin,NCI DAC,Yes,Jonathan Schoenfeld,Completed by GPA
scRNAseq of Human Urothelial Carcinoma,phs003405.v1.p1,Freddie Pruitt,NCI DAC,,William Kim,Completed by GPA
"A Randomized Phase 2 Study of Cabozantinib in Combination with Nivolumab in Advanced, Recurrent Metastatic Endometrial Cancer",phs003414.v1.p1,Freddie Pruitt,NCI DAC,,Stephanie Lheureux,Completed by GPA
Patient-Derived Models of Prostate Cancer for Personalized Medicine,phs003420.v1.p1,Ian Fingerman,NCI DAC,,Nora Navone,Completed by GPA
Extensive Convergent Evolution of BRCA2 Reversion Mutations Under Therapeutic Pressure by PARP Inhibition and Platinum Chemotherapy,phs003423.v1.p1,Freddie Pruitt,NCI DAC,,Alison Schram,Completed by GPA
Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Resected MMR-p Colorectal and Pancreatic Cancer,phs003425.v1.p1,Freddie Pruitt,NCI DAC,,Neeha Zaidi,Completed by GPA
Establishment of a Lifetime Cohort of Individuals Surviving Childhood Cancer,phs003434.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Melissa Hudson,Completed by GPA
Cancer Immune Monitoring and Analysis Centers - Cancer Immunologic Data Commons (CIMAC-CIDC) studies in DART (S1609): Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors,phs003443.v1.p1,Freddie Pruitt,NCI DAC,Yes,Michael Leblanc,Completed by GPA
"Correlative studies in Protocol E4412, which studied Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma, in collaboration with CIMAC-CIDC",phs003450.v1.p1,Freddie Pruitt,NCI DAC,Yes,Catherine Diefenbach,Completed by GPA
"Correlative studies for Protocol #14-C-0059, which studied anti-GD2-CAR T cells in GD2+ solid tumors, in collaboration with CIMAC-CIDC",phs003455.v2,Freddie Pruitt,NCI DAC,Yes,Rosandra Kaplan,Completed by GPA
Fiber-rich Foods to Treat Obesity and Prevent Colon Cancer,phs003465.v1.p1,Claire Zhu,NCI DAC,,Terryl Hartman,Completed by GPA
Impact of Chemotherapy on the Somatic Mutation Burden of Sperm and Other Tissues,phs003476.v1.p1,Freddie Pruitt,NCI DAC,,Jonathan Shoag,Completed by GPA
Environmental chemical body burden and prospective breast cancer risk in the cancer prevention study-3 cohort - CIDR,phs003494.v1.p1,Barbara Thomas,ES DAC,,Susan Neuhausen,Completed by GPA
Circulating tumor DNA analyses of breast cancer patients paired and over time,phs003500.v1.p1,Freddie Pruitt,NCI DAC,,Daniel Stover,Completed by GPA
Human Single-Cell Data,phs003508.v1.p1,Sharna Tingle,NHGRI,,Anupriya Agarwal,Completed by GPA
DNA methylation in prostate tumor and paired benign tissue for African and European ancestry men,phs003516.v1.p1,Freddie Pruitt,NCI DAC,,Brandon Pierce,Completed by GPA
Development and application of a scalable workflow for immunomagnetic separation of exRNA carrier subclasses and molecular analysis of their cargo.,phs003518.v1.p1,Justin Benavidez,NCI DAC,,Louise Laurent,Completed by GPA
"Correlative studies in Protocol BACCI, which studied Capecitabine, B",phs003526.v1.p1,Freddie Pruitt,NCI DAC,Yes,Andrew Nixon,Completed by GPA
"Correlative studies in Protocol NRG-LU004, which studied radiation and immunotherapy in lung cancer, in collaboration with CIMAC-CIDC",phs003528.v1.p1,Freddie Pruitt,NCI DAC,Yes,Steven Lin,Completed by GPA
"Dana-Farber/Harvard Cancer Center Experimental Therapeutics Trials Network Site (DF/HCC ETCTN Site) 9825, 9875, and 9984 Analyses",phs003534.v1.p1,Grace Mishkin,NCI DAC,,Geoffrey Shapiro,Completed by GPA
Dana-Farber/Harvard Cancer Center Experimental Therapeutics Trials Network Site (DF/HCC ETCTN Site) Trial 10057,phs003536.v1.p1,Freddie Pruitt,NCI DAC,Yes,Geoffrey Shapiro,Completed by GPA
Rapid Acceleration of Diagnostics - Underserved Populations (RADx-UP): Increasing COVID-19 vaccine uptake through a patient navigation intervention among underserved populations,phs003544.v1.p1,Shu Hui Chen,RADx,Yes,Hala Madanat,Completed by GPA
3D Genomic Mapping of Human Pancreatic Precancers,phs003549.v1.p1,Justin Benavidez,NCI DAC,,Laura Wood,Completed by GPA
The MD Anderson Cutaneous Melanoma Case Control Study,phs003555.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Chad Huff,Completed by GPA
Molecular characterization of Wilms tumor specimens,phs003559.v1.p1,Joseph Flores-Toro,NCI DAC,,Kenneth Chen,Completed by GPA
"Correlative studies in Protocol 18-279, which studies NeoVas, Montanide, nivolumab, and local ipilimunab in melanoma",phs003572.v1.p1,Freddie Pruitt,NCI DAC,Yes,Patrick Ott,Completed by GPA
Proteogenomic analysis of CALGB40601 (ALLIANCE) a neoadjuvant phase III HER2-positive breast cancer trial,phs003576.v1.p1,Grace Mishkin,NCI DAC,,Sumithra Mandrekar,Completed by GPA
"Sebaceous Neoplasm Tissue Study, 20190101",phs003580.v1.p1,Abid Al Reza,NCI DAC,,Gabriel Starrett,Completed by GPA
Correlative studies in NRG-GY021: Olaparib and tremelimumab in Ovarin cancer (CIMAC-CIDC),phs003583.v1.p1,Freddie Pruitt,NCI DAC,Yes,Sarah Adams,Completed by GPA
Correlative studies in Protocol #2017-0349: Nivolumab and Ipilimumab in AML/MDS post-allogenic transplantation (CIMAC-CDC),phs003585.v1.p1,Freddie Pruitt,NCI DAC,Yes,Gheath Al-Atrash,Completed by GPA
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial,phs003588.v1.p1,Abid Al Reza,NCI DAC,,Jung-Min Lee,Completed by GPA
ViPOR in Relapsed/Refractory B-Cell Lymphoma,phs003592.v1.p1,Abid Al Reza,NCI DAC,Yes,Christopher Melani,Completed by GPA
"Circulating, cell-free methylated DNA reveals cellular sources of allograft injury after liver transplant",phs003610.v1.p1,Freddie Pruitt,NCI DAC,,Anton Wellstein,Completed by GPA
Goblet Cell Adenocarcinoma Molecular Profiles,phs003611.v1.p1,Freddie Pruitt,NCI DAC,Yes,John Paul Shen,Completed by GPA
Defining intrinsic and acquired mechanisms of immune checkpoint blockade resistance in glioblastoma,phs003614.v1.p1,Freddie Pruitt,NCI DAC,,Gad Getz,Completed by GPA
Addition of atezolizumab to carboplatin significantly improves survival of patients with metastatic triple-negative breast cancer: TBCRC 043 phase 2 randomized clinical trial,phs003617.v1.p1,Freddie Pruitt,NCI DAC,,Jennifer Pietenpol,Completed by GPA
Whole Exome and mtDNA Genome Sequencing of Pediatric Chordomas,phs003622.v1.p1,Freddie Pruitt,NCI DAC,,Xiaowu Gai,Completed by GPA
Subtyping of Small Cell Lung Cancer using ChIP-seq of plasma cell-free nucleosomes and matched tumor transcriptomes,phs003628.v1.p1,Abid Al Reza,NCI DAC,,Anish Thomas,Completed by GPA
"Clonal Evolution of Patients with CLL following Ibrutinib, chlorambucil or watch and wait",phs003631.v1.p1,Freddie Pruitt,NCI DAC,,Gad Getz,Completed by GPA
APOLLO 4C: Proteogenomic analysis of breast cancer in younger (<40 yo) vs older patients (>=60 yo),phs003636.v1.p1,Sean Hanlon,NCI DAC,,Hai Hu,Completed by GPA
Collagen XVII promotes pancreatic cancer through regulation of PIK3R5,phs003641.v1.p1,Justin Benavidez,NCI DAC,,Andrew Liss,Completed by GPA
Characterization of the transcriptome for fibrolamellar,phs003643.v1.p1,Freddie Pruitt,NCI DAC,,Sanford Simon,Completed by GPA
Targeting SS18-SSX biology in sarcomerogenesis,phs003646.v1.p1,Justin Benavidez,NCI DAC,,Martin Hirst,Completed by GPA
Efficacy and immune effects of anakinra prophylaxis for neurologic toxicity and cytokine release syndrome in patients with lymphoma receiving axicabtagene ciloleucel,phs003655.v1.p1,Freddie Pruitt,NCI DAC,,Marcela Maus,Completed by GPA
Kids First: The genomic architecture of Hirschsprung Disease (HSCR),phs003662.v1.p1,Marcia Fournier,Kids First DAC,Yes,Aravinda Chakravarti,Completed by GPA
Characterizing the Risk of Chemotherapy Side Effects Based on Epigenetic Age and Modification by Resistance Training Intervention,phs003671.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Alexandra Binder,Completed by GPA
Multiomic analyses of neoadjuvant immunotherapy treated hepatocellular carcinoma,phs003672.v1.p1,Freddie Pruitt,NCI DAC,,Mark Yarchoan,Completed by GPA
Genomic and Immune Profiling of Breast Cancer Brain Metastases,phs003673.v1.p1,Freddie Pruitt,NCI DAC,,Carey Anders,Completed by GPA
Genomic mechanisms of resistance to tyrosine kinase inhibitors (TKIs) in HER2+ metastatic breast cancer (HER2+ MBC),phs003677.v1.p1,Freddie Pruitt,NCI DAC,,Gad Getz,Completed by GPA
MP2PRT: Evaluation of an inflammation polygenic risk score (iPRS) to predict cancer related cognitive impairment and fatigue in patients receiving chemotherapy for non-metastatic breast cancer in URCC0701 and URCC10055,phs003688.v1.p1,Grace Mishkin,NCI DAC,,Sarah Kerns,Completed by GPA
Single cell characterization of healthy and malignant hematopoiesis,phs003690.v1.p1,Joseph Flores-Toro,NCI DAC,,Ravindra Majeti,Completed by GPA
"Somatic mutations in 3,929 HPV-positive exfoliated cervical cell samples",phs003691.v1.p1,Geoffrey Tobias,NCI DAC,,Lisa Mirabello,Completed by GPA
Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection,phs003695.v1.p1,Freddie Pruitt,NCI DAC,,Craig Shriver,Completed by GPA
"Correlative studies in the OPTIMAL, trial (TOP17 05), which studied raivolumab, ipilimumab, and taxane in NSCLC, including studies in collaboration with CIMAC-CIDC",phs003698.v1.p1,Freddie Pruitt,NCI DAC,Yes,Jeffrey Clarke,Completed by GPA
MP2PRT-MNG: Identifying novel molecular markers of response to radiotherapy in meningiomas using samples from the RTOG-0539 (NCT00895622),phs003707.v2,Grace Mishkin,NCI DAC,,Kenneth Aldape,Completed by GPA
Mutation patterns predict drug response in acute myeloid leukemia,phs003715.v1.p1,Freddie Pruitt,NCI DAC,,Pamela Becker,Completed by GPA
CALGB 140202,phs003719.v1.p1,Grace Mishkin,NCI DAC,,Jason Merker,Completed by GPA
Peritoneal metastasis evolution,phs003722.v1.p1,Justin Benavidez,NCI DAC,,Kamila Naxerova,Completed by GPA
Multiomic profiling of adult acute myeloid leukemia patients,phs003728.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Ann-Kathrin Eisfeld,Completed by GPA
GENomics of CAncer DisparitiEs (GENCADE),phs003731.v1.p1,Justin Benavidez,NCI DAC,,Steven Patierno,Completed by GPA
CIDR: Elucidating Epigenetic Mechanisms of Racial/Ethnic Disparities in Pancreatic Cancer,phs003735.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Brian Huang,Completed by GPA
Single Cell RNA-sequencing of BCG na�ve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathway,phs003742.v1.p1,Joseph Flores-Toro,NCI DAC,,Vladimir Makarov,Completed by GPA
Identifying and Reducing Disparities in Patient-Reported Outcomes Among African American Prostate Cancer Survivors,phs003745.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Brian Gonzalez,Completed by GPA
Dynamic evolution of fibroblasts revealed by single cell RNA sequencing of human pancreatic cancer,phs003751.v1.p1,Freddie Pruitt,NCI DAC,,Andrew Liss,Completed by GPA
"Correlative studies for Protocol #ABTC-1603, which studied drugs aglatimagene besadenovec, temozolomide, nivolumab, and valacyclovir hydrchloride in newly diagnosed high-grade gliomas in collaboration with CIMAC-CIDC",phs003753.v1.p1,Freddie Pruitt,NCI DAC,Yes,Stuart Grossman,Completed by GPA
DirectHRD enables sensitive scar-based classification of homologous recombination deficiency (HRD),phs003760.v1.p1,Freddie Pruitt,NCI DAC,,Viktor Adalsteinsson,Completed by GPA
A matrix metalloproteinase biosensor-functionalized metastasis-on-a-chip platform for evaluating adrenocortical carcinoma progression,phs003764.v1.p1,Mousumi Ghosh,NCI DAC,,Priya Dedhia,Completed by GPA
Genomics studies of AML in patients older than 60 years of age (ECOG-ACRIN Cancer Research Group�s clinical trial e3999),phs003773.v1.p1,Freddie Pruitt,NCI DAC,Yes,Francine Garrett-Bakelman,Completed by GPA
Deidentified whole genome sequencing of matched tumor and normal from five pancreatic cancer patients,phs003775.v1.p1,Freddie Pruitt,NCI DAC,,Angelo De Marzo,Completed by GPA
A091401 Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Patients With Metastatic or Unresectable Sarcoma,phs003785.v1.p1,Grace Mishkin,NCI DAC,,Sandra D'Angelo,Completed by GPA
Mitigating Long-term Treatment-related Morbidity in Childhood Cancer Survivors,phs003792.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Smita Bhatia,Completed by GPA
Identifying Cell free DNA Methylation Signatures in Cerebrospinal Fluids for the Early Detection of Brain Metastasis in Non-Small Cell Lung Cancer,phs003794.v1.p1,Justin Benavidez,NCI DAC,,Hanlee Ji,Completed by GPA
A Phase II study: CRS207/GVAX plus anti-PD1 and anti-CTLA4 recruits mesothelin- and KRAS-specific T cells into PDAC,phs003798.v1.p1,Freddie Pruitt,NCI DAC,,Won Jin Ho,Completed by GPA
Randomized Phase II 2 x 2 Factorial Trial of the Addition of Carboplatin +/- Bevacizumab to Neoadjuvant Weekly Paclitaxel Followed by Dose-Dense AC in Hormone Receptor-Poor/HER2-Negative Resectable Breast Cancer: DNA Sequencing,phs003801.v1.p1,Grace Mishkin,NCI DAC,,William Sikov,Completed by GPA
Detection of tumors with microsatellite instability using minimal sequencing of cell-free DNA,phs003805.v1.p1,Freddie Pruitt,NCI DAC,,Gad Getz,Completed by GPA
"APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas",phs003812.v1.p1,Justin Benavidez,NCI DAC,,Helena Yu,Completed by GPA
RNA sequencing analysis of patient derived xenograft tissue PIM-084 treated with L-NMMA+alpelisib vs vehicle control,phs003814.v1.p1,Freddie Pruitt,NCI DAC,,Jenny Chang,Completed by GPA
Multiple Myeloma Genomic and Transcriptomic Studies,phs003817.v1.p1,Freddie Pruitt,NCI DAC,,Ravi Vij,Completed by GPA
CIDR: INTEGRAL Multiethnic Lung Cancer Study,phs003823.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Christopher Amos,Completed by GPA
"Depth of Response Correlates with Improved Outcomes for Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone",phs003827.v1.p1,Justin Benavidez,NCI DAC,,Irene Ghobrial,Completed by GPA
Droplet Hi-C for Fast and Scalable Profiling of Chromatin Architecture in Single Cells,phs003828.v1.p1,Sharna Tingle,NHGRI,,Bing Ren,Completed by GPA
"DO NOT USE ANYMORE! ""USC PE-GCS: Optimizing Engagement of Hispanic Colorectal Cancer Patients in Cancer Genomic Characterization Studies",phs003829.v1.p1,Freddie Pruitt,NCI DAC,Yes,Heinz Josef Lenz,Completed by GPA
TBK1 is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids,phs003840.v1.p1,Freddie Pruitt,NCI DAC,,Russell Jenkins,Completed by GPA
Feasibility of Circulating 5-hydroxymethylcytosine profiling in Osteosarcoma,phs003842.v1.p1,Freddie Pruitt,NCI DAC,,Mark Applebaum,Completed by GPA
Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer,phs003843.v1.p1,Freddie Pruitt,NCI DAC,,Ramaswamy Govindan,Completed by GPA
"Genomic landscape of multiple myeloma and of its precursor conditions, and its clinical implications",phs003846.v1.p1,Justin Benavidez,NCI DAC,,Irene Ghobrial,Completed by GPA
Functional Genomics and Tumor Microenvironment Analysis Reveal Prognostic Biological Subtypes in Mantle Cell Lymphoma,phs003849.v1.p1,Freddie Pruitt,NCI DAC,,Chengfeng Bi,Completed by GPA
Comprehensive proteogenomic landscape for natural history of prostate cancer,phs003852.v1.p1,Freddie Pruitt,NCI DAC,,Freddie Pruitt,Completed by GPA
Stanford Acute Myeloid Leukemia Single-Cell DNA Sequencing,phs003853.v1.p1,Joseph Flores-Toro,NCI DAC,,Ravindra Majeti,Completed by GPA
APOLLO5 - Applied Proteogenomics OrganizationaL Learning and Outcomes Network,phs003854.v1.p1,Sean Hanlon,NCI DAC,,Matthew Wilkerson,Completed by GPA
Single-cell RNA-sequencing of bone marrow and circulating tumor cells from patients with Multiple Myeloma and its precursor conditions,phs003855.v1.p1,Justin Benavidez,NCI DAC,,Irene Ghobrial,Completed by GPA
Li-Fraumeni Associated Pheochromocytoma,phs003861.v1.p1,Kathleen Calzone,NCI DAC,,Mark Raffeld,Completed by GPA
Symptom Clusters in Oncology Patients Receiving Chemotherapy,phs003863.v1.p1,Claire Zhu,NCI DAC,,Christine Miaskowski,Completed by GPA
Genomic Analysis of Relapsed/Refractory DLBCL,phs003868.v1.p1,Freddie Pruitt,NCI DAC,,Anne Novak,Completed by GPA
Fgl2 Regulates Fc?RIIB+ CD8+ T Cell Responses during Infection,phs003870.v1.p1,Reed Shabman,NIAID,,Mandy Ford,Completed by GPA
Single-cell Transcriptomic Characterization of Microscopic Colitis,phs003876.v1.p1,Freddie Pruitt,NCI DAC,,Alexandra-Chloe Villani,Completed by GPA
Spatial transcriptomics reveals segregation of tumor cell states in glioblastoma and marked immunosuppression within the perinecrotic niche,phs003877.v1.p1,Freddie Pruitt,NCI DAC,,Giselle Lopez,Completed by GPA
the study of somatic LINE1 activity in cancers,phs003888.v1.p1,Freddie Pruitt,NCI DAC,,Benjamin Greenbaum,Completed by GPA
Pursuing molecular biomarkers to guide adjuvent therapy for HPV+ head and neck cancers after transoral robotic surgery,phs003889.v1.p1,Freddie Pruitt,NCI DAC,,Devraj Basu,Completed by GPA
A single cohort study collecting interval timed incisional epidermal and dermal tissue samples during surgical procedures to profile temporal response of tissue after noxious stimuli,phs003890.v1.p1,Igor Panyutin,NCI DAC,,Andrew Mannes,Completed by GPA
Multiomic Landscape of Multiple Myeloma Precursor and Relapsed Disease,phs003892.v1.p1,Nathaniel Boyd,NCI DAC,,Ariosto Silva,Completed by GPA
Kids First: Genomics of Isolated Cleft Lip,phs003893.v1.p1,Marcia Fournier,Kids First DAC,Yes,Mary Marazita,Completed by GPA
Response? to Tagraxofusp in Blastic Plasmacytoid Dendritic Cell Neoplasm,phs003895.v1.p1,Freddie Pruitt,NCI DAC,,Naveen Pemmaraju,Completed by GPA
SMARCB1 missense mutants destabilize SWI/SNF complex stability and remodeling activity,phs003896.v1.p1,Justin Benavidez,NCI DAC,,Andrew Hong,Completed by GPA
Oncogenome of Kaposi sarcoma,phs003897.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Ethel Cesarman,Completed by GPA
Human Cancer-Targeted Immunity via Transgenic Hematopoietic Stem Cell Progeny,phs003898.v1.p1,Freddie Pruitt,NCI DAC,,Antoni Ribas,Completed by GPA
Diverse mechanisms of therapy resistance in relapsed childhood B-cell acute lymphoblastic leukemia (B-ALL): a report from the Children�s Oncology Group,phs003903.v1.p1,Joseph Flores-Toro,NCI DAC,,Xiaotu Ma,Completed by GPA
Uncovering genomic complexity of PAX5 internal tandem duplication using long-read and short-read sequencing,phs003904.v1.p1,Joseph Flores-Toro,NCI DAC,,Xiaotu Ma,Completed by GPA
Targeting EGFR in NF1 Mutant Melanoma,phs003906.v1.p1,Justin Benavidez,NCI DAC,,Markus Schober,Completed by GPA
Multiple myeloma clinical targeted sequencing of patient samples,phs003908.v1.p1,Freddie Pruitt,NCI DAC,,Brian Walker,Completed by GPA
ABTC-1603 (NCT03576612): Phase I Study of Neoadjuvant GMCI Plus Immune Checkpoint Inhibitor Combined with Standard of Care for Newly Diagnosed High-Grade Gliomas,phs003909.v1.p1,Freddie Pruitt,NCI DAC,,Patrick Wen,Completed by GPA
"LuTK02 (NCT04495153), CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC Patients",phs003910.v1.p1,Freddie Pruitt,NCI DAC,,Daniel Sterman,Completed by GPA
10221 (NCT04317105): A Phase I/II Biomarker Driven Combination Trial of Copanlisib and Immune Checkpoint Inhibitors in Patients with Advanced Solid Tumors,phs003911.v1.p1,Freddie Pruitt,NCI DAC,,Timothy Yap,Completed by GPA
Correlative study in Protocol NRG-G1002: A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer (CIMACC-CIDC),phs003912.v1.p1,Freddie Pruitt,NCI DAC,Yes,Thomas George,Completed by GPA
Genomic Profiling of Rare Tumors,phs003916.v1.p1,Freddie Pruitt,NCI DAC,,Andrew Futreal,Completed by GPA
A phase 1b study of Neoantigen Vaccine in combination with nivolumab and locally administered ipilimumab in patients with melanoma,phs003919.v1.p1,Freddie Pruitt,NCI DAC,,Patrick Ott,Completed by GPA
The formation and propagation of human Robertsonian chromosomes,phs003920.v1.p1,Justin Benavidez,NCI DAC,,Jennifer Gerton,Completed by GPA
Non-invasive characterization of human soft tissue sarcoma response to radiation therapy,phs003921.v1.p1,Mariam Eljanne,NCI DAC,,Everett Moding,Completed by GPA
Atezolizumab plus personalized neoantigen vaccination in patients with urothelial cancer: a phase 1 trial,phs003922.v1.p1,Freddie Pruitt,NCI DAC,,Matthew Galsky,Completed by GPA
Fractional Resistance to CDK4/6 Inhibition in ER+ Breast Cancer,phs003923.v1.p1,Freddie Pruitt,NCI DAC,,Philip Spanheimer,Completed by GPA
Genomic Characterization of HPV+ and HPV- Oropharyngeal Tumors,phs003925.v1.p1,Grace Mishkin,NCI DAC,,Cherie-Ann Nathan,Completed by GPA
Germline Sequence Variation in Cancer Genes among Rwandan Breast and Prostate Cancer Cases,phs003927.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Timothy Rebbeck,Completed by GPA
"GU 16-257: Neoadjuvant gemcitabine, cisplatin, plus nivolumab in patients with muscle- invasive bladder cancer with selective bladder sparing: CIMACC-CIDC (Study 2)",phs003928.v1.p1,Freddie Pruitt,NCI DAC,Yes,Matthew Galsky,Completed by GPA
"GU 16-257: Neoadjuvant gemcitabine, cisplatin, plus nivolumab in patients with muscle- invasive bladder cancer with selective bladder sparing: CIMACC-CIDC (Study 3)",phs003934.v1.p1,Freddie Pruitt,NCI DAC,Yes,Matthew Galsky,Completed by GPA
Studying Glioblastoma in a Human Organoid Tumor Transplantation Model,phs003936.v1.p1,Freddie Pruitt,NCI DAC,,Aparna Bhaduri,Completed by GPA
Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study,phs003945.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Jonine Bernstein,Completed by GPA
Integrating circulating tumor DNA analysis and radiomics for dynamic risk assessment in localized lung cancer,phs003947.v1.p1,Nathaniel Boyd,NCI DAC,,Maximilian Diehn,Completed by GPA
CIDR: Understanding the Increased Risk of Childhood Acute Lymphoblastic Leukemia in Latinos,phs003953.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Adam De Smith,Completed by GPA
Transcriptomic profiling of lung adenocarcinoma from never-smokers,phs003955.v1.p1,Geoffrey Tobias,NCI DAC,,Maria Landi,Completed by GPA
"A Phase 2 Study of M6620 (VX-970, berzosertib) in Combination with Carboplatin compared with Docetaxel in Combination with Carboplatin in Metastatic Castration-Resistant Prostate Cancer (10191)",phs003956.v1.p1,Grace Mishkin,NCI DAC,,Atish Choudhury,Completed by GPA
Spatially-resolved single-cell transcriptome landscape of response and resistance to CDK4/6 inhibitors in patients with hormone receptor-positive metastatic breast cancer,phs003957.v1.p1,Freddie Pruitt,NCI DAC,,Gad Getz,Completed by GPA
Epigenomics of Neurocognitive Function in Breast Cancer,phs003959.v1.p1,Claire Zhu,NCI DAC,,Yvette Conley,Completed by GPA
Genetics of Prostate Cancer Survival in the African American Population - CIDR,phs003960.v1.p1,Barbara Thomas,NCI DAC,,Robert Klein,Completed by GPA
P4HA1 mediates hypoxia-induced invasion in human pancreatic cancer organoids,phs003961.v1.p1,Joseph Flores-Toro,NCI DAC,,Michael Goggins,Completed by GPA
Somatic Mutations and Their Etiological Determinants for Breast Cancer in African American Women (B-CAUSE Study),phs003962.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Song Yao,Completed by GPA
NIH Childhood Cancer Study Collection for NCI Office of Data Sharing Data Jamboree,phs003964.v1.p1,Joseph Flores-Toro,NCI DAC,,Joseph Flores-Toro,Completed by GPA
Sequencing of 3D organoids derived from colorectal cancer patients,phs003965.v1.p1,Justin Benavidez,NCI DAC,,Anil Rustgi,Completed by GPA
Whole-exome sequencing of acute myeloid leukemia,phs003966.v1.p1,Joseph Flores-Toro,NCI DAC,,Elizabeth Sierra,Completed by GPA
NCI's collection of studies for general cancer research,phs003967.v1.p1,Freddie Pruitt,NCI DAC,,Freddie Pruitt,Completed by GPA
A Therapeutic Vaccine for Fibrolamellar Hepatocellular Carcinoma,phs003970.v1.p1,Freddie Pruitt,NCI DAC,,Jeremy Crawford,Completed by GPA
MagMAX mirVana Validation for RNA-Sequencing,phs003972.v1.p1,Justin Benavidez,NCI DAC,,Louise Laurent,Completed by GPA
Cell-free DNA Methylation Profiling for Lung Cancer Detection,phs003973.v1.p1,Freddie Pruitt,NCI DAC,,Maximilian Diehn,Completed by GPA
CIDR: Identifying High Penetrance Variants in African-American Families with Lung Cancer,phs003974.v1.p1,Barbara Thomas,NCI DAC,,Christopher Amos,Completed by GPA
Childhood Cancer Data Initiative (CCDI): Metastatic Osteosarcoma Spatial Profiling,phs003975.v1.p1,Abid Al Reza,NCI DAC,Yes,Troy McEachron,Completed by GPA
A perioperative study of Safusidenib in Patients with IDH1-mutated glioma,phs003976.v1.p1,Freddie Pruitt,NCI DAC,,Kate Drummond,Completed by GPA
Immediate postoperative minimal residual disease detection with MAESTRO predicts recurrence and survival in head and neck cancer patients treated with surgery,phs003981.v1.p1,Freddie Pruitt,NCI DAC,,Viktor Adalsteinsson,Completed by GPA
Chromatin Accessibility Profiling Identifies a Stem Cell-Like Subtype of Small Cell Lung Cancer with Poor Prognosis,phs003983.v1.p1,Kathleen Calzone,NCI DAC,,Anish Thomas,Completed by GPA
"Genomic Landscape and Preclinical Therapeutic Insights Developed from Xenograft, Organoid, and Cell Line Models in the NCI�s Patient-Derived Models Repository",phs003984.v1.p1,Grace Mishkin,NCI DAC,,James Doroshow,Completed by GPA
PE-CGS: Optimizing Engagement of Hispanic Colorectal Cancer Patients in Cancer Genomic Characterization Studies,phs003985.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,Yes,Heinz Josef Lenz,Completed by GPA
Single Cell RNA Sequencing of Metastatic Adrenocortical Carcinoma and Tumor-Free Tissue.,phs003987.v1.p1,Abid Al Reza,NCI DAC,,Rosandra Kaplan,Completed by GPA
Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study,,Emilie Charlisse Caga-Anan,NCI DAC,,Arul Chinnaiyan,Completed by GPA
Genomic analysis of adolescent and young adult acute lymphoblastic leukemia,,Emilie Charlisse Caga-Anan,NCI DAC,,Charles Mullighan,Completed by GPA
ESRRA-C11orf20 is a Recurrent Gene Fusion in Serous Ovarian Carcinoma,,Emilie Charlisse Caga-Anan,NCI DAC,,Patrick Brown,Completed by GPA
Therapeutic Resistance to PI3K-alpha Inhibitors,,Emilie Charlisse Caga-Anan,NCI DAC,,Dejan Juric,Completed by GPA
Genome-Wide Association Study of Colorectal Cancer in Japanese and African Americans,,Emilie Charlisse Caga-Anan,NCI DAC,,Loic Le Marchand,Completed by GPA
Molecular Profiling-based Assignment of Cancer Therapy for Patients with Advanced Solid Tumors (MPACT),,Kathleen Calzone,NCI DAC,,Alice Chen,Completed by GPA
"Dietary Sulfur, the Gut Microbiome and Colorectal Cancer",,Ian Fingerman,NCI DAC,,Andrew Chan,Completed by GPA
Patient-derived models of pancreatic cancer,,Emilie Charlisse Caga-Anan,NCI DAC,,Agnieszka Witkiewicz,Completed by GPA
Colon Cancer Family Registry Illumina GWAS,,Emilie Charlisse Caga-Anan,NCI DAC,,Graham Casey,Completed by GPA
BRE0776 - Genomic Profiling of ER+ Breast Cancers after Short Term Letrozole,,Freddie Pruitt,NCI DAC,,Ingrid Mayer,Completed by GPA
POB�MEN2�Natural�History�Study,,Kathleen Calzone,NCI DAC,,John Glod,Completed by GPA
Colon cancer and the intratumor microbial and immune microenvironment,,Grace Mishkin,NCI DAC,,Anton Bilchik,Completed by GPA
The Microbiome and Anal Cancer Pathogenesis in HIV-infected Men who have Sex with Men,,Emilie Charlisse Caga-Anan,NCI DAC,,Joel Palefsky,Completed by GPA
COLON MAP: Colon Molecular Atlas Project,,Natalie Abrams,NCI DAC,,Robert Coffey,Completed by GPA
Discovery and validation of early molecular breast cancer risk markers in benign breast disease,,Natalie Abrams,NCI DAC,,Christopher Umbricht,Completed by GPA
PCA Breast Pre-Cancer Atlas Center,,Natalie Abrams,NCI DAC,,Eun-Sil Shelley Hwang,Completed by GPA
Precancer Atlas of Familial Adenomatous Polyposis,,Natalie Abrams,NCI DAC,,Michael Snyder,Completed by GPA
Genomics and Mechanisms of Esophageal Carcinogenesis,,Claire Zhu,NCI DAC,,Antonia Sepulveda,Completed by GPA
"Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution",,Claire Zhu,NCI DAC,,Moumita Ghosh,Completed by GPA
Evaluating the protective effect of a tissue selective estrogen complex (TSEC) in women with newly diagnosed ductal carcinoma in situ,,Claire Zhu,NCI DAC,,"Swati Kulkarni,",Completed by GPA
Studies of the initiation and progression of small cell lung cancer using cells derived by differentiation from human pluripotent stem cells,,Claire Zhu,,,Harold Varmus,Completed by GPA
Development of 5hmC and 5mC biomarkers in cell-free circulating DNA for sensitive colon cancer detection and prognosis,,Claire Zhu,NCI DAC,,Bruce Bissonnette,Completed by GPA
Gene-Gene Interactions and Their Functional Roles in Prostate Cancer Aggressiveness,,Emilie Charlisse Caga-Anan,NCI DAC,,Hui-Yi Lin,Completed by GPA
Expanding the Encyclopedia of DNA Elements (ENCODE) in the Human and Mouse,,Sharna Tingle,,,Michael Snyder,Completed by GPA
Genetics of Mammographic Density in Latinas,,Mariam Eljanne,NCI DAC,,Elad Ziv,Completed by GPA
Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma,,Ian Fingerman,NCI DAC,,Loic Deleyrolle,Completed by GPA
Germline variant in SLCO2B1 and response to abiraterone acetate plus prednisone (AA) in new onset metastatic castration-resistant prostate cancer (mCRPC),,Freddie Pruitt,NCI DAC,,Lisa Albright,Completed by GPA
The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy,,Natalie Abrams,NCI DAC,,Avrum Spira,Completed by GPA
Scalable and Accurate Polygenic Risk Profiling with Low-pass Whole Genome Sequencing,,Sharna Tingle,,,Pickrell Joseph,Completed by GPA
Rigorous and reproducible mutational analysis of the urinary exosomal DNA,,Natalie Abrams,NCI DAC,,Raghu Kalluri,Completed by GPA
Targeted Therapy in Ex Vivo Medulloblastoma/PNET,,Freddie Pruitt,NCI DAC,,James Olson,Completed by GPA
Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer,,Natalie Abrams,NCI DAC,,Ajay Goel,Completed by GPA
"Colorectal cancer risk factors, risk predication and blood-based biomarker by tumor consensus molecular subtype",,Claire Zhu,NCI DAC,,Jennifer Davis,Completed by GPA
"Extending the Diversity, Reach and Generalizability of the WISDOM Study",,Claire Zhu,NCI DAC,,Laura Esserman,Completed by GPA
Novel temporal and spatial patterns of metastatic colonization from breast cancer rapid-autopsy tumor biopsies,,Ian Fingerman,NCI DAC,,Gabor Marth,Completed by GPA
"Understanding Racial Disparity in Endometrial Cancer through Tumor Genomics"", ""Tumor Methylomics Analysis Link with Racial Disparities in Ovarian Cancer"" and ""The Northwestern University Cancer Health Equity Research SPORE Biobank & Database (NU-CHERS)""",,Anil Wali,NCI DAC,,Melissa Simon,Completed by GPA
Single cell genome variation induced by mutational processes in cancer - HGSOC Trios Study,,Ying Huang,NCI DAC,,Sohrab Shah,Completed by GPA
Single Cell Transcriptomics of Adult Recurrent Respiratory Papillomatosis,,Kathleen Calzone,NCI DAC,,Clint Allen,Completed by GPA
Liquid Biopsy for Rapid Detection and Real Time Monitoring of FGFR-Altered Cancer,,Freddie Pruitt,NCI DAC,,Sameek Roychowdhury,Completed by GPA
Kids First: The Genetic Basis of Structural Pediatric Epilepsies,,Marcia Fournier,Kids First DAC,Yes,Ingo Helbig,Completed by GPA
Germline profiles of non-caucasian early onset colorectal cancer,,Freddie Pruitt,NCI DAC,,Jason Willis,Completed by GPA
Comparison of human serous cavity resident macrophages and dendritic cells to their murine counterparts,,Reed Shabman,NIAID,,Gwendalyn Randolph,Completed by GPA
Multi-platform analysis of matched well- and dedifferentiated tumors identify novel drivers of liposarcomagenesis,,Freddie Pruitt,NCI DAC,,Aimee Crago,Completed by GPA
Total RNA-seq of Human Tumor Cell Lines and Associated Extracellular Vesicles,,Abid Al Reza,NCI DAC,,Jennifer Jones,Completed by GPA
Single-cell RNA sequencing in silent corticotroph tumors confirms impaired POMC processing and provides new insights into their invasive behavior,,Justin Benavidez,NCI DAC,,Anthony Heaney,Completed by GPA
Single-cell and spatial transcriptomic study of newly diagnosed HPV-related oropharyngeal cancer,,Kathleen Calzone,NCI DAC,,Clint Allen,Completed by GPA
Biopsy analysis of trial S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with anti-PD-1-refractory melanoma,,Freddie Pruitt,NCI DAC,,Antoni Ribas,Completed by GPA
Differences in Tumor Biology of Multiple Myeloma in Association with African Ancestry,,Emilie Charlisse Caga-Anan,NCI DAC,,Linda Baughn,Completed by GPA
Multi-omic Analysis of Acute Myeloid Leukemia Clonal Evolution,,Justin Benavidez,NCI DAC,,Linde Miles,Completed by GPA
SWOG S1512: A Phase II Study of PD-1 Blockade with Pembrolizumab In Patients with Locally Advanced and Metastatic Desmoplastic,,Freddie Pruitt,NCI DAC,,Antoni Ribas,Completed by GPA
CALGB 40903 (Alliance): Analysis of Genomic Alterations Associated with Response to Aromatase Inhibitor Therapy for ER-positive Postmenopausal Ductal Carcinoma in Situ (DCIS),,Grace Mishkin,NCI DAC,,Eun-Sil Shelley Hwang,Completed by GPA
Integrating Contemporary Biospecimens and Immunomethylomics into the study of the Glioma Genetics and Immunity - CIDR,,Barbara Thomas,NCI DAC,,Stephen Francis,Completed by GPA
Molecular Subtypes of Diffuse Large B-cell Lymphoma are Associated with Distinct Pathogenic Mechanisms and Outcomes,phs000450.v6,Ian Fingerman,NCI DAC,,Margaret Shipp,Awaiting GPA's Approval
Center for Mendelian Genomics [CMG] - University of Washington Center for Mendelian Genomics,phs000693.v7.p3,Sharna Tingle,NHGRI,Yes,Chia-Lin Wei,Awaiting GPA's Approval
STAGING: Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profiles,phs000749.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Sagar Lonial,Awaiting GPA's Approval
Baylor College of Medicine Advancing Sequencing in Childhood Cancer Care (BASIC3) Clinical Exome Sequencing Study,phs001026.v4,Sharna Tingle,NHGRI,,Sharon Plon,Awaiting GPA's Approval
Scalable Whole-exome Sequencing of Cell-free DNA Reveals High Concordance with Metastatic Tumors,phs001417.v3,Ian Fingerman,NCI DAC,,Viktor Adalsteinsson,Awaiting GPA's Approval
�CSER: Incorporation of Genomic Sequencing into Pediatric Cancer Care,phs001683.v3,Sharna Tingle,NHGRI,Yes,Sharon Plon,Awaiting GPA's Approval
NCI Expanded Genome-Wide Association Study of Renal Cell Carcinoma,phs001736.v3,Geoffrey Tobias,NCI DAC,,Mark Purdue,Awaiting GPA's Approval
Gabriella Miller Kids First - Novel Cancer Susceptibility in Families (from BASIC3),phs001878.v3,Sharna Tingle,NHGRI,,Sharon Plon,Awaiting GPA's Approval
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer,phs002239.v1.p1,Natalie Abrams,NCI DAC,,Ajay Goel,Awaiting GPA's Approval
Functional multiomics of cellular therapy and immune checkpoint blockade therapy for solid tumors,phs002762.v2,Mariam Eljanne,NCI DAC,,Theodore Nowicki,Awaiting GPA's Approval
Non-breast/ovarian tumors in germline BRCA1/2 carriers,phs003348.v2,Mariam Eljanne,NCI DAC,,Kara Maxwell,Awaiting GPA's Approval
CIDR: Multi-Ancestry Mapping of Pancreatic Cancer Susceptibility Loci: The Pancreatic Cancer Case Control Consortium and Pancreatic Cancer Cohort Consortium � PanScan Collaboration,phs003492.v1.p1,Barbara Thomas,NCI DAC,,Alison Klein,Awaiting GPA's Approval
INTEGRATING GENOMIC AND TRANSCRIPTOMIC DATA TO IDENTIFY BREAST CANCER SUSCEPTIBILITY GENES,phs003535.v2,Emilie Charlisse Caga-Anan,NCI DAC,,Wei Zheng,Awaiting GPA's Approval
Cutaneous squamous cell carcinoma: integrating germline and somatic alterations that underlie tumor progression,phs003681.v1.p1,Emilie Charlisse Caga-Anan,NCI DAC,,Gad Getz,Awaiting GPA's Approval
Project 1: Carolina Breast Cancer Study (CBCS): Linking Tumor Biology to Social,phs003725.v2,Freddie Pruitt,NCI DAC,,Melissa Troester,Awaiting GPA's Approval
"Programs, Origins, and Immunomodulatory Functions of Myeloid Cells in Gliomas",phs003756.v2,Justin Benavidez,NCI DAC,,Bradley Bernstein,Awaiting GPA's Approval
Epidemiologic Study of Hepatocellular Carcinoma in the US,,Emilie Charlisse Caga-Anan,,,Herbert Yu,Awaiting GPA's Approval
TMZ Microdialysis,,Kathleen Calzone,,,,Awaiting GPA's Approval
Tissue Procurement and Natural History Study of Neurendocrine Neoplasms (NENs) including Adenocortical Carcinoma (ACC),,Kathleen Calzone,,,Jaydira Del Rivero,Awaiting GPA's Approval
Cancer Target Discovery and Development Network: Validation of Biomarkers in Prostate Cancer,,Freddie Pruitt,NCI DAC,,Carlos Moreno,Awaiting GPA's Approval
Clinical and Genetic Studies of Li-Fraumeni Syndrome,,Geoffrey Tobias,NCI DAC,,Sharon Savage,Awaiting GPA's Approval
Role of the Cohesin complex in normal and malignant hematopoiesis,,Mariam Eljanne,NCI DAC,,Aaron Viny,Awaiting GPA's Approval
GECCO GxE Interaction Substudy,,Emilie Charlisse Caga-Anan,NCI DAC,,Ulrike Peters,Awaiting GPA's Approval
Uncovering colorectal cancer etiology and biology by integrating proteomics with other omics data,,Emilie Charlisse Caga-Anan,NCI DAC,,Xingyi Guo,Awaiting GPA's Approval
DNA Repair Capacity for Lung Disease Risk Assessment,,Emilie Charlisse Caga-Anan,NCI DAC,,Steven Belinsky,Awaiting GPA's Approval
